10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2018

OR

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: 001-36181

CareTrust REIT, Inc.

(Exact name of registrant as specified in its charter)

Maryland	46-3999490
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
905 Calle Amanecer, Suite 300, San Clemente, CA	92673
(Address of principal executive offices)	(Zip Code)

(949) 542-3130

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    x  Yes    ¨  No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    x  Yes    ¨  No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

Large accelerated filer	x	Accelerated filer	¨
Non-accelerated filer	¨	Smaller reporting company	¨
		Emerging growth company	¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    ¨  Yes    x  No

As of November 2, 2018, there were 83,883,818 shares of common stock outstanding.

INDEX

PART I—FINANCIAL INFORMATION
Item 1.	Financial Statements (Unaudited)
	Condensed Consolidated Balance Sheets	1
	Condensed Consolidated Income Statements	2
	Condensed Consolidated Statements of Equity	3
	Condensed Consolidated Statements of Cash Flows	4
	Notes to Condensed Consolidated Financial Statements	5
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	28
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	36
Item 4.	Controls and Procedures	36
PART II—OTHER INFORMATION
Item 1.	Legal Proceedings	37
Item 1A.	Risk Factors	37
Item 6.	Exhibits	37
	Signatures	38

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements.

CARETRUST REIT, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share and per share amounts)

	September 30, 2018			December 31, 2017
	(Unaudited)
Assets:
Real estate investments, net	$	1,189,449		$	1,152,261
Other real estate investments, net	18,083			17,949
Cash and cash equivalents	15,745			6,909
Accounts and other receivables, net	12,384			5,254
Prepaid expenses and other assets	3,792			895
Deferred financing costs, net	904			1,718
Total assets	$	1,240,357		$	1,184,986
Liabilities and Equity:
Senior unsecured notes payable, net	$	294,963		$	294,395
Senior unsecured term loan, net	99,588			99,517
Unsecured revolving credit facility	90,000			165,000
Accounts payable and accrued liabilities	18,510			17,413
Dividends payable	17,246			14,044
Total liabilities	520,307			590,369
Commitments and contingencies (Note 10)
Equity:
Preferred stock, $0.01 par value; 100,000,000 shares authorized, no shares issued and outstanding as of September 30, 2018 and December 31, 2017	—			—
Common stock, $0.01 par value; 500,000,000 shares authorized, 83,353,226 and 75,478,202 shares issued and outstanding as of September 30, 2018 and December 31, 2017, respectively	834			755
Additional paid-in capital	915,235			783,237
Cumulative distributions in excess of earnings	(196,019		)	(189,375		)
Total equity	720,050			594,617
Total liabilities and equity	$	1,240,357		$	1,184,986

See accompanying notes to condensed consolidated financial statements.

1

CARETRUST REIT, INC.

CONDENSED CONSOLIDATED INCOME STATEMENTS

(in thousands, except per share amounts)

(Unaudited)

	For the Three Months Ended September 30,				For the Nine Months Ended September 30,
	2018		2017		2018		2017
Revenues:
Rental income	$	35,332	$	29,404	$	103,856	$	85,254
Tenant reimbursements	2,990		2,543		8,974		7,253
Independent living facilities	871		825		2,515		2,407
Interest and other income	317		176		1,235		1,471
Total revenues	39,510		32,948		116,580		96,385
Expenses:
Depreciation and amortization	11,351		9,745		34,227		28,156
Interest expense	6,805		5,592		21,182		17,690
Loss on the extinguishment of debt	—		—		—		11,883
Property taxes	2,990		2,543		8,974		7,253
Independent living facilities	766		698		2,226		2,003
Impairment of real estate investment	—		—		—		890
General and administrative	3,088		3,059		9,638		8,426
Total expenses	25,000		21,637		76,247		76,301
Other income:
Gain on sale of real estate	—		—		2,051		—
Gain on disposition of other real estate investment	—		—		—		3,538
Net income	$	14,510	$	11,311	$	42,384	$	23,622
Earnings per common share:
Basic	$	0.18	$	0.15	$	0.54	$	0.33
Diluted	$	0.18	$	0.15	$	0.54	$	0.33
Weighted-average number of common shares:
Basic	81,490		75,471		77,811		71,693
Diluted	81,490		75,471		77,811		71,693
Dividends declared per common share	$	0.205	$	0.185	$	0.615	$	0.555

See accompanying notes to condensed consolidated financial statements.

2

CARETRUST REIT, INC.

CONDENSED CONSOLIDATED STATEMENTS OF EQUITY

(in thousands, except share and per share amounts)

(Unaudited)

	Common Stock			Additional Paid-in Capital			Cumulative Distributions in Excess of Earnings			Total Equity
	Shares	Amount
Balance at December 31, 2016	64,816,350	$	648	$	611,475		$	(159,693	)	$	452,430
Issuance of common stock, net	10,573,089	106		170,213			—			170,319
Vesting of restricted common stock, net of shares withheld for employee taxes	88,763	1		(867		)	—			(866		)
Amortization of stock-based compensation	—	—		2,416			—			2,416
Common dividends ($0.74 per share)	—	—		—			(55,556		)	(55,556		)
Net income	—	—		—			25,874			25,874
Balance at December 31, 2017	75,478,202	755		783,237			(189,375		)	594,617
Issuance of common stock, net	7,760,723	78		130,472			—			130,550
Vesting of restricted common stock, net of shares withheld for employee taxes	114,301	1		(1,290		)	—			(1,289		)
Amortization of stock-based compensation	—	—		2,816			—			2,816
Common dividends ($0.615 per share)	—	—		—			(49,028		)	(49,028		)
Net income	—	—		—			42,384			42,384
Balance at September 30, 2018	83,353,226	$	834	$	915,235		$	(196,019	)	$	720,050

See accompanying notes to condensed consolidated financial statements.

3

CARETRUST REIT, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

(Unaudited)

	For the Nine Months Ended September 30,
	2018			2017
Cash flows from operating activities:
Net income	$	42,384		$	23,622
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization (including a below-market ground lease)	34,240			28,168
Amortization of deferred financing costs	1,453			1,615
Loss on the extinguishment of debt	—			11,883
Amortization of stock-based compensation	2,816			1,792
Straight-line rental income	(1,631		)	(117		)
Noncash interest income	(228		)	(496		)
Gain on sale of real estate	(2,051		)	—
Interest income distribution from other real estate investment	—			1,500
Impairment of real estate investment	—			890
Change in operating assets and liabilities:
Accounts and other receivables, net	(5,499		)	(6,948		)
Prepaid expenses and other assets	(159		)	(182		)
Accounts payable and accrued liabilities	1,065			5,206
Net cash provided by operating activities	72,390			66,933
Cash flows from investing activities:
Acquisitions of real estate	(75,621		)	(222,463		)
Improvements to real estate	(5,401		)	(621		)
Purchases of equipment, furniture and fixtures	(1,262		)	(359		)
Investment in real estate mortgage and other loans receivable	(2,598		)	—
Principal payments received on real estate mortgage and other loans receivable	893			—
Sale of other real estate investment	—			7,500
Escrow deposits for acquisitions of real estate	(1,000		)	(1,000		)
Net proceeds from the sale of real estate	13,004			—
Net cash used in investing activities	(71,985		)	(216,943		)
Cash flows from financing activities:
Proceeds from the issuance of common stock, net	130,546			170,414
Proceeds from the issuance of senior unsecured notes payable	—			300,000
Borrowings under unsecured revolving credit facility	60,000			158,000
Payments on senior unsecured notes payable	—			(267,639		)
Payments on unsecured revolving credit facility	(135,000		)	(158,000		)
Payments of deferred financing costs	—			(6,047		)
Net-settle adjustment on restricted stock	(1,288		)	(866		)
Dividends paid on common stock	(45,827		)	(38,544		)
Net cash provided by financing activities	8,431			157,318
Net increase in cash and cash equivalents	8,836			7,308
Cash and cash equivalents, beginning of period	6,909			7,500
Cash and cash equivalents, end of period	$	15,745		$	14,808
Supplemental disclosures of cash flow information:
Interest paid	$	15,772		$	19,349
Supplemental schedule of noncash operating, investing and financing activities:
Increase in dividends payable	$	3,202		$	2,971
Application of escrow deposit to acquisition of real estate	$	—		$	700

See accompanying notes to condensed consolidated financial statements.

4

CARETRUST REIT, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —

(Unaudited)

1. ORGANIZATION

Description of Business—CareTrust REIT, Inc.’s (“CareTrust REIT” or the “Company”) primary business consists of acquiring, financing, developing and owning real property to be leased to third-party tenants in the healthcare sector. As of September 30, 2018, the Company owned and leased to independent operators, including The Ensign Group, Inc. (“Ensign”), 190 skilled nursing, multi-service campuses, assisted living and independent living facilities consisting of 18,693 operational beds and units located in Arizona, California, Colorado, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Maryland, Michigan, Minnesota, Montana, Nebraska, Nevada, New Mexico, North Carolina, Ohio, Oregon, South Dakota, Texas, Utah, Virginia, Washington and Wisconsin. The Company also owns and operates three independent living facilities which have a total of 264 units located in Texas and Utah. As of September 30, 2018, the Company also had other real estate investments consisting of two preferred equity investments totaling $5.7 million and a mortgage loan receivable of $12.3 million.

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation—The accompanying condensed consolidated financial statements of the Company reflect, for all periods presented, the historical financial position, results of operations and cash flows of the Company and its consolidated subsidiaries consisting of (i) the net-leased skilled nursing, multi-service campuses, assisted living and independent living facilities, (ii) the operations of the three independent living facilities that the Company owns and operates; and (iii) the preferred equity investments and the mortgage loan receivable.

The accompanying condensed consolidated financial statements of the Company were prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and Article 10 of Regulation S-X. Accordingly, the condensed consolidated financial statements do not include all of the disclosures required by GAAP for a complete set of annual audited financial statements. The condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2017. In the opinion of management, all adjustments which are of a normal and recurring nature and considered necessary for a fair presentation of the results of the interim periods presented have been included. The results of operations for the interim periods are not necessarily indicative of results for the full year. All intercompany transactions and account balances within the Company have been eliminated.

Estimates and Assumptions—The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Management believes that the assumptions and estimates used in preparation of the underlying consolidated financial statements are reasonable. Actual results, however, could differ from those estimates and assumptions.

Real Estate Depreciation and Amortization—Real estate costs related to the acquisition and improvement of properties are capitalized and amortized over the expected useful life of the asset on a straight-line basis. Repair and maintenance costs are charged to expense as incurred and significant replacements and betterments are capitalized. Repair and maintenance costs include all costs that do not extend the useful life of the real estate asset. The Company considers the period of future benefit of an asset to determine its appropriate useful life. Expenditures for tenant improvements are capitalized and amortized over the shorter of the tenant’s lease term or expected useful life. The Company anticipates the estimated useful lives of its assets by class to be generally as follows:

Buildings	25-40 years
Building improvements	10-25 years
Tenant improvements	Shorter of lease term or expected useful life
Integral equipment, furniture and fixtures	5 years
Identified intangible assets	Shorter of lease term or expected useful life

Real Estate Acquisition Valuation— In accordance with Accounting Standards Codification (“ASC”) 805, Business Combinations, the Company records the acquisition of income-producing real estate as a business combination. If the acquisition does not meet the definition of a business, the Company records the acquisition as an asset acquisition. Under both methods, all assets acquired and liabilities assumed are measured at their acquisition date fair values. For transactions that are

5

CARETRUST REIT, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —

(Unaudited)

business combinations, acquisition costs are expensed as incurred and restructuring costs that do not meet the definition of a liability at the acquisition date are expensed in periods subsequent to the acquisition date. For transactions that are asset acquisitions, acquisition costs are capitalized as incurred.

The Company assesses the acquisition date fair values of all tangible assets, identifiable intangibles and assumed liabilities using methods similar to those used by independent appraisers, generally utilizing a discounted cash flow analysis that applies appropriate discount and/or capitalization rates and available market information. Estimates of future cash flows are based on a number of factors, including historical operating results, known and anticipated trends, and market and economic conditions. The fair value of tangible assets of an acquired property considers the value of the property as if it were vacant.

Estimates of the fair values of the tangible assets, identifiable intangibles and assumed liabilities require the Company’s management to make significant assumptions to estimate market lease rates, property-operating expenses, carrying costs during lease-up periods, discount rates, market absorption periods, and the number of years the property will be held for investment. The use of inappropriate assumptions would result in an incorrect valuation of the Company’s acquired tangible assets, identifiable intangibles and assumed liabilities, which would impact the amount of the Company’s net income.

As part of the Company’s real estate acquisitions, the Company may commit to provide contingent payments to a seller or lessee (e.g., an earn-out payable upon the applicable property achieving certain financial metrics). Typically, when the contingent payments are funded, cash rent is increased by the amount funded multiplied by a rate stipulated in the agreement. Generally, if the contingent payment is an earn-out provided to the seller, the payment is capitalized to the property’s basis. If the contingent payment is an earn-out provided to the lessee, the payment is recorded as a lease incentive and is amortized as a yield adjustment over the life of the lease.

Impairment of Long-Lived Assets—At each reporting period, management evaluates the Company’s real estate investments for impairment indicators, including the evaluation of the useful lives of the Company’s assets. Management also assesses the carrying value of the Company’s real estate investments whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. The judgment regarding the existence of impairment indicators is based on factors such as, but not limited to, market conditions, operator performance and legal structure. If indicators of impairment are present, management evaluates the carrying value of the related real estate investments in relation to the future undiscounted cash flows of the underlying facilities. Provisions for impairment losses related to long-lived assets are recognized when expected future undiscounted cash flows are determined to be less than the carrying values of the assets. An adjustment is made to the net carrying value of the real estate investments for the excess of carrying value over fair value. All impairments are taken as a period cost at that time, and depreciation is adjusted going forward to reflect the new value assigned to the asset.

If the Company decides to sell real estate properties, it evaluates the recoverability of the carrying amounts of the assets. If the evaluation indicates that the carrying value is not recoverable from estimated net sales proceeds, the property is written down to estimated fair value less costs to sell.

In the event of impairment, the fair value of the real estate investment is determined by market research, which includes valuing the property in its current use as well as other alternative uses, and involves significant judgment. Management’s estimates of cash flows and fair values of the properties are based on current market conditions and consider matters such as rental rates and occupancies for comparable properties, recent sales data for comparable properties, and, where applicable, contracts or the results of negotiations with purchasers or prospective purchasers. The Company’s ability to accurately estimate future cash flows and estimate and allocate fair values impacts the timing and recognition of impairments. While the Company believes its assumptions are reasonable, changes in these assumptions may have a material impact on financial results.

Other Real Estate Investments, Net — Included in Other Real Estate Investments, Net are two preferred equity investments and one mortgage loan receivable. Preferred equity investments are accounted for at unpaid principal balance, plus accrued return, net of reserves. The Company recognizes return income on a quarterly basis based on the outstanding investment including any accrued and unpaid return, to the extent there is outside contributed equity or cumulative earnings from operations. As the preferred member of the joint venture, the Company is not entitled to share in the joint venture’s earnings or losses. Rather, the Company is entitled to receive a preferred return, which is deferred if the cash flow of the joint venture is insufficient to pay all of the accrued preferred return. The unpaid accrued preferred return is added to the balance of the preferred equity investment up to the estimated economic outcome assuming a hypothetical liquidation of the book value of

6

CARETRUST REIT, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —

(Unaudited)

the joint venture. The Company anticipates any unpaid accrued preferred return, whether recorded or unrecorded by the Company, will be repaid upon redemption or as available cash flow is distributed from the joint venture.

The Company’s mortgage loan receivable is recorded at amortized cost, which consists of the outstanding unpaid principal balance, net of unamortized costs and fees directly associated with the origination of the loan.

Interest income on the Company’s mortgage loan receivable is recognized over the life of the investment using the interest method. Origination costs and fees directly related to mortgage loans receivable are amortized over the term of the loan as an adjustment to interest income.

The Company evaluates at each reporting period each of its other real estate investments for indicators of impairment. An investment is impaired when, based on current information and events, it is probable that the Company will be unable to collect all amounts due according to the existing contractual terms. A reserve is established for the excess of the carrying value of the investment over its fair value.

Cash and Cash Equivalents—Cash and cash equivalents consist of bank term deposits and money market funds with original maturities of three months or less at time of purchase and therefore approximate fair value. The fair value of these investments is determined based on “Level 1” inputs, which consist of unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets. The Company places its cash and short-term investments with high credit quality financial institutions.

The Company’s cash and cash equivalents balance periodically exceeds federally insurable limits. The Company monitors the cash balances in its operating accounts and adjusts the cash balances as appropriate; however, these cash balances could be impacted if the underlying financial institutions fail or are subject to other adverse conditions in the financial markets. To date, the Company has experienced no loss or lack of access to cash in its operating accounts.

Prepaid expenses and other assets—Prepaid expenses and other assets consist of prepaid expenses, deposits, pre-acquisition costs and other loans receivable. Included in other loans receivable at September 30, 2018 is a bridge loan to Eduro Healthcare, LLC, (“Eduro”) under which the Company agreed to fund up to $4.0 million until the earlier of (i) the date Eduro enters into a new credit facility, (ii) the date that Eduro terminates as to any facility, or (iii) November 30, 2018. Borrowings under the bridge loan accrue interest at a base rate of greater of prime rate or 4.75% plus margin of 2.5%. The borrowings under the bridge loan accrue interest and, as of September 30, 2018, approximately $1.8 million has been drawn and was outstanding.

Deferred Financing Costs—External costs incurred from placement of the Company’s debt are capitalized and amortized on a straight-line basis over the terms of the related borrowings, which approximates the effective interest method. Deferred financing costs on the Company’s Notes and Term Loan (each as defined in Note 6, Debt, below) are netted against the outstanding debt amounts on the Company’s balance sheet. Deferred financing costs on the Company’s Revolving Facility (as defined in Note 6, Debt, below) are included in assets on the Company’s balance sheet. Amortization of deferred financing costs is classified as interest expense in the Company’s condensed consolidated income statements. Accumulated amortization of deferred financing costs was $4.6 million and $3.2 million at September 30, 2018 and December 31, 2017, respectively.

When financings are terminated, unamortized deferred financing costs, as well as charges incurred for the termination, are expensed at the time the termination is made. Gains and losses from the extinguishment of debt are presented within income from continuing operations in the Company’s condensed consolidated income statements.

Revenue Recognition —The Company recognizes rental revenue, including rental abatements, lease incentives and contractual fixed increases attributable to operating leases, if any, from tenants under lease arrangements with minimum fixed and determinable increases on a straight-line basis over the non-cancellable term of the related leases when collectability is reasonably assured. The Company evaluates the collectability of rents and other receivables on a regular basis based on factors including, among others, payment history, the operations, the asset type and current economic conditions. Tenant recoveries related to the reimbursement of real estate taxes, insurance, repairs and maintenance, and other operating expenses are recognized as revenue in the period the expenses are incurred and presented gross if the Company is the primary obligor and, with respect to purchasing goods and services from third-party suppliers, has discretion in selecting the supplier and bears the associated credit risk. For each of the three and nine months ended September 30, 2018 and 2017, such tenant reimbursement

7

CARETRUST REIT, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —

(Unaudited)

revenues consisted of real estate taxes. Contingent revenue, if any, is not recognized until all possible contingencies have been eliminated.

If the Company’s evaluation of applicable factors indicates it may not recover the full value of the receivable, the Company provides a reserve against the portion of the receivable that it estimates may not be recovered. This analysis requires the Company to determine whether there are factors indicating a receivable may not be fully collectible and to estimate the amount of the receivable that may not be collected. As of September 30, 2018 and December 31, 2017, Accounts and other receivables, net included $1.3 million and $0.8 million for unpaid cash rents and $11.6 million and $9.6 million for other tenant receivables, respectively, of which $10.4 million was reserved as of September 30, 2018 and December 31, 2017, related to the properties previously net leased to subsidiaries of Pristine Senior Living, LLC (“Pristine”). See Note 3, Real Estate Investments, Net for further discussion.

The Company evaluates the collectability of straight-line rent receivable balances on an ongoing basis and provides reserves against receivables it determines may not be fully recoverable. The Company recorded straight-line rental income of $0.7 million and $2,000 during the three months ended September 30, 2018 and 2017, respectively. The Company recorded straight-line rental income of $1.6 million and $0.1 million during the nine months ended September 30, 2018 and 2017, respectively. Accounts and other receivables, net included $2.1 million and $0.5 million in straight-line rents receivable at September 30, 2018 and December 31, 2017, respectively.

Income Taxes—The Company has elected to be taxed as a real estate investment trust (“REIT”) under the Internal Revenue Code of 1986, as amended (the “Code”). The Company believes it has been organized and has operated, and the Company intends to continue to operate, in a manner to qualify for taxation as a REIT under the Code. To qualify as a REIT, the Company must meet certain organizational and operational requirements, including a requirement to distribute to its stockholders at least 90% of the Company’s annual REIT taxable income (computed without regard to the dividends paid deduction or net capital gain and which does not necessarily equal net income as calculated in accordance with GAAP). As a REIT, the Company generally will not be subject to federal income tax to the extent it distributes as qualifying dividends all of its REIT taxable income to its stockholders. If the Company fails to qualify as a REIT in any taxable year, it will be subject to federal income tax on its taxable income at regular corporate income tax rates and generally will not be permitted to qualify for treatment as a REIT for federal income tax purposes for the four taxable years following the year during which qualification is lost unless the Internal Revenue Service grants the Company relief under certain statutory provisions.

Stock-Based Compensation—The Company accounts for share-based payment awards in accordance with ASC Topic 718, Compensation – Stock Compensation (“ASC 718”). ASC 718 requires that the cost resulting from all share-based payment transactions be recognized in the financial statements. ASC 718 requires all entities to apply a fair value-based measurement method in accounting for share-based payment transactions with directors, officers and employees except for equity instruments held by employee share ownership plans. See Note 8, Stock-Based Compensation, for further discussion.

Concentration of Credit Risk—The Company is subject to concentrations of credit risk consisting primarily of operating leases on the Company’s owned properties. See Note 11, Concentration of Risk, for a discussion of major operator concentration.

Segment Disclosures —The Financial Accounting Standards Board (“FASB”) accounting guidance regarding disclosures about segments of an enterprise and related information establishes standards for the manner in which public business enterprises report information about operating segments. The Company has one reportable segment consisting of investments in healthcare-related real estate assets.

Earnings (Loss) Per Share—The Company calculates earnings (loss) per share (“EPS”) in accordance with ASC Topic 260, Earnings Per Share. Basic EPS is computed by dividing net income applicable to common stock by the weighted-average number of common shares outstanding during the period. Diluted EPS reflects the additional dilution for all potentially-dilutive securities.

Beds, Units, Occupancy and Other Measures—Beds, units, occupancy and other non-financial measures used to describe real estate investments included in these Notes to the condensed consolidated financial statements are presented on an unaudited basis and are not subject to review by the Company’s independent auditors in accordance with the standards of the Public Company Accounting Oversight Board.

8

CARETRUST REIT, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —

(Unaudited)

Recent Accounting Pronouncements

In February 2016, the FASB issued Accounting Standards Update (“ASU”) No. 2016-02, Leases (Topic 842) (“ASC 842”) that sets out the principles for the recognition, measurement, presentation, and disclosure of leases for both parties to a contract (i.e., lessees and lessors). ASC 842 requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase of the leased asset by the lessee. This classification will determine whether the lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. Leases with a term of 12 months or less will be accounted for similar to existing guidance for operating leases today. ASC 842 is expected to result in the recognition of a right-to-use asset and related liability to account for the Company’s future obligations for which it is the lessee. As of September 30, 2018, the remaining contractual payments under the Company’s lease agreements aggregated $0.2 million. Additionally, ASC 842 will require that lessees and lessors capitalize, as initial direct costs, only those costs that are incurred due to the execution of a lease. Under ASC 842, allocated payroll costs and other costs that are incurred regardless of whether the lease is obtained will no longer be capitalized as initial direct costs and instead will be expensed as incurred. During the nine months ended September 30, 2018, the Company did not capitalize any allocated payroll costs. Lessors will continue to account for leases using an approach that is substantially equivalent to existing guidance for sales-type leases, direct financing leases, and operating leases. ASC 842 is effective for reporting periods beginning after December 15, 2018, with early adoption permitted. Tenant recoveries that qualify as lease components, which relate to the right to use the leased asset (e.g., property taxes, insurance), will be accounted for under ASC 842. Tenant recoveries that qualify as non-lease components, which relate to payments for goods or services that are transferred separately from the right to use the underlying asset, including tenant recoveries related to payments for maintenance activities and common area expenses, will be accounted for under the new revenue recognition ASC 606 (as defined below) upon adoption of the new lease ASC 842 on January 1, 2019 for any new lease or any modified lease.

In July 2018, the FASB finalized an amendment to ASC 842 that allows lessors to elect, as a practical expedient, not to separate lease and non-lease components (such as services rendered) in a contract for the purpose of revenue recognition and disclosure. The practical expedient can only be applied to leasing arrangements for which (i) the timing and pattern of transfer are the same for the lease and non-lease components and (ii) the lease component, if accounted for separately, would be classified as an operating lease. Under this practical expedient, contracts that are predominantly lease-based would be accounted for under ASC 842, and contracts that are predominantly service-based would be accounted for under ASC 606. Further, this amendment also provides for an additional (and optional) transition method to adopt the new lease requirements by allowing entities to initially apply the requirements by recognizing a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. The Company plans to elect this practical expedient and apply the optional transition method for its operating leases, using the cumulative-effect adjustment to the opening balance sheet as of January 1, 2019. The Company is still evaluating the full impact of the adoption of ASC 842 on January 1, 2019 to its consolidated financial statements.

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326) (“ASU 2016-13”) that changes the impairment model for most financial instruments by requiring companies to recognize an allowance for expected losses, rather than incurred losses as required currently by the other-than-temporary impairment model. ASU 2016-13 will apply to most financial assets measured at amortized cost and certain other instruments, including trade and other receivables, loans, held-to-maturity debt securities, net investments in leases, and off-balance-sheet credit exposures (e.g., loan commitments). ASU 2016-13 is effective for reporting periods beginning after December 15, 2019, with early adoption permitted, and will be applied as a cumulative adjustment to retained earnings as of the effective date. The Company is currently assessing the potential effect the adoption of ASU 2016-13 will have on the Company’s condensed consolidated financial statements.

Recent Accounting Standards Adopted by the Company

On January 1, 2018, the Company adopted ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606) (“ASC 606”). ASC 606 requires an entity to recognize the revenue to depict the transfer of promised goods or services to

9

CARETRUST REIT, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —

(Unaudited)

customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. ASC 606 supersedes the revenue requirements in Revenue Recognition (Topic 605) and most industry-specific guidance throughout the Industry Topics of the ASC. ASC 606 does not apply to lease contracts within the scope of Leases (Topic 840). Based on a review of the Company’s revenue streams from independent living facilities, the Company’s consolidated financial statements include revenues generated through services provided to residents of independent living facilities that are ancillary to the residents’ contractual rights to occupy living and common-area space at the communities, such as meals, transportation and activities. While these revenue streams are subject to the application of Topic 606, the revenues associated with these services are generally recognized on a monthly basis, the period in which the related services are performed. Therefore, the adoption of ASC 606 did not have a material effect on the Company’s condensed consolidated financial statements since the revenue recognition under ASC 606 is similar to the recognition pattern prior to the adoption of ASC 606.

3. REAL ESTATE INVESTMENTS, NET

The following tables summarize the Company’s investment in owned properties as of September 30, 2018 and December 31, 2017 (dollars in thousands):

	September 30, 2018			December 31, 2017
Land	$	163,665		$	151,879
Buildings and improvements	1,168,192			1,114,605
Integral equipment, furniture and fixtures	85,592			80,729
Identified intangible assets	2,382			2,382
Real estate investments	1,419,831			1,349,595
Accumulated depreciation and amortization	(230,382		)	(197,334		)
Real estate investments, net	$	1,189,449		$	1,152,261

As of September 30, 2018, 92 of the Company’s 193 facilities were leased to subsidiaries of Ensign under eight master leases (the “Ensign Master Leases”) which commenced on June 1, 2014. The obligations under the Ensign Master Leases are guaranteed by Ensign. A default by any subsidiary of Ensign with regard to any facility leased pursuant to an Ensign Master Lease will result in a default under all of the Ensign Master Leases. As of September 30, 2018, annualized revenues from the Ensign Master Leases were $59.1 million and are escalated annually by an amount equal to the product of (1) the lesser of the percentage change in the Consumer Price Index (“CPI”) (but not less than zero) or 2.5%, and (2) the prior year’s rent. In addition to rent, the subsidiaries of Ensign that are tenants under the Ensign Master Leases are solely responsible for the costs related to the leased properties (including property taxes, insurance, and maintenance and repair costs).

As of September 30, 2018, 98 of the Company’s 193 facilities were leased to various other operators under triple-net leases. All of these leases contain annual escalators based on CPI, some of which are subject to a cap, or fixed rent escalators.

The Company’s three remaining properties as of September 30, 2018 are the independent living facilities that the Company owns and operates.

The Company has only two identified intangible assets which relate to a below-market ground lease and three acquired operating leases. The ground lease has a remaining term of 80 years.

10

CARETRUST REIT, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —

(Unaudited)

As of September 30, 2018, the Company’s total future minimum rental revenues for all of its tenants were (dollars in thousands):

Year	Amount
Remaining 2018	$	35,223
2019	141,977
2020	142,525
2021	143,094
2022	143,678
Thereafter	1,169,183
	$	1,775,680

Recent Real Estate Acquisitions

The following table summarizes the Company’s acquisitions for the nine months ended September 30, 2018 (dollar amounts in thousands):

Type of Property	Purchase Price(1)			Initial Annual Cash Rent		Number of Properties		Number of Beds/Units(2)
Skilled nursing	$	57,074		$	5,144	7		621
Multi-service campuses	20,277		(3)	1,564		1		122
Assisted living	—			—		—		—
Total	$	77,351		$	6,708	$	8	743

(1) Purchase price includes capitalized acquisition costs.

(2) The number of beds/units includes operating beds at acquisition date.

(3) The Company has committed to fund approximately $1.4 million in revenue-producing capital expenditures over the next 24 months based on the in-place lease yield, which is included in the purchase price.

Lease Amendments and Related Agreements

Pristine Lease Termination. On February 27, 2018, the Company announced that it entered into a Lease Termination Agreement (the “LTA”) with Pristine for its nine remaining properties, with a target completion date of April 30, 2018. Under the LTA, Pristine agreed to continue to operate the facilities until possession could be surrendered, and the operations therein transitioned, to operator(s) designated by the Company. Among other things, Pristine also agreed to amend certain pending agreements to sell the rights to certain Ohio Medicaid beds (the “Bed Sales Agreements”) and cooperate with the Company to turn over any claim or control it might have had with respect to the sale process and the proceeds thereof, if any, to the Company. The transactions were timely completed, and on May 1, 2018, Trio Healthcare, Inc (“Trio”) took over operations in the seven facilities based primarily in the Dayton, Ohio area under a new 15-year master lease, while Hillstone Healthcare, Inc. (“Hillstone”) assumed the operation of the two facilities in Willard and Toledo, Ohio under a new 12-year master lease. In addition, amendments to the Bed Sales Agreements were subsequently executed, confirming the Company as the sole seller of the bed rights and the sole recipient of any proceeds therefrom. The aggregate annual base rent due under the new master leases with Trio and Hillstone is approximately $10.0 million, subject to CPI-based or fixed escalators.

Under the LTA, the Company agreed, upon Pristine’s full performance of the terms thereof, to terminate Pristine’s master lease and all future obligations of the tenant thereunder; however, under the terms of the master lease the Company’s security interest in Pristine’s accounts receivable has survived any such termination. Such security interest was subject to the prior lien and security interest of Pristine’s working capital lender, Capital One, National Association (“CONA”), with whom the Company has an existing intercreditor agreement that defines the relative rights and responsibilities of CONA and with its respect to the loan and lease collateral represented by Pristine’s accounts receivable and the Company’s respective security interests therein.

11

CARETRUST REIT, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —

(Unaudited)

Sale of Real Estate Investments

During the nine months ended September 30, 2018, the Company sold three assisted living facilities consisting of 102 units located in Idaho with an aggregate carrying value of $10.9 million for an aggregate price of $13.0 million. In connection with the sale, the Company recognized a gain of $2.1 million.

Impairment of Real Estate Investment

During the nine months ended September 30, 2017, the Company recorded an impairment loss of $0.9 million related to its investment in La Villa Rehab & Healthcare Center (“La Villa”). In April 2017, the Company and Ensign mutually determined that La Villa had reached the natural end of its useful life as a skilled nursing facility and that the facility was no longer economically viable, the improvements thereon could not be economically repurposed to any other use, and the cost to remove the obsolete improvements and reclaim the underlying land for redevelopment was expected to exceed the market value of the land. Ensign agreed to wind up and terminate the operations of the facility and the Company transferred title to the property to Ensign. There was no adjustment to the contractual rent under the applicable master lease.

4. OTHER REAL ESTATE INVESTMENTS

In July 2016, the Company completed a $2.2 million preferred equity investment with an affiliate of Cascadia Development, LLC. The preferred equity investment yields a return equal to prime plus 9.5% but in no event less than 12.0% calculated on a quarterly basis on the outstanding carrying value of the investment. The investment was used to develop a 99-bed skilled nursing facility in Nampa, Idaho. In connection with its investment, CareTrust REIT holds an option to purchase the development at a fixed-formula price upon stabilization, with an initial lease yield of at least 9.0%. The project was completed in the fourth quarter 2017 and began lease-up during the first quarter of 2018.

In September 2016, the Company completed a $2.3 million preferred equity investment with an affiliate of Cascadia Development, LLC. The preferred equity investment yields a return equal to prime plus 9.5% but in no event less than 12.0% calculated on a quarterly basis on the outstanding carrying value of the investment. The investment was used to develop a 99-bed skilled nursing facility in Boise, Idaho. In connection with its investment, CareTrust REIT holds an option to purchase the development at a fixed-formula price upon stabilization, with an initial lease yield of at least 9.0%. The project was completed in the first quarter 2018 and began lease-up in the second quarter of 2018.

During the three months ended September 30, 2017, the Company recognized $0.2 million in interest income from its preferred equity investments. The Company recognized no interest income from its preferred equity investments in the three months ended September 30, 2018. During the nine months ended September 30, 2018 and 2017, the Company recognized $0.2 million and $1.5 million, respectively, in interest income from its preferred equity investments, of which $0 and $975,000, respectively, was received in cash. Any unpaid amounts were added to the outstanding carrying values of the preferred equity investments.

In October 2017, the Company provided the Providence Group a mortgage loan secured by a skilled nursing facility for approximately $12.5 million, which bears a fixed interest rate of 9%. The mortgage loan requires Providence Group to make monthly principal and interest payments and is set to mature on October 26, 2020. During the three and nine months ended September 30, 2018, the Company recognized $0.3 million and $0.9 million, respectively, of interest income related to the mortgage loan.

5. FAIR VALUE MEASUREMENTS

Under GAAP, the Company is required to measure certain financial instruments at fair value on a recurring basis. In addition, the Company is required to measure other financial instruments and balances at fair value on a non-recurring basis (e.g., carrying value of impaired long-lived assets). Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The GAAP fair value framework uses a three-tiered approach. Fair value measurements are classified and disclosed in one of the following three categories:

12

CARETRUST REIT, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —

(Unaudited)

• Level 1: unadjusted quoted prices in active markets that are accessible at the measurement date for identical assets or liabilities;

• Level 2: quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which significant inputs and significant value drivers are observable in active markets; and

• Level 3: prices or valuation techniques where little or no market data is available that requires inputs that are both significant to the fair value measurement and unobservable.

Financial Instruments: Considerable judgment is necessary to estimate the fair value of financial instruments. The estimates of fair value presented herein are not necessarily indicative of the amounts that could be realized upon disposition of the financial instruments. A summary of the face values, carrying amounts and fair values of the Company’s financial instruments as of September 30, 2018 and December 31, 2017 using Level 2 inputs for the Notes (as defined in Note 6, Debt, below), and Level 3, inputs for all other financial instruments, is as follows (dollars in thousands):

	September 30, 2018						December 31, 2017
	Face Value		Carrying Amount		Fair Value		Face Value		Carrying Amount		Fair Value
Financial assets:
Preferred equity investments	$	4,531	$	5,746	$	6,022	$	4,531	$	5,550	$	5,423
Mortgage loan receivable	12,423		12,337		12,423		12,517		12,399		12,517
Financial liabilities:
Senior unsecured notes payable	$	300,000	$	294,963	$	294,000	$	300,000	$	294,395	$	307,500

Cash and cash equivalents, accounts receivable, and accounts payable and accrued liabilities: These balances approximate their fair values due to the short-term nature of these instruments.

Other loans receivable: The carrying amounts were accounted for at the unpaid loan balance. These balances approximate their fair values due to the short-term nature of these instruments.

Preferred equity investments: The carrying amounts were accounted for at the unpaid principal balance, plus accrued return, net of reserves, assuming a hypothetical liquidation of the book values of the joint ventures. The fair values of the preferred equity investments were estimated using an internal valuation model that considered the expected future cash flows of the investment, the underlying collateral value and other credit enhancements.

Mortgage loan receivable: The mortgage loan receivable is recorded at amortized cost, which consists of the outstanding unpaid principal balance, net of unamortized costs and fees directly associated with the origination of the loan. The fair values of the mortgage loan receivable were estimated using an internal valuation model that considered the expected future cash flows of the investment, the underlying collateral value and other credit enhancements.

Senior unsecured notes payable: The fair value of the Notes (as defined below) was determined using third-party quotes derived from orderly trades.

Unsecured revolving credit facility and senior unsecured term loan: The fair values approximate their carrying values as the interest rates are variable and approximate prevailing market interest rates for similar debt arrangements.

6. DEBT

The following table summarizes the balance of the Company’s indebtedness as of September 30, 2018 and December 31, 2017 (dollars in thousands):

13

CARETRUST REIT, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —

(Unaudited)

	September 30, 2018							December 31, 2017
	Principal Amount		Deferred Loan Fees			Carrying Value		Principal Amount		Deferred Loan Fees			Carrying Value
Senior unsecured notes payable	$	300,000	$	(5,037	)	$	294,963	$	300,000	$	(5,605	)	$	294,395
Senior unsecured term loan	100,000		(412		)	99,588		100,000		(483		)	99,517
Unsecured revolving credit facility	90,000		—			90,000		165,000		—			165,000
	$	490,000	$	(5,449	)	$	484,551	$	565,000	$	(6,088	)	$	558,912

Senior Unsecured Notes Payable

On May 10, 2017, the Company’s wholly owned subsidiary, CTR Partnership, L.P. (the “Operating Partnership”), and its wholly owned subsidiary, CareTrust Capital Corp. (together with the Operating Partnership, the “Issuers”), completed an underwritten public offering of $300.0 million aggregate principal amount of 5.25% Senior Notes due 2025 (the “Notes”). The Notes were issued at par, resulting in gross proceeds of $300.0 million and net proceeds of approximately $294.0 million after deducting underwriting fees and other offering expenses. The Company used the net proceeds from the offering of the Notes to redeem all $260.0 million aggregate principal amount outstanding of its 5.875% Senior Notes due 2021, including payment of the redemption price at 102.938% and all accrued and unpaid interest thereon. The Company used the remaining portion of the net proceeds of the offering to pay borrowings outstanding under its senior unsecured revolving credit facility. The Notes mature on June 1, 2025 and bear interest at a rate of 5.25% per year. Interest on the Notes is payable on June 1 and December 1 of each year, beginning on December 1, 2017.

The Issuers may redeem the Notes any time before June 1, 2020 at a redemption price of 100% of the principal amount of the Notes redeemed plus accrued and unpaid interest on the Notes, if any, to, but not including, the redemption date, plus a “make-whole” premium described in the indenture governing the Notes and, at any time on or after June 1, 2020, at the redemption prices set forth in the indenture. At any time on or before June 1, 2020, up to 40% of the aggregate principal amount of the Notes may be redeemed with the net proceeds of certain equity offerings if at least 60% of the originally issued aggregate principal amount of the Notes remains outstanding. In such case, the redemption price will be equal to 105.25% of the aggregate principal amount of the Notes to be redeemed plus accrued and unpaid interest, if any, to, but not including, the redemption date. If certain changes of control of the Company occur, holders of the Notes will have the right to require the Issuers to repurchase their Notes at 101% of the principal amount plus accrued and unpaid interest, if any, to, but not including, the repurchase date.

The obligations under the Notes are fully and unconditionally guaranteed, jointly and severally, on an unsecured basis, by the Company and certain of the Company’s wholly owned existing and, subject to certain exceptions, future material subsidiaries (other than the Issuers); provided, however, that such guarantees are subject to automatic release under certain customary circumstances, as described in Note 12, Summarized Condensed Consolidating Information.

The indenture contains customary covenants such as limiting the ability of the Company and its restricted subsidiaries to: incur or guarantee additional indebtedness; incur or guarantee secured indebtedness; pay dividends or distributions on, or redeem or repurchase, capital stock; make certain investments or other restricted payments; sell assets; enter into transactions with affiliates; merge or consolidate or sell all or substantially all of their assets; and create restrictions on the ability of the Issuers and their restricted subsidiaries to pay dividends or other amounts to the Issuers. The indenture also requires the Company and its restricted subsidiaries to maintain a specified ratio of unencumbered assets to unsecured indebtedness. These covenants are subject to a number of important and significant limitations, qualifications and exceptions. The indenture also contains customary events of default.

As of September 30, 2018, the Company was in compliance with all applicable financial covenants under the indenture.

Unsecured Revolving Credit Facility and Term Loan

On August 5, 2015, the Company, CareTrust GP, LLC, the Operating Partnership, as the borrower, and certain of its wholly-owned subsidiaries entered into a credit and guaranty agreement with KeyBank National Association, as administrative agent, an issuing bank and swingline lender, and the lenders party thereto (the “Credit Agreement”). The Credit Agreement initially provided for an unsecured asset-based revolving credit facility (the “Revolving Facility”) with commitments in an

14

CARETRUST REIT, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —

(Unaudited)

aggregate principal amount of $300.0 million from a syndicate of banks and other financial institutions, and an accordion feature that allowed the Operating Partnership to increase the borrowing availability by up to an additional $200.0 million. A portion of the proceeds of the Revolving Facility were used to pay off and terminate the Company’s existing secured asset-based revolving credit facility under a credit agreement dated May 30, 2014, with SunTrust Bank, as administrative agent, and the lenders party thereto.

On February 1, 2016, the Company, CareTrust GP, LLC, the Operating Partnership, as the borrower, and certain of its wholly owned subsidiaries entered into the First Amendment (the “Amendment”) to the Credit Agreement. Pursuant to the Amendment, (i) commitments in respect of the Revolving Facility were increased by $100.0 million to $400.0 million total, (ii) a new $100.0 million non-amortizing unsecured term loan (the “Term Loan” and, together with the Revolving Facility, the “Credit Facility”) was funded, and (iii) the uncommitted incremental facility was increased by $50.0 million to $250.0 million. The Revolving Facility continues to mature on August 5, 2019, subject to two, six-month extension options. The Term Loan, which matures on February 1, 2023, may be prepaid at any time subject to a 2% premium in the first year after issuance and a 1% premium in the second year after issuance. Approximately $95.0 million of the proceeds of the Term Loan were used to pay off and terminate the Company’s existing secured mortgage indebtedness under the Fifth Amended and Restated Loan Agreement, dated May 30, 2014 with General Electric Capital Corporation, as agent and lender, and the other lenders party thereto. The Company expects to use borrowings under the Credit Facility for working capital purposes, to fund acquisitions and for general corporate purposes.

As of September 30, 2018, there was $90.0 million outstanding under the Revolving Facility.

The interest rates applicable to loans under the Revolving Facility are, at the Company’s option, equal to either a base rate plus a margin ranging from 0.75% to 1.40% per annum or applicable LIBOR plus a margin ranging from 1.75% to 2.40% per annum based on the debt to asset value ratio of the Company and its subsidiaries (subject to decrease at the Company’s election if the Company obtains certain specified investment grade ratings on its senior long term unsecured debt). In addition, the Company pays a commitment fee on the unused portion of the commitments under the Revolving Facility of 0.15% or 0.25% per annum, based upon usage of the Revolving Facility (unless the Company obtains certain specified investment grade ratings on its senior long term unsecured debt and elects to decrease the applicable margin as described above, in which case the Company will pay a facility fee on the revolving commitments ranging from 0.125% to 0.30% per annum based upon the credit ratings of its senior long term unsecured debt).

Pursuant to the Amendment, the interest rates applicable to the Term Loan are, at the Company’s option, equal to either a base rate plus a margin ranging from 0.95% to 1.60% per annum or applicable LIBOR plus a margin ranging from 1.95% to 2.60% per annum based on the debt to asset value ratio of the Company and its subsidiaries (subject to decrease at the Company’s election if the Company obtains certain specified investment grade ratings on its senior long term unsecured debt).

The Credit Facility is guaranteed, jointly and severally, by the Company and its wholly-owned subsidiaries that are party to the Credit Agreement (other than the Operating Partnership). The Credit Agreement contains customary covenants that, among other things, restrict, subject to certain exceptions, the ability of the Company and its subsidiaries to grant liens on their assets, incur indebtedness, sell assets, make investments, engage in acquisitions, mergers or consolidations, amend certain material agreements and pay certain dividends and other restricted payments. The Credit Agreement requires the Company to comply with financial maintenance covenants to be tested quarterly, consisting of a maximum debt to asset value ratio, a minimum fixed charge coverage ratio, a minimum tangible net worth, a maximum cash distributions to operating income ratio, a maximum secured debt to asset value ratio and a maximum secured recourse debt to asset value ratio. The Credit Agreement also contains certain customary events of default, including that the Company is required to operate in conformity with the requirements for qualification and taxation as a REIT.

As of September 30, 2018, the Company was in compliance with all applicable financial covenants under the Credit Agreement.

Interest Expense

During the three months ended September 30, 2018, the Company incurred $6.8 million of interest expense, which included $0.5 million of amortization of deferred financing costs. During the three months ended September 30, 2017, the Company incurred $5.6 million of interest expense, which included $0.5 million of amortization of deferred financing costs. During the nine months ended September 30, 2018, the Company incurred $21.2 million of interest expense, which included $1.5 million of amortization of deferred financing costs. During the nine months ended September 30, 2017, the Company

15

CARETRUST REIT, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —

(Unaudited)

incurred $17.7 million of interest expense, which included $1.6 million of amortization of deferred financing costs. As of September 30, 2018 and December 31, 2017, the Company’s interest payable was $5.3 million and $1.4 million, respectively.

Loss on the Extinguishment of Debt

During the nine months ended September 30, 2017, the loss on the extinguishment of debt included the redemption price, stated at 102.938%, of $7.6 million and a $4.2 million write-off of deferred financing costs associated with the redemption of the Company’s 5.875% Senior Notes due 2021. 

7. EQUITY

Common Stock

At-The-Market Offering—During the second quarter of 2017, the Company entered into an equity distribution agreement to issue and sell, from time to time, up to $300.0 million in aggregate offering price of its common stock through an “at-the-market” equity offering program (the “ATM Program”). The following table summarizes the quarterly ATM Program activity for 2018 (in thousands, except per share amounts):

	For the Three Months Ended
	March 31, 2018		June 30, 2018		September 30, 2018		Total
Number of shares	—		2,989		4,772		7,761
Average sales price per share	$	—	$	16.13	$	17.62	$	17.04
Gross proceeds*	$	—	$	48,198	$	84,077	$	132,275

*Total gross proceeds is before $0.6 million and $1.1 million of commissions paid to the sales agents during the three months ended June 30, 2018 and September 30, 2018, respectively.

As of September 30, 2018, the Company had approximately $103.8 million available for future issuances under the ATM Program.

Dividends on Common Stock—The following table summarizes the cash dividends per share of common stock declared by the Company’s Board of Directors for 2018:

	For the Three Months Ended
	March 31, 2018		June 30, 2018		September 30, 2018
Dividends declared	$	0.205	$	0.205	$	0.205
Dividends payment date	April 13, 2018		July 13, 2018		October 15, 2018

8. STOCK-BASED COMPENSATION

All stock-based awards are subject to the terms of the CareTrust REIT, Inc. and CTR Partnership, L.P. Incentive Award Plan (the “Plan”). The Plan provides for the granting of stock-based compensation, including stock options, restricted stock, performance awards, restricted stock units and other incentive awards to officers, employees and directors in connection with their employment with or services provided to the Company.

Restricted Stock Awards — In connection with the separation of Ensign’s healthcare business and its real estate business into two separate and independently publicly traded companies (the “Spin-Off”), employees of Ensign who had unvested shares of restricted stock were given one share of CareTrust REIT unvested restricted stock totaling 207,580 shares at the Spin-Off. These restricted shares are subject to a time vesting provision only and the Company does not recognize any stock compensation expense associated with these awards. During the nine months ended September 30, 2018, 10,960 shares vested or were forfeited. As of September 30, 2018, there were 4,020 unvested restricted stock awards outstanding that were issued in connection with the Spin-Off.

In February 2018, the Compensation Committee of the Company’s Board of Directors granted 141,060 shares of restricted stock to officers and employees. Each share had a fair market value on the date of grant of $15.13 per share, based on the market price of the Company’s common stock on that date, and the shares vest in four equal annual installments beginning on the first anniversary of the grant date. Additionally, the Compensation Committee granted 120,460 performance stock awards to officers and employees. Each share had a fair market value on the date of grant of $15.13 per share, based on the market price of the Company’s common stock on that date, and the shares may vest if the threshold performance criterion is met.

In May 2018, the Compensation Committee of the Company's Board of Directors granted 26,462 shares of restricted stock to members of the Board of Directors. Each share had a fair market value on the date of grant of $16.44 per share, based on the market price of the Company's common stock on that date, and the shares vest in full on the earlier to occur of May 30, 2019 or when the Company holds its 2019 Annual Meeting.

The following table summarizes the stock-based compensation expense recognized (dollars in thousands):

	For the Three Months Ended September 30,				For the Nine Months Ended September 30,
	2018		2017		2018		2017
Stock-based compensation expense	$	988	$	656	$	2,816	$	1,792

As of September 30, 2018, there was $5.4 million of unamortized stock-based compensation expense related to unvested awards and the weighted-average remaining vesting period of such awards was 2.2 years.

16

CARETRUST REIT, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —

(Unaudited)

9. EARNINGS PER COMMON SHARE

The following table presents the calculation of basic and diluted EPS for the Company’s common stock for the three and nine months ended September 30, 2018 and 2017, and reconciles the weighted-average common shares outstanding used in the calculation of basic EPS to the weighted-average common shares outstanding used in the calculation of diluted EPS (amounts in thousands, except per share amounts):

	For the Three Months Ended September 30,						For the Nine Months Ended September 30,
	2018			2017			2018			2017
Numerator:
Net income	$	14,510		$	11,311		$	42,384		$	23,622
Less: Net income allocated to participating securities	(84		)	(83		)	(282		)	(277		)
Numerator for basic and diluted earnings available to common stockholders	$	14,426		$	11,228		$	42,102		$	23,345
Denominator:
Weighted-average basic common shares outstanding	81,490			75,471			77,811			71,693
Weighted-average diluted common shares outstanding	81,490			75,471			77,811			71,693
Earnings per common share, basic	$	0.18		$	0.15		$	0.54		$	0.33
Earnings per common share, diluted	$	0.18		$	0.15		$	0.54		$	0.33

The Company’s unvested restricted shares associated with its incentive award plan and unvested restricted shares issued to employees of Ensign at the Spin-Off have been excluded from the above calculation of earnings per diluted share for the three and nine months ended September 30, 2018 and 2017, as their inclusion would have been anti-dilutive.

10. COMMITMENTS AND CONTINGENCIES

U.S. Government Settlement—In October 2013, Ensign completed and executed a settlement agreement (the “Settlement Agreement”) with the U.S. Department of Justice (“DOJ”). This settlement agreement fully and finally resolved a DOJ investigation of Ensign related primarily to claims submitted to the Medicare program for rehabilitation services provided at skilled nursing facilities in California and certain ancillary claims. Pursuant to the Settlement Agreement, Ensign made a single lump-sum remittance to the government in the amount of $48.0 million in October 2013. Ensign denied engaging in any illegal conduct and agreed to the settlement amount without any admission of wrongdoing in order to resolve the allegations and avoid the uncertainty and expense of protracted litigation.

In connection with the settlement and effective as of October 1, 2013, Ensign entered into a five-year corporate integrity agreement (the “CIA”) with the Office of Inspector General-Health and Human Services. The CIA acknowledges the existence of Ensign’s current compliance program, and requires that Ensign continue, during the term of the CIA, to maintain a compliance program designed to promote compliance with the statutes, regulations, and written directives of Medicare, Medicaid, and all other Federal health care programs. Ensign is also required to maintain several elements of its existing program during the term of the CIA, including maintaining a compliance officer, a compliance committee of the board of directors, and a code of conduct. The CIA requires that Ensign conduct certain additional compliance-related activities during the term of the CIA, including various training and monitoring procedures, and maintaining a disciplinary process for compliance obligations.

Participation in federal healthcare programs by Ensign is not affected by the Settlement Agreement or the CIA. In the event of an uncured material breach of the CIA, Ensign could be excluded from participation in federal healthcare programs and/or subject to prosecution. The Company is subject to certain continuing operational obligations as part of Ensign’s compliance program pursuant to the CIA, but otherwise has no liability related to the DOJ investigation.

17

CARETRUST REIT, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —

(Unaudited)

Legal Matters—The Company and its subsidiaries are and may become from time to time a party to various claims and lawsuits arising in the ordinary course of business, which are not individually or in the aggregate anticipated to have a material adverse effect on the Company’s results of operations, financial condition or cash flows. Claims and lawsuits may include matters involving general or professional liability asserted against the Company’s tenants, which are the responsibility of the Company’s tenants and for which the Company is entitled to be indemnified by its tenants under the insurance and indemnification provisions in the applicable leases.

11. CONCENTRATION OF RISK

Major operator concentrations – As of September 30, 2018, Ensign leased 92 skilled nursing, multi-service campuses, assisted living and independent living facilities which had a total of 9,805 operational beds and are located in Arizona, California, Colorado, Idaho, Iowa, Nebraska, Nevada, Texas, Utah and Washington. The four states in which Ensign leases the highest concentration of properties are California, Texas, Utah and Arizona. As of September 30, 2018, Ensign represents $59.1 million, or 42%, of the Company’s rental income on an annualized run-rate basis.

Ensign is subject to the registration and reporting requirements of the SEC and is required to file with the SEC annual reports containing audited financial information and quarterly reports containing unaudited financial information. Ensign’s financial statements, as filed with the SEC, can be found at Ensign’s website http://www.ensigngroup.net.

12. SUMMARIZED CONDENSED CONSOLIDATING INFORMATION

The Notes issued by the Operating Partnership and CareTrust Capital Corp. on May 10, 2017 are jointly and severally, fully and unconditionally, guaranteed by CareTrust REIT, Inc., as the parent guarantor (the “Parent Guarantor”), and the wholly owned subsidiaries of the Parent Guarantor other than the Issuers (collectively, the “Subsidiary Guarantors” and, together with the Parent Guarantor, the “Guarantors”), subject to automatic release under certain customary circumstances, including if the Subsidiary Guarantor is sold or sells all or substantially all of its assets, the Subsidiary Guarantor is designated “unrestricted” for covenant purposes under the indenture governing the Notes, the Subsidiary Guarantor’s guarantee of other indebtedness which resulted in the creation of the guarantee of the Notes is terminated or released, or the requirements for legal defeasance or covenant defeasance or to discharge the indenture have been satisfied.

The following provides information regarding the entity structure of the Parent Guarantor, the Issuers and the Subsidiary Guarantors:

CareTrust REIT, Inc. – The Parent Guarantor was formed on October 29, 2013 in anticipation of the Spin-Off and the related transactions and was a wholly owned subsidiary of Ensign prior to the effective date of the Spin-Off on June 1, 2014. The Parent Guarantor did not conduct any operations or have any business prior to the date of the consummation of the Spin-Off related transactions.

CTR Partnership, L.P. and CareTrust Capital Corp. – The Issuers, each of which is a wholly owned subsidiary of the Parent Guarantor, were formed on May 8, 2014 and May 9, 2014, respectively, in anticipation of the Spin-Off and the related transactions. The Issuers did not conduct any operations or have any business prior to the date of the consummation of the Spin-Off related transactions.

Subsidiary Guarantors – The Subsidiary Guarantors consist of all of the subsidiaries of the Parent Guarantor other than the Issuers.

Pursuant to Rule 3-10 of Regulation S-X, the following summarized consolidating information is provided for the Parent Guarantor, the Issuers, and the Subsidiary Guarantors. There are no subsidiaries of the Company other than the Issuers and the Subsidiary Guarantors. This summarized financial information has been prepared from the financial statements of the Company and the books and records maintained by the Company.

18

CARETRUST REIT, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —

(Unaudited)

CONDENSED CONSOLIDATING BALANCE SHEETS

SEPTEMBER 30, 2018

(in thousands, except share and per share amounts)

	Parent Guarantor			Issuers		Combined Subsidiary Guarantors		Elimination			Consolidated
Assets:
Real estate investments, net	$	—		$	856,659	$	332,790	$	—		$	1,189,449
Other real estate investments, net	—			12,337		5,746		—			18,083
Cash and cash equivalents	—			15,745		—		—			15,745
Accounts and other receivables, net	—			9,567		2,817		—			12,384
Prepaid expenses and other assets	—			3,789		3		—			3,792
Deferred financing costs, net	—			904		—		—			904
Investment in subsidiaries	737,296			474,524		—		(1,211,820		)	—
Intercompany	—			—		136,277		(136,277		)	—
Total assets	$	737,296		$	1,373,525	$	477,633	$	(1,348,097	)	$	1,240,357
Liabilities and Equity:
Senior unsecured notes payable, net	$	—		$	294,963	$	—	$	—		$	294,963
Senior unsecured term loan, net	—			99,588		—		—			99,588
Unsecured revolving credit facility	—			90,000		—		—			90,000
Accounts payable and accrued liabilities	—			15,401		3,109		—			18,510
Dividends payable	17,246			—		—		—			17,246
Intercompany	—			136,277		—		(136,277		)	—
Total liabilities	17,246			636,229		3,109		(136,277		)	520,307
Equity:
Common stock, $0.01 par value; 500,000,000 shares authorized, 83,353,226 shares issued and outstanding as of September 30, 2018	834			—		—		—			834
Additional paid-in capital	915,235			629,525		321,761		(951,286		)	915,235
Cumulative distributions in excess of earnings	(196,019		)	107,771		152,763		(260,534		)	(196,019		)
Total equity	720,050			737,296		474,524		(1,211,820		)	720,050
Total liabilities and equity	$	737,296		$	1,373,525	$	477,633	$	(1,348,097	)	$	1,240,357

19

CARETRUST REIT, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —

(Unaudited)

CONDENSED CONSOLIDATING BALANCE SHEETS

DECEMBER 31, 2017

(in thousands, except share and per share amounts)

	Parent Guarantor			Issuers		Combined Subsidiary Guarantors		Elimination			Consolidated
Assets:
Real estate investments, net	$	—		$	805,826	$	346,435	$	—		$	1,152,261
Other real estate investments, net	—			12,399		5,550		—			17,949
Cash and cash equivalents	—			6,909		—		—			6,909
Accounts and other receivables, net	—			2,945		2,309		—			5,254
Prepaid expenses and other assets	—			893		2		—			895
Deferred financing costs, net	—			1,718		—		—			1,718
Investment in subsidiaries	619,075			444,120		—		(1,063,195		)	—
Intercompany	—			—		92,061		(92,061		)	—
Total assets	$	619,075		$	1,274,810	$	446,357	$	(1,155,256	)	$	1,184,986
Liabilities and Equity:
Senior unsecured notes payable, net	$	—		$	294,395	$	—	$	—		$	294,395
Senior unsecured term loan, net	—			99,517		—		—			99,517
Unsecured revolving credit facility	—			165,000		—		—			165,000
Accounts payable and accrued liabilities	—			15,176		2,237		—			17,413
Dividends payable	14,044			—		—		—			14,044
Intercompany	—			92,061		—		(92,061		)	—
Total liabilities	14,044			666,149		2,237		(92,061		)	590,369
Equity:
Common stock, $0.01 par value; 500,000,000 shares authorized, 75,478,202 shares issued and outstanding as of December 31, 2017	755			—		—		—			755
Additional paid-in capital	783,237			546,097		321,761		(867,858		)	783,237
Cumulative distributions in excess of earnings	(178,961		)	62,564		122,359		(195,337		)	(189,375		)
Total equity	605,031			608,661		444,120		(1,063,195		)	594,617
Total liabilities and equity	$	619,075		$	1,274,810	$	446,357	$	(1,155,256	)	$	1,184,986

20

CARETRUST REIT, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —

(Unaudited)

CONDENSED CONSOLIDATING INCOME STATEMENTS

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2018

(in thousands)

	Parent Guarantor		Issuers		Combined Subsidiary Guarantors		Elimination			Consolidated
Revenues:
Rental income	$	—	$	20,554	$	14,778	$	—		$	35,332
Tenant reimbursements	—		1,804		1,186		—			2,990
Independent living facilities	—		—		871		—			871
Interest and other income	—		317		—		—			317
Total revenues	—		22,675		16,835		—			39,510
Expenses:
Depreciation and amortization	—		6,833		4,518		—			11,351
Interest expense	—		6,805		—		—			6,805
Property taxes	—		1,804		1,186		—			2,990
Independent living facilities	—		—		766		—			766
General and administrative	987		2,101		—		—			3,088
Total expenses	987		17,543		6,470		—			25,000
Income in Subsidiary	15,497		10,365		—		(25,862		)	—
Net income	$	14,510	$	15,497	$	10,365	$	(25,862	)	$	14,510

21

CARETRUST REIT, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —

(Unaudited)

CONDENSED CONSOLIDATING INCOME STATEMENTS

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2017

(in thousands)

	Parent Guarantor		Issuers		Combined Subsidiary Guarantors		Elimination			Consolidated
Revenues:
Rental income	$	—	$	14,987	$	14,417	$	—		$	29,404
Tenant reimbursements	—		1,341		1,202		—			2,543
Independent living facilities	—		—		825		—			825
Interest and other income	—		—		176		—			176
Total revenues	—		16,328		16,620		—			32,948
Expenses:
Depreciation and amortization	—		5,014		4,731		—			9,745
Interest expense	—		5,592		—		—			5,592
Property taxes	—		1,341		1,202		—			2,543
Independent living facilities	—		—		698		—			698
General and administrative	671		2,388		—		—			3,059
Total expenses	671		14,335		6,631		—			21,637
Income in Subsidiary	11,982		9,989		—		(21,971		)	—
Net income	$	11,311	$	11,982	$	9,989	$	(21,971	)	$	11,311

22

CARETRUST REIT, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —

(Unaudited)

CONDENSED CONSOLIDATING INCOME STATEMENTS

FOR THE NINE MONTHS ENDEDSEPTEMBER 30, 2018

(in thousands)

	Parent Guarantor		Issuers		Combined Subsidiary Guarantors		Elimination			Consolidated
Revenues:
Rental income	$	—	$	60,122	$	43,734	$	—		$	103,856
Tenant reimbursements	—		5,360		3,614		—			8,974
Independent living facilities	—		—		2,515		—			2,515
Interest and other income	—		1,039		196		—			1,235
Total revenues	—		66,521		50,059		—			116,580
Expenses:
Depreciation and amortization	—		20,488		13,739		—			34,227
Interest expense	—		21,182		—		—			21,182
Property taxes	—		5,360		3,614		—			8,974
Independent living facilities	—		—		2,226		—			2,226
General and administrative	2,822		6,740		76		—			9,638
Total expenses	2,822		53,770		19,655		—			76,247
Gain on sale of real estate	—		2,051		—		—			2,051
Income in Subsidiary	45,206		30,404		—		(75,610		)	—
Net income	$	42,384	$	45,206	$	30,404	$	(75,610	)	$	42,384

23

CARETRUST REIT, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —

(Unaudited)

CONDENSED CONSOLIDATING INCOME STATEMENTS

FOR THE NINE MONTHS ENDEDSEPTEMBER 30, 2017

(in thousands)

	Parent Guarantor		Issuers		Combined Subsidiary Guarantors		Elimination			Consolidated
Revenues:
Rental income	$	—	$	42,503	$	42,751	$	—		$	85,254
Tenant reimbursements	—		3,577		3,676		—			7,253
Independent living facilities	—		—		2,407		—			2,407
Interest and other income	—		—		1,471		—			1,471
Total revenues	—		46,080		50,305		—			96,385
Expenses:
Depreciation and amortization	—		13,730		14,426		—			28,156
Interest expense	—		17,690		—		—			17,690
Loss on the extinguishment of debt	—		11,883		—		—			11,883
Property taxes	—		3,577		3,676		—			7,253
Independent living facilities	—		—		2,003		—			2,003
Impairment of real estate investment	—		—		890		—			890
General and administrative	1,948		6,416		62		—			8,426
Total expenses	1,948		53,296		21,057		—			76,301
Gain on disposition of other real estate investment	—		—		3,538		—			3,538
Income in Subsidiary	25,570		32,786		—		(58,356		)	—
Net income	$	23,622	$	25,570	$	32,786	$	(58,356	)	$	23,622

24

CARETRUST REIT, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —

(Unaudited)

CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS

FOR THE NINE MONTHS ENDEDSEPTEMBER 30, 2018

(in thousands)

	Parent Guarantor			Issuers			Combined Subsidiary Guarantors			Elimination			Consolidated
Cash flows from operating activities:
Net cash (used in) provided by operating activities	$	(7	)	$	28,087		$	44,310		$	—		$	72,390
Cash flows from investing activities:
Acquisitions of real estate	—			(75,621		)	—			—			(75,621		)
Improvements to real estate	—			(5,376		)	(25		)	—			(5,401		)
Purchases of equipment, furniture and fixtures	—			(1,193		)	(69		)	—			(1,262		)
Investment in real estate mortgage and other loans receivable	—			(2,598		)	—			—			(2,598		)
Principal payments received on real estate mortgage and other loans receivable	—			893			—			—			893
Escrow deposit for acquisitions of real estate	—			(1,000		)	—			—			(1,000		)
Net proceeds from the sale of real estate	—			13,004			—			—			13,004
Distribution from subsidiary	45,827			—			—			(45,827		)	—
Intercompany financing	(129,251		)	44,216			—			85,035			—
Net cash used in investing activities	(83,424		)	(27,675		)	(94		)	39,208			(71,985		)
Cash flows from financing activities:
Proceeds from the issuance of common stock, net	130,546			—			—			—			130,546
Borrowings under unsecured revolving credit facility	—			60,000			—			—			60,000
Payments on unsecured revolving credit facility	—			(135,000		)	—			—			(135,000		)
Net-settle adjustment on restricted stock	(1,288		)	—			—			—			(1,288		)
Dividends paid on common stock	(45,827		)	—			—			—			(45,827		)
Distribution to Parent	—			(45,827		)	—			45,827			—
Intercompany financing	—			129,251			(44,216		)	(85,035		)	—
Net cash provided by (used in) financing activities	83,431			8,424			(44,216		)	(39,208		)	8,431
Net increase in cash and cash equivalents	—			8,836			—			—			8,836
Cash and cash equivalents beginning of period	—			6,909			—			—			6,909
Cash and cash equivalents end of period	$	—		$	15,745		$	—		$	—		$	15,745

25

CARETRUST REIT, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —

(Unaudited)

CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS

FOR THE NINE MONTHS ENDEDSEPTEMBER 30, 2017

(in thousands)

	Parent Guarantor			Issuers			Combined Subsidiary Guarantors			Elimination			Consolidated
Cash flows from operating activities:
Net cash (used in) provided by operating activities:	$	(157	)	$	17,946		$	49,144		$	—		$	66,933
Cash flows from investing activities:
Acquisitions of real estate	—			(222,463		)	—			—			(222,463		)
Improvements to real estate	—			(571		)	(50		)	—			(621		)
Purchases of equipment, furniture and fixtures	—			(292		)	(67		)	—			(359		)
Escrow deposit for acquisitions of real estate	—			(1,000		)	—			—			(1,000		)
Sale of other real estate investment	—			—			7,500			—			7,500
Distribution from subsidiary	38,544			—			—			(38,544		)	—
Intercompany financing	(169,391		)	56,527			—			112,864			—
Net cash (used in) provided by investing activities	(130,847		)	(167,799		)	7,383			74,320			(216,943		)
Cash flows from financing activities:
Proceeds from the issuance of common stock, net	170,414			—			—			—			170,414
Proceeds from the issuance of senior unsecured notes payable	—			300,000			—			—			300,000
Borrowings under unsecured revolving credit facility	—			158,000			—			—			158,000
Payments on senior unsecured notes payable	—			(267,639		)	—			—			(267,639		)
Payments on unsecured revolving credit facility	—			(158,000		)	—			—			(158,000		)
Payments of deferred financing costs	—			(6,047		)	—			—			(6,047		)
Net-settle adjustment on restricted stock	(866		)	—			—			—			(866		)
Dividends paid on common stock	(38,544		)	—			—			—			(38,544		)
Distribution to Parent	—			(38,544		)	—			38,544			—
Intercompany financing	—			169,391			(56,527		)	(112,864		)	—
Net cash provided by (used in) financing activities	131,004			157,161			(56,527		)	(74,320		)	157,318
Net increase in cash and cash equivalents	—			7,308			—			—			7,308
Cash and cash equivalents beginning of period	—			7,500			—			—			7,500
Cash and cash equivalents end of period	$	—		$	14,808		$	—		$	—		$	14,808

26

CARETRUST REIT, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —

(Unaudited)

13. SUBSEQUENT EVENTS

The Company evaluates subsequent events in accordance with ASC Topic 855, Subsequent Events. The Company evaluates subsequent events up until the date the condensed consolidated financial statements are issued.

In October 2018, the Company, in two separate transactions, acquired one skilled nursing facility and one multi-service campus. The aggregate purchase price was approximately $12.0 million, which includes estimated capitalized acquisition costs. These two acquisitions will generate initial annual cash rents of approximately $1.1 million and were funded using $7.0 million in cash on hand and $5.0 million in borrowings under the Company’s senior unsecured revolving credit facility.

27

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Forward-Looking Statements

Certain statements in this report may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Those forward-looking statements include all statements that are not historical statements of fact and those regarding our intent, belief or expectations, including, but not limited to, statements regarding: future financing plans, business strategies, growth prospects and operating and financial performance; expectations regarding the making of distributions and the payment of dividends; and compliance with and changes in governmental regulations.

Words such as “anticipate(s),” “expect(s),” “intend(s),” “plan(s),” “believe(s),” “may,” “will,” “would,” “could,” “should,” “seek(s)” and similar expressions, or the negative of these terms, are intended to identify such forward-looking statements. These statements are based on management’s current expectations and beliefs and are subject to a number of risks and uncertainties that could lead to actual results differing materially from those projected, forecasted or expected. Although we believe that the assumptions underlying the forward-looking statements are reasonable, we can give no assurance that our expectations will be attained. Factors which could have a material adverse effect on our operations and future prospects or which could cause actual results to differ materially from our expectations include, but are not limited to: (i) the ability to achieve some or all of the benefits that we expect to achieve from the separation of the real estate business of Ensign Group, Inc. (“Ensign”) into a separate and independent publicly-traded company upon the distribution of all of the outstanding shares of common stock of the Company to Ensign stockholders on a pro rata basis (the “Spin-Off”); (ii) the ability and willingness of our tenants to meet and/or perform their obligations under the triple-net leases we have entered into with them and the ability and willingness of Ensign to meet and/or perform its other contractual arrangements that it entered into with us in connection with the Spin-Off, and any of its obligations to indemnify, defend and hold us harmless from and against various claims, litigation and liabilities; (iii) the ability of our tenants to comply with laws, rules and regulations in the operation of the properties we lease to them; (iv) the ability and willingness of our tenants, including Ensign, to renew their leases with us upon their expiration, and the ability to reposition our properties on the same or better terms in the event of nonrenewal or in the event we replace an existing tenant, and obligations, including indemnification obligations, we may incur in connection with the replacement of an existing tenant; (v) the availability of and the ability to identify suitable acquisition opportunities and the ability to acquire and lease the respective properties on favorable terms; (vi) the ability to generate sufficient cash flows to service our outstanding indebtedness; (vii) access to debt and equity capital markets; (viii) fluctuating interest rates; (ix) the ability to retain our key management personnel; (x) the ability to maintain our status as a real estate investment trust (“REIT”); (xi) changes in the U.S. tax law and other state, federal or local laws, whether or not specific to REITs; (xii) other risks inherent in the real estate business, including potential liability relating to environmental matters and illiquidity of real estate investments; and (xiii) any additional factors included in our Annual Report on Form 10-K for the year ended December 31, 2017, including in the section entitled “Risk Factors” in Item 1A of Part I of such report, as such risk factors may be amended, supplemented or superseded from time to time by other reports we file with the Securities and Exchange Commission (the “SEC”).

Forward-looking statements speak only as of the date of this report. Except in the normal course of our public disclosure obligations, we expressly disclaim any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in our expectations or any change in events, conditions or circumstances on which any statement is based.

Overview

CareTrust REIT is a self-administered, publicly-traded REIT engaged in the ownership, acquisition, development and leasing of seniors housing and healthcare-related properties. As of September 30, 2018, the 92 facilities leased to Ensign had a total of 9,805 operational beds and units which are located in Arizona, California, Colorado, Idaho, Iowa, Nebraska, Nevada, Texas, Utah and Washington and the 98 remaining leased properties had a total of 8,888 operational beds and units and are located in California, Colorado, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Maryland, Michigan, Minnesota, Montana, New Mexico, North Carolina, Oregon, South Dakota, Texas, Virginia, Washington and Wisconsin. We also own and operate three independent living facilities (“ILFs”), which had a total of 264 units located in Texas and Utah. As of September 30, 2018, we also had other real estate investments consisting of two preferred equity investments totaling $5.7 million and a mortgage loan receivable of $12.3 million.

28

Recent Transactions

Recent Investments

From January 1, 2018 through November 5, 2018, we acquired eight skilled nursing facilities and two multi-service campuses for approximately $89.4 million, which includes actual and estimated capitalized acquisition costs and a $1.4 million commitment to fund revenue-producing capital expenditures over the next 24 months on one newly acquired multi-service campus. These acquisitions are expected to generate initial annual cash revenues of approximately $7.8 million and an initial blended yield of approximately 8.7%. See Note 3, Real Estate Investments, Net and Note 13, Subsequent Events in the Notes to condensed consolidated financial statements for additional information.

Lease Amendments and Related Agreements

Pristine Lease Termination. On February 27, 2018 (the “LTA Effective Date”) we entered into a Lease Termination Agreement (the “LTA”) with affiliates of Pristine Senior Living, LLC (“Pristine”) under which Pristine agreed to surrender the nine remaining facilities operated by Pristine, with a completion date of April 30, 2018. Under the LTA, Pristine agreed to continue to operate the facilities until possession could be surrendered, and the operations therein transitioned, to operator(s) designated by us. Among other things, Pristine also agreed to amend certain pending agreements to sell the rights to certain Ohio Medicaid beds (the “Bed Sales Agreements”) and cooperate with us to turn over any claim or control it might have had with respect to the sale process and the proceeds thereof, if any, to us. The transactions were timely completed, and on May 1, 2018, Trio Healthcare, Inc (“Trio”) took over operations in the seven facilities based primarily in the Dayton, Ohio area under a new 15-year master lease, while Hillstone Healthcare, Inc. (“Hillstone”) assumed the operation of the two facilities in Willard and Toledo, Ohio under a new 12-year master lease. In addition, amendments to the Bed Sales Agreements were subsequently executed, confirming us as the sole seller of the bed rights and the sole recipient of any proceeds therefrom. The aggregate annual base rent due under the new master leases with Trio and Hillstone is approximately $10.0 million, subject to CPI-based or fixed escalators.

Under the LTA we agreed, upon Pristine’s full performance of the terms thereof, to terminate Pristine’s master lease and all future obligations of the tenant thereunder; however, under the terms of the master lease the Company’s security interest in Pristine’s accounts receivable has survived any such termination. Such security interest was subject to the prior lien and security interest of Pristine’s working capital lender, Capital One, National Association (“CONA”), with whom the Company has an existing intercreditor agreement that defines the relative rights and responsibilities of CONA and with its respect to the loan and lease collateral represented by Pristine’s accounts receivable and the Company’s respective security interests therein.

OnPointe Lease Terminations. On March 12, 2018, we terminated two separate facility leases between us and affiliates of OnPointe Health (“OnPointe”), which covered two properties located in Albuquerque, New Mexico and Brownsville, Texas. The Brownsville lease termination also terminated an option agreement which would have granted the tenant the right, under certain circumstances, to purchase the Brownsville property. OnPointe continued to operate the facilities following the lease terminations, and worked cooperatively with us to effectuate an orderly transfer of the operations in the two properties to two existing CareTrust tenants.

On May 1, 2018, OnPointe completed the operational transfers of both facilities. An affiliate of Eduro Healthcare, LLC (“Eduro”) assumed operational responsibility for the Albuquerque property, and we entered into a lease amendment with Eduro amending their existing master lease with us to add the Albuquerque property thereto. An affiliate of Providence Group, Inc. (“Providence”) assumed operational responsibility for the Brownsville property, and we entered into a lease amendment with Providence amending their existing master lease with us to add the Brownsville property thereto. The aggregate annual base rent increase under the Eduro and Providence master leases, as amended, is approximately equivalent to the aggregate annual base rent we were receiving under the two OnPointe leases.

At-The-Market Offering of Common Stock

In May 2017, we entered into an equity distribution agreement to issue and sell, from time to time, up to $300.0 million in aggregate offering price of our common stock through an “at-the-market” equity offering program (the “ATM Program”). The following table summarizes the quarterly ATM Program activity for 2018 (shares and dollars in thousands, except per share amounts):

29

	For the Three Months Ended
	March 31, 2018		June 30, 2018		September 30, 2018		Total
Number of shares	—		2,989		4,772		7,761
Average sales price per share	$	—	$	16.13	$	17.62	$	17.04
Gross proceeds*	$	—	$	48,198	$	84,077	$	132,275

*Total gross proceeds is before $0.6 million and $1.1 million of commissions paid to the sales agents during the three months ended June 30, 2018 and September 30, 2018, respectively.

As of September 30, 2018, we had approximately $103.8 million available for future issuances under the ATM Program. From October 1, 2018 to November 5, 2018, there has been no activity under our ATM program.

Results of Operations

Operating Results

Three Months Ended September 30, 2018 Compared to Three Months Ended September 30, 2017:

	Three Months Ended September 30,				Increase (Decrease)		Percentage Difference
	2018		2017
	(dollars in thousands)
Revenues:
Rental income	$	35,332	$	29,404	$	5,928	20	%
Tenant reimbursements	2,990		2,543		447		18	%
Independent living facilities	871		825		46		6	%
Interest and other income	317		176		141		80	%
Expenses:
Depreciation and amortization	11,351		9,745		1,606		16	%
Interest expense	6,805		5,592		1,213		22	%
Property taxes	2,990		2,543		447		18	%
Independent living facilities	766		698		68		10	%
General and administrative	3,088		3,059		29		*

 * - Not Meaningful

Rental income. Rental income was $35.3 million for the three months ended September 30, 2018 compared to $29.4 million for the three months ended September 30, 2017. The $5.9 million or 20% increase in rental income is primarily due to $5.3 million from real estate investments made after July 1, 2017, $0.6 million from increases in rental rates for our existing tenants and $0.7 million of straight-line rent, partially offset by a $0.4 million decrease in cash rents as of September 30, 2018 and a $0.3 million decrease in rental income due to the sale of three assisted living facilities in March 2018.

Independent living facilities. Revenues and expenses from our three ILFs that we own and operate increased less than $0.1 million for the three months ended September 30, 2018 compared to the three months ended September 30, 2017.

Interest and other income. Interest and other income increased $0.1 million or 80% for the three months ended September 30, 2018 to $0.3 million compared to $0.2 million for the three months ended September 30, 2017. The increase was primarily due to $0.3 million of interest income associated with the mortgage loan receivable that we provided to the Providence Group in October 2017, offset by a decrease of interest income of $0.2 million due to the cessation of preferred equity investment for GAAP purposes.

Depreciation and amortization. Depreciation and amortization expense increased $1.6 million or 16% for the three months ended September 30, 2018 to $11.4 million compared to $9.7 million for the three months ended September 30, 2017, primarily due to new real estate investments made after July 1, 2017.

Interest expense. Interest expense increased $1.2 million or 22% for the three months ended September 30, 2018 to $6.8 million compared to $5.6 million for the three months ended September 30, 2017. The increase was primarily due to a

30

higher weighted average outstanding balance on our unsecured revolving credit facility and higher LIBOR interest rates for the three months ended September 30, 2018 compared to the three months ended September 30, 2017.

General and administrative expense. General and administrative expense remained consistent at $3.1 million for both the three months ended September 30, 2018 and 2017.

Nine Months EndedSeptember 30, 2018 Compared to Nine Months EndedSeptember 30, 2017:

	Nine Months Ended September 30,				Increase (Decrease)			Percentage Difference
	2018		2017
	(dollars in thousands)
Revenues:
Rental income	$	103,856	$	85,254	$	18,602		22	%
Tenant reimbursements	8,974		7,253		1,721			24	%
Independent living facilities	2,515		2,407		108			4	%
Interest and other income	1,235		1,471		(236		)	(16	)%
Expenses:
Depreciation and amortization	34,227		28,156		6,071			22	%
Interest expense	21,182		17,690		3,492			20	%
Loss on the extinguishment of debt	—		11,883		(11,883		)	*
Property taxes	8,974		7,253		1,721			24	%
Independent living facilities	2,226		2,003		223			11	%
Impairment of real estate investment	—		890		(890		)	*
General and administrative	9,638		8,426		1,212			14	%

 * - Not Meaningful

Rental income. Rental income was $103.9 million for the nine months ended September 30, 2018 compared to $85.3 million for the nine months ended September 30, 2017. The $18.6 million or 22% increase in rental income is primarily due to $16.6 million from real estate investments made after January 1, 2017, $2.1 million from increases in rental rates for our existing tenants and $1.5 million of straight-line rent, partially offset by a $1.1 million decrease in cash rents as of September 30, 2018 and a $0.5 million decrease in rental income due to the sale of three assisted living facilities in March 2018.

Independent living facilities. Revenues from our three ILFs that we own and operate increased $0.1 million or 4% for the nine months ended September 30, 2018 compared to the nine months ended September 30, 2017. The expenses from our three ILFs increased $0.2 million or 11% for the nine months ended September 30, 2018 compared to the nine months ended September 30, 2017.

Interest and other income. Interest and other income decreased $0.2 million for the nine months ended September 30, 2018 to $1.2 million compared to $1.5 million for the nine months ended September 30, 2017. The decrease was primarily due to the interest income associated with the disposition in May 2017 of one preferred equity investment, partially offset by an increase of interest income related to the mortgage loan receivable that we provided to the Providence Group in October 2017.

Depreciation and amortization. Depreciation and amortization expense increased $6.1 million or 22% for the nine months ended September 30, 2018 to $34.2 million compared to $28.2 million for the nine months ended September 30, 2017, primarily due to new real estate investments made after January 1, 2017.

Interest expense. Interest expense increased $3.5 million or 20% for the nine months ended September 30, 2018 to $21.2 million compared to $17.7 million for the nine months ended September 30, 2017. The increase was primarily due to a higher weighted average outstanding balance on our unsecured revolving credit facility and higher LIBOR interest rates for the nine months ended September 30, 2018 compared to the nine months ended September 30, 2017.

Loss on the extinguishment of debt. Loss on the extinguishment of debt for the nine months ended September 30, 2017 consisted of $7.6 million related to the redemption of our 5.875% Senior Notes due 2021 at a redemption price of 102.938%, and a $4.2 million write-off of deferred financing costs associated with such redemption that was completed during the nine months ended September 30, 2017.

31

Impairment of real estate investments. In April 2017, we and Ensign mutually determined that La Villa Rehab & Healthcare Center (“La Villa”) had reached the natural end of its useful life as a skilled nursing facility and that the facility was no longer economically viable, the improvements thereon could not be economically repurposed to any other use, and the cost to remove the obsolete improvements and reclaim the underlying land for redevelopment was expected to exceed the market value of the land. Ensign agreed to wind up and terminate the operations of the facility and we transferred title to the property to Ensign. There was no adjustment to the contractual rent under the applicable master lease. As a result of the transfer, we wrote-off the net book value of La Villa during the nine months ended September 30, 2017.

General and administrative expense. General and administrative expense increased $1.2 million or 14% for the nine months ended September 30, 2018 to $9.6 million compared to $8.4 million for the nine months ended September 30, 2017. The increase is primarily related to an increase in the amortization of stock-based compensation of $1.0 million and higher cash wages of $0.2 million.

Liquidity and Capital Resources

To qualify as a REIT for federal income tax purposes, we are required to distribute at least 90% of our REIT taxable income, determined without regard to the dividends paid deduction and excluding any net capital gains, to our stockholders on an annual basis. Accordingly, we intend to make, but are not contractually bound to make, regular quarterly dividends to common stockholders from cash flow from operating activities. All such dividends are at the discretion of our board of directors.

During the nine months ended September 30, 2018, we sold 7.8 million shares of common stock under our ATM Program for gross proceeds of $132.3 million. As of September 30, 2018, we had approximately $103.8 million available for future issuances under the ATM Program. See “Recent Transactions—At-The-Market Offering of Common Stock.” In addtion, as of September 30, 2018, there was $90.0 million outstanding under the Revolving Facility (as defined below). See Note 6, Debt, and Note 7, Equity, in the Notes to condensed consolidated financial statements for additional information on the Revolving Facility and ATM Program, respectively. We believe that our available cash, expected operating cash flows, and the remaining availability under our ATM Program and Credit Facility (as defined below) will provide sufficient funds for our operations, anticipated scheduled debt service payments and dividend plans for at least the next twelve months.

We intend to invest in and/or develop additional healthcare properties as suitable opportunities arise and adequate sources of financing are available. We expect that future investments in and/or development of properties, including any improvements or renovations of current or newly-acquired properties, will depend on and will be financed by, in whole or in part, our existing cash, borrowings available to us under the Credit Facility, future borrowings or the proceeds from sales of shares of our common stock pursuant to our ATM Program or additional issuances of common stock or other securities. In addition, we may seek financing from U.S. government agencies, including through Fannie Mae and the U.S. Department of Housing and Urban Development, in appropriate circumstances in connection with acquisitions and refinancing of existing mortgage loans.

We have filed an automatic shelf registration statement with the U.S. Securities and Exchange Commission that expires in May 2020, which will allow us or certain of our subsidiaries, as applicable, to offer and sell shares of common stock, preferred stock, warrants, rights, units and debt securities through underwriters, dealers or agents or directly to purchasers, in one or more offerings on a continuous or delayed basis, in amounts, at prices and on terms we determine at the time of the offering.

Although we are subject to restrictions on our ability to incur indebtedness, we expect that we will be able to refinance existing indebtedness or incur additional indebtedness for acquisitions or other purposes, if needed. However, there can be no assurance that we will be able to refinance our indebtedness, incur additional indebtedness or access additional sources of capital, such as by issuing common stock or other debt or equity securities, on terms that are acceptable to us or at all.

Cash Flows

The following table presents selected data from our condensed consolidated statements of cash flows for the periods presented:

32

	For the Nine Months Ended September 30,
	2018			2017
	(dollars in thousands)
Net cash provided by operating activities	$	72,390		$	66,933
Net cash used in investing activities	(71,985		)	(216,943		)
Net cash provided by financing activities	8,431			157,318
Net increase in cash and cash equivalents	8,836			7,308
Cash and cash equivalents, beginning of period	6,909			7,500
Cash and cash equivalents, end of period	$	15,745		$	14,808

Nine Months Ended September 30, 2018 Compared to Nine Months Ended September 30, 2017

Net cash provided by operating activities for the nine months ended September 30, 2018 was $72.4 million compared to $66.9 million for the nine months ended September 30, 2017, an increase of $5.5 million. The increase was primarily due to an increase of $18.8 million in net income, partially offset a $10.6 million decrease in noncash income and expenses and a $2.7 million change in operating assets and liabilities.

Net cash used in investing activities for the nine months ended September 30, 2018 was $72.0 million compared to $216.9 million for the nine months ended September 30, 2017, a decrease of $145.0 million. The decrease was primarily the result of a $146.8 million decrease in cash used to acquire real estate, $13.0 million increase in net proceeds from the sale of real estate and $0.9 million increase from principal payments received on real estate mortgage and other loans receivable, partially offset by prior period cash proceeds of $7.5 million related to the sale of other real estate investments, an increase of $4.7 million in improvements to real estate, $2.6 million of investments in other loan receivables and an increase of $0.9 million of purchases of furniture, fixtures and equipment.

Net cash provided by financing activities for the nine months ended September 30, 2018 was $8.4 million compared to $157.3 million for the nine months ended September 30, 2017, a decrease of $148.9 million. This decrease was primarily due to a decrease of $107.3 million in net borrowings, a $39.9 million decrease in net proceeds from common stock sales under our ATM Program, an increase in dividends paid of $7.3 million and $0.4 million of net-settle adjustments on restricted stock, partially offset by a $6.0 million decrease in payments of deferred financing costs.

Indebtedness

Senior Unsecured Notes

On May 10, 2017, our wholly owned subsidiary, CTR Partnership, L.P. (the “Operating Partnership”), and its wholly owned subsidiary, CareTrust Capital Corp. (together with the Operating Partnership, the “Issuers”), completed a public offering of $300.0 million aggregate principal amount of 5.25% Senior Notes due 2025 (the “Notes”). The Notes were issued at par, resulting in gross proceeds of $300.0 million and net proceeds of approximately $294.0 million after deducting underwriting fees and other offering expenses. We used the net proceeds from the offering of the Notes to redeem all $260.0 million aggregate principal amount outstanding of our 5.875% Senior Notes due 2021, including payment of the redemption price of 102.938% and all accrued and unpaid interest thereon. We used the remaining portion of the net proceeds of the offering to pay borrowings outstanding under our senior unsecured revolving credit facility. The Notes mature on June 1, 2025 and bear interest at a rate of 5.25% per year. Interest on the Notes is payable on June 1 and December 1 of each year, beginning on December 1, 2017.

The Issuers may redeem the Notes any time before June 1, 2020 at a redemption price of 100% of the principal amount of the Notes redeemed plus accrued and unpaid interest on the Notes, if any, to, but not including, the redemption date, plus a “make-whole” premium described in the indenture governing the Notes and, at any time on or after June 1, 2020, at the redemption prices set forth in the indenture. At any time on or before June 1, 2020, up to 40% of the aggregate principal amount of the Notes may be redeemed with the net proceeds of certain equity offerings if at least 60% of the originally issued aggregate principal amount of the Notes remains outstanding. In such case, the redemption price will be equal to 105.25% of the aggregate principal amount of the Notes to be redeemed plus accrued and unpaid interest, if any, to, but not including the redemption date. If certain changes of control of CareTrust REIT occur, holders of the Notes will have the right to require the Issuers to repurchase their Notes at 101% of the principal amount plus accrued and unpaid interest, if any, to, but not including, the repurchase date.

33

The obligations under the Notes are fully and unconditionally guaranteed, jointly and severally, on an unsecured basis, by CareTrust REIT and certain of CareTrust REIT’s wholly owned existing and, subject to certain exceptions, future material subsidiaries (other than the Issuers); provided, however, that such guarantees are subject to automatic release under certain customary circumstances, including if the subsidiary guarantor is sold or sells all or substantially all of its assets, the subsidiary guarantor is designated “unrestricted” for covenant purposes under the indenture, the subsidiary guarantor’s guarantee of other indebtedness which resulted in the creation of the guarantee of the Notes is terminated or released, or the requirements for legal defeasance or covenant defeasance or to discharge the indenture have been satisfied. See Note 12, Summarized Condensed Consolidating Information.

The indenture contains customary covenants such as limiting the ability of CareTrust REIT and its restricted subsidiaries to: incur or guarantee additional indebtedness; incur or guarantee secured indebtedness; pay dividends or distributions on, or redeem or repurchase, capital stock; make certain investments or other restricted payments; sell assets; enter into transactions with affiliates; merge or consolidate or sell all or substantially all of their assets; and create restrictions on the ability of the Issuers and their restricted subsidiaries to pay dividends or other amounts to the Issuers. The indenture also requires CareTrust REIT and its restricted subsidiaries to maintain a specified ratio of unencumbered assets to unsecured indebtedness. These covenants are subject to a number of important and significant limitations, qualifications and exceptions. The indenture also contains customary events of default.

As of September 30, 2018, we were in compliance with all applicable financial covenants under the indenture.

Unsecured Revolving Credit Facility and Term Loan

On August 5, 2015, the Company, CareTrust GP, LLC, the Operating Partnership, as the borrower, and certain of its wholly-owned subsidiaries entered into a credit and guaranty agreement with KeyBank National Association, as administrative agent, an issuing bank and swingline lender, and the lenders party thereto (the “Credit Agreement”). The Credit Agreement initially provided for an unsecured asset-based revolving credit facility (the “Revolving Facility”) with commitments in an aggregate principal amount of $300.0 million from a syndicate of banks and other financial institutions, and an accordion feature that allowed the Operating Partnership to increase the borrowing availability by up to an additional $200.0 million. A portion of the proceeds of the Revolving Facility were used to pay off and terminate the Company’s existing secured asset-based revolving credit facility under a credit agreement dated May 30, 2014, with SunTrust Bank, as administrative agent, and the lenders party thereto.

On February 1, 2016, the Company, CareTrust GP, LLC, the Operating Partnership, as the borrower, and certain of its wholly owned subsidiaries entered into the First Amendment (the “Amendment”) to the Credit Agreement. Pursuant to the Amendment, (i) commitments in respect of the Revolving Facility were increased by $100.0 million to $400.0 million total, (ii) a new $100.0 million non-amortizing unsecured term loan (the “Term Loan” and, together with the Revolving Facility, the “Credit Facility”) was funded and (iii) the uncommitted incremental facility was increased by $50.0 million to $250.0 million. We do not currently have any commitments for increased loans under the uncommitted incremental facility. The Revolving Facility continues to mature on August 5, 2019, subject to two, six-month extension options. The Term Loan, which matures on February 1, 2023, may be prepaid at any time subject to a 2% premium in the first year after issuance and a 1% premium in the second year after issuance.

Approximately $95.0 million of the proceeds of the Term Loan were used to pay off and terminate our existing secured mortgage indebtedness under the Fifth Amended and Restated Loan Agreement, dated May 30, 2014. We expect to use borrowings under the Credit Facility for working capital purposes, to fund acquisitions and for general corporate purposes.

As of September 30, 2018, there was $90.0 million outstanding under the Revolving Facility.

The interest rates applicable to loans under the Revolving Facility are, at the Company’s option, equal to either a base rate plus a margin ranging from 0.75% to 1.40% per annum or applicable LIBOR plus a margin ranging from 1.75% to 2.40% per annum based on the debt to asset value ratio of the Company and its subsidiaries (subject to decrease at the Company’s election if the Company obtains certain specified investment grade ratings on its senior long term unsecured debt).

In addition, the Company pays a commitment fee on the unused portion of the commitments under the Revolving Facility of 0.15% or 0.25% per annum, based upon usage of the Revolving Facility (unless the Company obtains certain specified investment grade ratings on its senior long term unsecured debt and elects to decrease the applicable margin as described above, in which case the Company will pay a facility fee on the revolving commitments ranging from 0.125% to 0.30% per annum based upon the credit ratings of its senior long term unsecured debt).

34

Pursuant to the Amendment, the interest rates applicable to the Term Loan are, at the Company’s option, equal to a base rate plus a margin ranging from 0.95% to 1.60% per annum or applicable LIBOR plus a margin ranging from 1.95% to 2.60% per annum based on the debt to asset value ratio of the Company and its subsidiaries (subject to decrease at the Company’s election if the Company obtains certain specified investment grade ratings on its senior long term unsecured debt).

The Credit Facility is guaranteed, jointly and severally, by the Company and its wholly owned subsidiaries that are party to the Credit Agreement (other than the Operating Partnership). The Credit Agreement contains customary covenants that, among other things, restrict, subject to certain exceptions, the ability of the Company and its subsidiaries to grant liens on their assets, incur indebtedness, sell assets, make investments, engage in acquisitions, mergers or consolidations, amend certain material agreements and pay certain dividends and other restricted payments. The Credit Agreement requires the Company to comply with financial maintenance covenants to be tested quarterly, consisting of a maximum debt to asset value ratio, a minimum fixed charge coverage ratio, a minimum tangible net worth, a maximum cash distributions to operating income ratio, a maximum secured debt to asset value ratio and a maximum secured recourse debt to asset value ratio. The Credit Agreement also contains certain customary events of default, including that the Company is required to operate in conformity with the requirements for qualification and taxation as a REIT.

As of September 30, 2018, the Company was in compliance with all applicable financial covenants under the Credit Agreement.

Obligations and Commitments

The following table summarizes our contractual obligations and commitments as of September 30, 2018 (in thousands):

	Payments Due by Period
	Total		Less than 1 Year		1 Year to Less than 3 Years		3 Years to Less than 5 Years		More than 5 years
Senior unsecured notes payable (1)	$	410,250	$	15,750	$	31,500	$	31,500	$	331,500
Senior unsecured term loan (2)	118,446		4,250		8,513		105,683		—
Unsecured revolving credit facility (3)	93,737		93,737		—		—		—
Operating lease	195		140		55		—		—
Total	$	622,628	$	113,877	$	40,068	$	137,183	$	331,500

(1) Amounts include interest payments of $110.3 million.

(2) Amounts include interest payments of $18.4 million.

(3) The unsecured revolving credit facility includes payments related to the unused credit facility fee.

Capital Expenditures

We anticipate incurring average annual capital expenditures of $400 to $500 per unit in connection with the operations of our three ILFs. Capital expenditures for each property leased under our triple-net leases are generally the responsibility of the tenant, except that, for the facilities leased to subsidiaries of Ensign under eight master leases (“Ensign Master Leases”), the tenant will have an option to require us to finance certain capital expenditures up to an aggregate of 20% of our initial investment in such property, subject to a corresponding rent increase at the time of funding. For our other triple-net master leases, the tenants also have the option to request capital expenditure funding that would also be subject to a corresponding rent increase at the time of funding.

Critical Accounting Policies and Estimates

Our condensed consolidated financial statements included in Item 1 of this Quarterly Report on Form 10-Q have been prepared in accordance with GAAP for interim financial information set forth in the Accounting Standards Codification, as published by the Financial Accounting Standards Board. GAAP requires us to make estimates and assumptions regarding future events that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. We base these estimates on our experience and assumptions we believe to be reasonable under the circumstances. However, if our judgment or interpretation of the facts and circumstances relating to various transactions or other matters had been different, we may have applied a different accounting treatment, resulting in a different presentation of our financial statements. We periodically

35

reevaluate our estimates and assumptions, and in the event they prove to be different from actual results, we make adjustments in subsequent periods to reflect more current estimates and assumptions about matters that are inherently uncertain. Please refer to “Critical Accounting Policies and Estimates” in the “Management Discussion and Analysis of Financial Condition and Results of Operations” section of our Annual Report on Form 10-K for the year ended December 31, 2017, filed with the SEC on February 27, 2018, for further information regarding the critical accounting policies that affect our more significant estimates and judgments used in the preparation of our condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q. There have been no material changes in such critical accounting policies during the nine months ended September 30, 2018.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

Our primary market risk exposure is interest rate risk with respect to our variable rate indebtedness.

Our Credit Agreement provides for revolving commitments in an aggregate principal amount of $400.0 million from a syndicate of banks and other financial institutions. The interest rates per annum applicable to loans under the Revolving Facility are, at the Company’s option, equal to either a base rate plus a margin ranging from 0.75% to 1.40% per annum or applicable LIBOR plus a margin ranging from 1.75% to 2.40% per annum, based on the debt to asset value ratio of the Company and its subsidiaries (subject to decrease at the Company’s election if the Company obtains certain specified investment grade ratings on its senior long term unsecured debt). Pursuant to the Amendment, the interest rates applicable to the Term Loan are, at the Company’s option, equal to a base rate plus a margin ranging from 0.95% to 1.60% per annum or applicable LIBOR plus a margin ranging from 1.95% to 2.60% per annum based on the debt to asset value ratio of the Company and its subsidiaries (subject to decrease at the Company’s election if the Company obtains certain specified investment grade ratings on its senior long term unsecured debt). As of September 30, 2018, we had a $100.0 million Term Loan outstanding and there was $90.0 million outstanding under the Revolving Facility.

An increase in interest rates could make the financing of any acquisition by us more costly as well as increase the costs of our variable rate debt obligations. Rising interest rates could also limit our ability to refinance our debt when it matures or cause us to pay higher interest rates upon refinancing and increase interest expense on refinanced indebtedness. Assuming a 100 basis point increase in the interest rates related to our variable rate debt, and assuming no change in our outstanding debt balance as described above, interest expense would have increased approximately $1.4 million for the nine months ended September 30, 2018.

We may, in the future, manage, or hedge, interest rate risks related to our borrowings by means of interest rate swap agreements. However, the REIT provisions of the Internal Revenue Code of 1986, as amended, substantially limit our ability to hedge our assets and liabilities. See “Risk Factors — Risks Related to Our Status as a REIT — Complying with REIT requirements may limit our ability to hedge effectively and may cause us to incur tax liabilities,” which is included in our Annual Report on Form 10-K for the year ended December 31, 2017. As of September 30, 2018, we had no swap agreements to hedge our interest rate risks. We also expect to manage our exposure to interest rate risk by maintaining a mix of fixed and variable rates for our indebtedness.

Item 4. Controls and Procedures.

Disclosure Controls and Procedures

We maintain disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (“Exchange Act”)) that are designed to ensure that information required to be disclosed in our reports under the Exchange Act is processed, recorded, summarized and reported within the time periods specified in the SEC’s rules and regulations and that such information is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow for timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

As of September 30, 2018, we carried out an evaluation, under the supervision and with the participation of management, including our Chief Executive Officer and Chief Financial Officer, regarding the effectiveness of our disclosure controls and procedures. Based on the foregoing, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective, at the reasonable assurance level, as of September 30, 2018.

Changes in Internal Control over Financial Reporting

36

There has been no change in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the quarter ended September 30, 2018, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II—OTHER INFORMATION

Item 1. Legal Proceedings.

The Company and its subsidiaries are and may become from time to time a party to various claims and lawsuits arising in the ordinary course of business, but none of the Company or any of its subsidiaries is, and none of their respective properties are, the subject of any material legal proceedings. Claims and lawsuits may include matters involving general or professional liability asserted against our tenants, which are the responsibility of our tenants and for which the Company is entitled to be indemnified by its tenants under the insurance and indemnification provisions in the applicable leases.

Item 1A. Risk Factors.

We have disclosed under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2017 risk factors which materially affect our business, financial condition, or results of operations. There have been no material changes from the risk factors previously disclosed.

Item 6. Exhibits.

Exhibit Number	Description of the Document
2.1	Separation and Distribution Agreement, dated as of May 23, 2014, by and between The Ensign Group, Inc. and CareTrust REIT, Inc. (Exhibit 2.1 to the Company’s Current Report on Form 8-K, filed on June 5, 2014, is incorporated herein by reference).
3.1	Articles of Amendment and Restatement of CareTrust REIT, Inc. (Exhibit 3.1 to the Company’s Registration Statement on Form 10, filed on May 13, 2014, is incorporated herein by reference).
3.2	Articles of Amendment, dated May 30, 2018, to the Articles of Amendment and Restatement of CareTrust REIT, Inc.  (Exhibit 3.1 to the Company’s Current Report on Form 8-K, filed on May 31, 2018, is incorporated herein by reference).
3.3	Amended and Restated Bylaws of CareTrust REIT, Inc. (Exhibit 3.1 to the Company’s Current Report on Form 8-K, filed on April 5, 2018, is incorporated herein by reference).
*31.1	Certification of Chief Executive Officer, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
*31.2	Certification of Chief Financial Officer, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
**32	Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
*101.INS	XBRL Instance Document
*101.SCH	XBRL Taxonomy Extension Schema Document
*101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document
*101.DEF	XBRL Taxonomy Extension Definition Linkbase Document
*101.LAB	XBRL Taxonomy Extension Label Linkbase Document
*101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document
* Filed herewith
** Furnished herewith

37

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	CareTrust REIT, Inc.
November 5, 2018	By:	/s/ Gregory K. Stapley
		Gregory K. Stapley
		President and Chief Executive Officer (duly authorized officer)
November 5, 2018	By:	/s/ William M. Wagner
		William M. Wagner
		Chief Financial Officer and Treasurer (principal financial officer and principal accounting officer)

38

EX-31.1

Exhibit 31.1

CERTIFICATION

I, Gregory K. Stapley, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of CareTrust REIT, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

By:	/s/ Gregory K. Stapley
	Gregory K. Stapley
	President and Chief Executive Officer

Date: November 5, 2018

EX-31.2

Exhibit 31.2

CERTIFICATION

I, William M. Wagner, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of CareTrust REIT, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

By:	/s/ William M. Wagner
	William M. Wagner
	Chief Financial Officer and Treasurer

Date: November 5, 2018

EX-32

Exhibit 32

Certification of Chief Executive Officer and

Chief Financial Officer Pursuant to

18 U.S.C. Section 1350, As Adopted Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report on Form 10-Q of CareTrust REIT, Inc. (the “Company”) for the quarterly period ended September 30, 2018, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Gregory K. Stapley, as President and Chief Executive Officer of the Company, and William M. Wagner, as Chief Financial Officer and Treasurer of the Company, each hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to their knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

	/s/ Gregory K. Stapley
Name:	Gregory K. Stapley
Title:	President and Chief Executive Officer
Date:	November 5, 2018
	/s/ William M. Wagner
Name:	William M. Wagner
Title:	Chief Financial Officer and Treasurer
Date:	November 5, 2018

XML

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2018	Nov. 02, 2018
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2018
Document Fiscal Year Focus	2018
Document Fiscal Period Focus	Q3
Trading Symbol	CTRE
Entity Registrant Name	CareTrust REIT, Inc.
Entity Central Index Key	0001590717
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Common Stock, Shares Outstanding		83,883,818

XML

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017
Assets:
Real estate investments, net	$ 1,189,449	$ 1,152,261
Other real estate investments, net	18,083	17,949
Cash and cash equivalents	15,745	6,909
Accounts and other receivables, net	12,384	5,254
Prepaid expenses and other assets	3,792	895
Deferred financing costs, net	904	1,718
Total assets	1,240,357	1,184,986
Liabilities and Equity:
Senior unsecured notes payable, net	294,963	294,395
Senior unsecured term loan, net	99,588	99,517
Unsecured revolving credit facility	90,000	165,000
Accounts payable and accrued liabilities	18,510	17,413
Dividends payable	17,246	14,044
Total liabilities	520,307	590,369
Commitments and contingencies
Equity:
Preferred stock, $0.01 par value; 100,000,000 shares authorized, no shares issued and outstanding as of September 30, 2018 and December 31, 2017	0	0
Common stock, $0.01 par value; 500,000,000 shares authorized, 83,353,226 and 75,478,202 shares issued and outstanding as of September 30, 2018 and December 31, 2017, respectively	834	755
Additional paid-in capital	915,235	783,237
Cumulative distributions in excess of earnings	(196,019)	(189,375)
Total equity	720,050	594,617
Total liabilities and equity	$ 1,240,357	$ 1,184,986

XML

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2018	Dec. 31, 2017
Statement of Financial Position [Abstract]
Preferred stock, par value (in usd per share)	$ 0.01	$ 0.01
Preferred stock, authorized (shares)	100,000,000	100,000,000
Preferred stock, issued (shares)	0	0
Preferred stock, outstanding (shares)	0	0
Common stock, par value (in usd per share)	$ 0.01	$ 0.01
Common stock, authorized (shares)	500,000,000	500,000,000
Common stock, issued (shares)	83,353,226	75,478,202
Common stock, outstanding (shares)	83,353,226	75,478,202

XML

Condensed Consolidated Income Statements - USD ($) shares in Thousands, $ in Thousands	3 Months Ended				9 Months Ended		12 Months Ended
	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017	Dec. 31, 2017
Revenues:
Rental income	$ 35,332			$ 29,404	$ 103,856	$ 85,254
Tenant reimbursements	2,990			2,543	8,974	7,253
Independent living facilities	871			825	2,515	2,407
Interest and other income	317			176	1,235	1,471
Total revenues	39,510			32,948	116,580	96,385
Expenses:
Depreciation and amortization	11,351			9,745	34,227	28,156
Interest expense	6,805			5,592	21,182	17,690
Loss on the extinguishment of debt	0			0	0	11,883
Property taxes	2,990			2,543	8,974	7,253
Independent living facilities	766			698	2,226	2,003
Impairment of real estate investment	0			0	0	890
General and administrative	3,088			3,059	9,638	8,426
Total expenses	25,000			21,637	76,247	76,301
Other income:
Gain on sale of real estate	0			0	2,051	0
Gain on disposition of other real estate investment	0			0	0	3,538
Net income	$ 14,510			$ 11,311	$ 42,384	$ 23,622	$ 25,874
Earnings per common share:
Basic (in usd per share)	$ 0.18			$ 0.15	$ 0.54	$ 0.33
Diluted (in usd per share)	$ 0.18			$ 0.15	$ 0.54	$ 0.33
Weighted-average number of common shares:
Basic (in shares)	81,490			75,471	77,811	71,693
Diluted (in shares)	81,490			75,471	77,811	71,693
Dividends declared per common share (in usd per share)	$ 0.205	$ 0.205	$ 0.205	$ 0.185	$ 0.615	$ 0.555	$ 0.74

XML

Condensed Consolidated Statements of Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Cumulative Distributions in Excess of Earnings
Beginning balance at Dec. 31, 2016	$ 452,430	$ 648	$ 611,475	$ (159,693)
Beginning balance (in shares) at Dec. 31, 2016		64,816,350
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net	170,319	$ 106	170,213
Issuance of common stock, net, (in shares)		10,573,089
Vesting of restricted common stock, net of shares withheld for employee taxes	(866)	$ 1	(867)
Vesting of restricted common stock, net of shares withheld for employee taxes (in shares)		88,763
Amortization of stock-based compensation	2,416		2,416
Common dividends ($0.615 and $0.74 per share for the nine months ended 9/30/2018 and year ended 12/31/2017, respectively) (in usd per share)	(55,556)			(55,556)
Net income	25,874			25,874
Ending balance at Dec. 31, 2017	594,617	$ 755	783,237	(189,375)
Ending balance (in shares) at Dec. 31, 2017		75,478,202
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net	130,550	$ 78	130,472
Issuance of common stock, net, (in shares)		7,760,723
Vesting of restricted common stock, net of shares withheld for employee taxes	(1,289)	$ 1	(1,290)
Vesting of restricted common stock, net of shares withheld for employee taxes (in shares)		114,301
Amortization of stock-based compensation	2,816		2,816
Common dividends ($0.615 and $0.74 per share for the nine months ended 9/30/2018 and year ended 12/31/2017, respectively) (in usd per share)	(49,028)			(49,028)
Net income	42,384			42,384
Ending balance at Sep. 30, 2018	$ 720,050	$ 834	$ 915,235	$ (196,019)
Ending balance (in shares) at Sep. 30, 2018		83,353,226

XML

Condensed Consolidated Statements of Equity (Parenthetical) - $ / shares	3 Months Ended				9 Months Ended		12 Months Ended
	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017	Dec. 31, 2017
Statement of Stockholders' Equity [Abstract]
Common dividends (in usd per share)	$ 0.205	$ 0.205	$ 0.205	$ 0.185	$ 0.615	$ 0.555	$ 0.74

XML

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Cash flows from operating activities:
Net income	$ 42,384	$ 23,622
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization (including a below-market ground lease)	34,240	28,168
Amortization of deferred financing costs	1,453	1,615
Loss on the extinguishment of debt	0	11,883
Amortization of stock-based compensation	2,816	1,792
Straight-line rental income	(1,631)	(117)
Noncash interest income	(228)	(496)
Gain on sale of real estate	(2,051)	0
Interest income distribution from other real estate investment	0	1,500
Impairment of real estate investment	0	890
Change in operating assets and liabilities:
Accounts and other receivables, net	(5,499)	(6,948)
Prepaid expenses and other assets	(159)	(182)
Accounts payable and accrued liabilities	1,065	5,206
Net cash provided by operating activities	72,390	66,933
Cash flows from investing activities:
Acquisitions of real estate	(75,621)	(222,463)
Improvements to real estate	(5,401)	(621)
Purchases of equipment, furniture and fixtures	(1,262)	(359)
Investment in real estate mortgage and other loans receivable	(2,598)	0
Principal payments received on real estate mortgage and other loans receivable	893	0
Sale of other real estate investment	0	7,500
Escrow deposits for acquisitions of real estate	(1,000)	(1,000)
Net proceeds from the sale of real estate	13,004	0
Net cash used in investing activities	(71,985)	(216,943)
Cash flows from financing activities:
Proceeds from the issuance of common stock, net	130,546	170,414
Proceeds from the issuance of senior unsecured notes payable	0	300,000
Borrowings under unsecured revolving credit facility	60,000	158,000
Payments on senior unsecured notes payable	0	(267,639)
Payments on unsecured revolving credit facility	(135,000)	(158,000)
Payments of deferred financing costs	0	(6,047)
Net-settle adjustment on restricted stock	(1,288)	(866)
Dividends paid on common stock	(45,827)	(38,544)
Net cash provided by financing activities	8,431	157,318
Net increase in cash and cash equivalents	8,836	7,308
Cash and cash equivalents, beginning of period	6,909	7,500
Cash and cash equivalents, end of period	15,745	14,808
Supplemental disclosures of cash flow information:
Interest paid	15,772	19,349
Supplemental schedule of noncash operating, investing and financing activities:
Increase in dividends payable	3,202	2,971
Application of escrow deposit to acquisition of real estate	$ 0	$ 700

XML

Organization

9 Months Ended

Sep. 30, 2018

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Organization

ORGANIZATION

Description of Business—CareTrust REIT, Inc.’s (“CareTrust REIT” or the “Company”) primary business consists of acquiring, financing, developing and owning real property to be leased to third-party tenants in the healthcare sector. As of September 30, 2018, the Company owned and leased to independent operators, including The Ensign Group, Inc. (“Ensign”), 190 skilled nursing, multi-service campuses, assisted living and independent living facilities consisting of 18,693 operational beds and units located in Arizona, California, Colorado, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Maryland, Michigan, Minnesota, Montana, Nebraska, Nevada, New Mexico, North Carolina, Ohio, Oregon, South Dakota, Texas, Utah, Virginia, Washington and Wisconsin. The Company also owns and operates three independent living facilities which have a total of 264 units located in Texas and Utah. As of September 30, 2018, the Company also had other real estate investments consisting of two preferred equity investments totaling $5.7 million and a mortgage loan receivable of $12.3 million.

XML

Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2018

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation—The accompanying condensed consolidated financial statements of the Company reflect, for all periods presented, the historical financial position, results of operations and cash flows of the Company and its consolidated subsidiaries consisting of (i) the net-leased skilled nursing, multi-service campuses, assisted living and independent living facilities, (ii) the operations of the three independent living facilities that the Company owns and operates; and (iii) the preferred equity investments and the mortgage loan receivable.

The accompanying condensed consolidated financial statements of the Company were prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and Article 10 of Regulation S-X. Accordingly, the condensed consolidated financial statements do not include all of the disclosures required by GAAP for a complete set of annual audited financial statements. The condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2017. In the opinion of management, all adjustments which are of a normal and recurring nature and considered necessary for a fair presentation of the results of the interim periods presented have been included. The results of operations for the interim periods are not necessarily indicative of results for the full year. All intercompany transactions and account balances within the Company have been eliminated.

Estimates and Assumptions—The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Management believes that the assumptions and estimates used in preparation of the underlying consolidated financial statements are reasonable. Actual results, however, could differ from those estimates and assumptions.

Real Estate Depreciation and Amortization—Real estate costs related to the acquisition and improvement of properties are capitalized and amortized over the expected useful life of the asset on a straight-line basis. Repair and maintenance costs are charged to expense as incurred and significant replacements and betterments are capitalized. Repair and maintenance costs include all costs that do not extend the useful life of the real estate asset. The Company considers the period of future benefit of an asset to determine its appropriate useful life. Expenditures for tenant improvements are capitalized and amortized over the shorter of the tenant’s lease term or expected useful life. The Company anticipates the estimated useful lives of its assets by class to be generally as follows:

Buildings	25-40 years
Building improvements	10-25 years
Tenant improvements	Shorter of lease term or expected useful life
Integral equipment, furniture and fixtures	5 years
Identified intangible assets	Shorter of lease term or expected useful life

Real Estate Acquisition Valuation— In accordance with Accounting Standards Codification (“ASC”) 805, Business Combinations, the Company records the acquisition of income-producing real estate as a business combination. If the acquisition does not meet the definition of a business, the Company records the acquisition as an asset acquisition. Under both methods, all assets acquired and liabilities assumed are measured at their acquisition date fair values. For transactions that are business combinations, acquisition costs are expensed as incurred and restructuring costs that do not meet the definition of a liability at the acquisition date are expensed in periods subsequent to the acquisition date. For transactions that are asset acquisitions, acquisition costs are capitalized as incurred.

The Company assesses the acquisition date fair values of all tangible assets, identifiable intangibles and assumed liabilities using methods similar to those used by independent appraisers, generally utilizing a discounted cash flow analysis that applies appropriate discount and/or capitalization rates and available market information. Estimates of future cash flows are based on a number of factors, including historical operating results, known and anticipated trends, and market and economic conditions. The fair value of tangible assets of an acquired property considers the value of the property as if it were vacant.

Estimates of the fair values of the tangible assets, identifiable intangibles and assumed liabilities require the Company’s management to make significant assumptions to estimate market lease rates, property-operating expenses, carrying costs during lease-up periods, discount rates, market absorption periods, and the number of years the property will be held for investment. The use of inappropriate assumptions would result in an incorrect valuation of the Company’s acquired tangible assets, identifiable intangibles and assumed liabilities, which would impact the amount of the Company’s net income.

As part of the Company’s real estate acquisitions, the Company may commit to provide contingent payments to a seller or lessee (e.g., an earn-out payable upon the applicable property achieving certain financial metrics). Typically, when the contingent payments are funded, cash rent is increased by the amount funded multiplied by a rate stipulated in the agreement. Generally, if the contingent payment is an earn-out provided to the seller, the payment is capitalized to the property’s basis. If the contingent payment is an earn-out provided to the lessee, the payment is recorded as a lease incentive and is amortized as a yield adjustment over the life of the lease.

Impairment of Long-Lived Assets—At each reporting period, management evaluates the Company’s real estate investments for impairment indicators, including the evaluation of the useful lives of the Company’s assets. Management also assesses the carrying value of the Company’s real estate investments whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. The judgment regarding the existence of impairment indicators is based on factors such as, but not limited to, market conditions, operator performance and legal structure. If indicators of impairment are present, management evaluates the carrying value of the related real estate investments in relation to the future undiscounted cash flows of the underlying facilities. Provisions for impairment losses related to long-lived assets are recognized when expected future undiscounted cash flows are determined to be less than the carrying values of the assets. An adjustment is made to the net carrying value of the real estate investments for the excess of carrying value over fair value. All impairments are taken as a period cost at that time, and depreciation is adjusted going forward to reflect the new value assigned to the asset.

If the Company decides to sell real estate properties, it evaluates the recoverability of the carrying amounts of the assets. If the evaluation indicates that the carrying value is not recoverable from estimated net sales proceeds, the property is written down to estimated fair value less costs to sell.

In the event of impairment, the fair value of the real estate investment is determined by market research, which includes valuing the property in its current use as well as other alternative uses, and involves significant judgment. Management’s estimates of cash flows and fair values of the properties are based on current market conditions and consider matters such as rental rates and occupancies for comparable properties, recent sales data for comparable properties, and, where applicable, contracts or the results of negotiations with purchasers or prospective purchasers. The Company’s ability to accurately estimate future cash flows and estimate and allocate fair values impacts the timing and recognition of impairments. While the Company believes its assumptions are reasonable, changes in these assumptions may have a material impact on financial results.

Other Real Estate Investments, Net — Included in Other Real Estate Investments, Net are two preferred equity investments and one mortgage loan receivable. Preferred equity investments are accounted for at unpaid principal balance, plus accrued return, net of reserves. The Company recognizes return income on a quarterly basis based on the outstanding investment including any accrued and unpaid return, to the extent there is outside contributed equity or cumulative earnings from operations. As the preferred member of the joint venture, the Company is not entitled to share in the joint venture’s earnings or losses. Rather, the Company is entitled to receive a preferred return, which is deferred if the cash flow of the joint venture is insufficient to pay all of the accrued preferred return. The unpaid accrued preferred return is added to the balance of the preferred equity investment up to the estimated economic outcome assuming a hypothetical liquidation of the book value of the joint venture. The Company anticipates any unpaid accrued preferred return, whether recorded or unrecorded by the Company, will be repaid upon redemption or as available cash flow is distributed from the joint venture.

The Company’s mortgage loan receivable is recorded at amortized cost, which consists of the outstanding unpaid principal balance, net of unamortized costs and fees directly associated with the origination of the loan.

Interest income on the Company’s mortgage loan receivable is recognized over the life of the investment using the interest method. Origination costs and fees directly related to mortgage loans receivable are amortized over the term of the loan as an adjustment to interest income.

The Company evaluates at each reporting period each of its other real estate investments for indicators of impairment. An investment is impaired when, based on current information and events, it is probable that the Company will be unable to collect all amounts due according to the existing contractual terms. A reserve is established for the excess of the carrying value of the investment over its fair value.

Cash and Cash Equivalents—Cash and cash equivalents consist of bank term deposits and money market funds with original maturities of three months or less at time of purchase and therefore approximate fair value. The fair value of these investments is determined based on “Level 1” inputs, which consist of unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets. The Company places its cash and short-term investments with high credit quality financial institutions.

The Company’s cash and cash equivalents balance periodically exceeds federally insurable limits. The Company monitors the cash balances in its operating accounts and adjusts the cash balances as appropriate; however, these cash balances could be impacted if the underlying financial institutions fail or are subject to other adverse conditions in the financial markets. To date, the Company has experienced no loss or lack of access to cash in its operating accounts.

Prepaid expenses and other assets—Prepaid expenses and other assets consist of prepaid expenses, deposits, pre-acquisition costs and other loans receivable. Included in other loans receivable at September 30, 2018 is a bridge loan to Eduro Healthcare, LLC, (“Eduro”) under which the Company agreed to fund up to $4.0 million until the earlier of (i) the date Eduro enters into a new credit facility, (ii) the date that Eduro terminates as to any facility, or (iii) November 30, 2018. Borrowings under the bridge loan accrue interest at a base rate of greater of prime rate or 4.75% plus margin of 2.5%. The borrowings under the bridge loan accrue interest and, as of September 30, 2018, approximately $1.8 million has been drawn and was outstanding.

Deferred Financing Costs—External costs incurred from placement of the Company’s debt are capitalized and amortized on a straight-line basis over the terms of the related borrowings, which approximates the effective interest method. Deferred financing costs on the Company’s Notes and Term Loan (each as defined in Note 6, Debt, below) are netted against the outstanding debt amounts on the Company’s balance sheet. Deferred financing costs on the Company’s Revolving Facility (as defined in Note 6, Debt, below) are included in assets on the Company’s balance sheet. Amortization of deferred financing costs is classified as interest expense in the Company’s condensed consolidated income statements. Accumulated amortization of deferred financing costs was $4.6 million and $3.2 million at September 30, 2018 and December 31, 2017, respectively.

When financings are terminated, unamortized deferred financing costs, as well as charges incurred for the termination, are expensed at the time the termination is made. Gains and losses from the extinguishment of debt are presented within income from continuing operations in the Company’s condensed consolidated income statements.

Revenue Recognition —The Company recognizes rental revenue, including rental abatements, lease incentives and contractual fixed increases attributable to operating leases, if any, from tenants under lease arrangements with minimum fixed and determinable increases on a straight-line basis over the non-cancellable term of the related leases when collectability is reasonably assured. The Company evaluates the collectability of rents and other receivables on a regular basis based on factors including, among others, payment history, the operations, the asset type and current economic conditions. Tenant recoveries related to the reimbursement of real estate taxes, insurance, repairs and maintenance, and other operating expenses are recognized as revenue in the period the expenses are incurred and presented gross if the Company is the primary obligor and, with respect to purchasing goods and services from third-party suppliers, has discretion in selecting the supplier and bears the associated credit risk. For each of the three and nine months ended September 30, 2018 and 2017, such tenant reimbursement revenues consisted of real estate taxes. Contingent revenue, if any, is not recognized until all possible contingencies have been eliminated.

If the Company’s evaluation of applicable factors indicates it may not recover the full value of the receivable, the Company provides a reserve against the portion of the receivable that it estimates may not be recovered. This analysis requires the Company to determine whether there are factors indicating a receivable may not be fully collectible and to estimate the amount of the receivable that may not be collected. As of September 30, 2018 and December 31, 2017, Accounts and other receivables, net included $1.3 million and $0.8 million for unpaid cash rents and $11.6 million and $9.6 million for other tenant receivables, respectively, of which $10.4 million was reserved as of September 30, 2018 and December 31, 2017, related to the properties previously net leased to subsidiaries of Pristine Senior Living, LLC (“Pristine”). See Note 3, Real Estate Investments, Net for further discussion.

The Company evaluates the collectability of straight-line rent receivable balances on an ongoing basis and provides reserves against receivables it determines may not be fully recoverable. The Company recorded straight-line rental income of $0.7 million and $2,000 during the three months ended September 30, 2018 and 2017, respectively. The Company recorded straight-line rental income of $1.6 million and $0.1 million during the nine months ended September 30, 2018 and 2017, respectively. Accounts and other receivables, net included $2.1 million and $0.5 million in straight-line rents receivable at September 30, 2018 and December 31, 2017, respectively.

Income Taxes—The Company has elected to be taxed as a real estate investment trust (“REIT”) under the Internal Revenue Code of 1986, as amended (the “Code”). The Company believes it has been organized and has operated, and the Company intends to continue to operate, in a manner to qualify for taxation as a REIT under the Code. To qualify as a REIT, the Company must meet certain organizational and operational requirements, including a requirement to distribute to its stockholders at least 90% of the Company’s annual REIT taxable income (computed without regard to the dividends paid deduction or net capital gain and which does not necessarily equal net income as calculated in accordance with GAAP). As a REIT, the Company generally will not be subject to federal income tax to the extent it distributes as qualifying dividends all of its REIT taxable income to its stockholders. If the Company fails to qualify as a REIT in any taxable year, it will be subject to federal income tax on its taxable income at regular corporate income tax rates and generally will not be permitted to qualify for treatment as a REIT for federal income tax purposes for the four taxable years following the year during which qualification is lost unless the Internal Revenue Service grants the Company relief under certain statutory provisions.

Stock-Based Compensation—The Company accounts for share-based payment awards in accordance with ASC Topic 718, Compensation – Stock Compensation (“ASC 718”). ASC 718 requires that the cost resulting from all share-based payment transactions be recognized in the financial statements. ASC 718 requires all entities to apply a fair value-based measurement method in accounting for share-based payment transactions with directors, officers and employees except for equity instruments held by employee share ownership plans. See Note 8, Stock-Based Compensation, for further discussion.

Concentration of Credit Risk—The Company is subject to concentrations of credit risk consisting primarily of operating leases on the Company’s owned properties. See Note 11, Concentration of Risk, for a discussion of major operator concentration.

Segment Disclosures —The Financial Accounting Standards Board (“FASB”) accounting guidance regarding disclosures about segments of an enterprise and related information establishes standards for the manner in which public business enterprises report information about operating segments. The Company has one reportable segment consisting of investments in healthcare-related real estate assets.

Earnings (Loss) Per Share—The Company calculates earnings (loss) per share (“EPS”) in accordance with ASC Topic 260, Earnings Per Share. Basic EPS is computed by dividing net income applicable to common stock by the weighted-average number of common shares outstanding during the period. Diluted EPS reflects the additional dilution for all potentially-dilutive securities.

Beds, Units, Occupancy and Other Measures—Beds, units, occupancy and other non-financial measures used to describe real estate investments included in these Notes to the condensed consolidated financial statements are presented on an unaudited basis and are not subject to review by the Company’s independent auditors in accordance with the standards of the Public Company Accounting Oversight Board.

Recent Accounting Pronouncements

In February 2016, the FASB issued Accounting Standards Update (“ASU”) No. 2016-02, Leases (Topic 842) (“ASC 842”) that sets out the principles for the recognition, measurement, presentation, and disclosure of leases for both parties to a contract (i.e., lessees and lessors). ASC 842 requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase of the leased asset by the lessee. This classification will determine whether the lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. Leases with a term of 12 months or less will be accounted for similar to existing guidance for operating leases today. ASC 842 is expected to result in the recognition of a right-to-use asset and related liability to account for the Company’s future obligations for which it is the lessee. As of September 30, 2018, the remaining contractual payments under the Company’s lease agreements aggregated $0.2 million. Additionally, ASC 842 will require that lessees and lessors capitalize, as initial direct costs, only those costs that are incurred due to the execution of a lease. Under ASC 842, allocated payroll costs and other costs that are incurred regardless of whether the lease is obtained will no longer be capitalized as initial direct costs and instead will be expensed as incurred. During the nine months ended September 30, 2018, the Company did not capitalize any allocated payroll costs. Lessors will continue to account for leases using an approach that is substantially equivalent to existing guidance for sales-type leases, direct financing leases, and operating leases. ASC 842 is effective for reporting periods beginning after December 15, 2018, with early adoption permitted. Tenant recoveries that qualify as lease components, which relate to the right to use the leased asset (e.g., property taxes, insurance), will be accounted for under ASC 842. Tenant recoveries that qualify as non-lease components, which relate to payments for goods or services that are transferred separately from the right to use the underlying asset, including tenant recoveries related to payments for maintenance activities and common area expenses, will be accounted for under the new revenue recognition ASC 606 (as defined below) upon adoption of the new lease ASC 842 on January 1, 2019 for any new lease or any modified lease.

In July 2018, the FASB finalized an amendment to ASC 842 that allows lessors to elect, as a practical expedient, not to separate lease and non-lease components (such as services rendered) in a contract for the purpose of revenue recognition and disclosure. The practical expedient can only be applied to leasing arrangements for which (i) the timing and pattern of transfer are the same for the lease and non-lease components and (ii) the lease component, if accounted for separately, would be classified as an operating lease. Under this practical expedient, contracts that are predominantly lease-based would be accounted for under ASC 842, and contracts that are predominantly service-based would be accounted for under ASC 606. Further, this amendment also provides for an additional (and optional) transition method to adopt the new lease requirements by allowing entities to initially apply the requirements by recognizing a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. The Company plans to elect this practical expedient and apply the optional transition method for its operating leases, using the cumulative-effect adjustment to the opening balance sheet as of January 1, 2019. The Company is still evaluating the full impact of the adoption of ASC 842 on January 1, 2019 to its consolidated financial statements.

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326) (“ASU 2016-13”) that changes the impairment model for most financial instruments by requiring companies to recognize an allowance for expected losses, rather than incurred losses as required currently by the other-than-temporary impairment model. ASU 2016-13 will apply to most financial assets measured at amortized cost and certain other instruments, including trade and other receivables, loans, held-to-maturity debt securities, net investments in leases, and off-balance-sheet credit exposures (e.g., loan commitments). ASU 2016-13 is effective for reporting periods beginning after December 15, 2019, with early adoption permitted, and will be applied as a cumulative adjustment to retained earnings as of the effective date. The Company is currently assessing the potential effect the adoption of ASU 2016-13 will have on the Company’s condensed consolidated financial statements.

Recent Accounting Standards Adopted by the Company

On January 1, 2018, the Company adopted ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606) (“ASC 606”). ASC 606 requires an entity to recognize the revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. ASC 606 supersedes the revenue requirements in Revenue Recognition (Topic 605) and most industry-specific guidance throughout the Industry Topics of the ASC. ASC 606 does not apply to lease contracts within the scope of Leases (Topic 840). Based on a review of the Company’s revenue streams from independent living facilities, the Company’s consolidated financial statements include revenues generated through services provided to residents of independent living facilities that are ancillary to the residents’ contractual rights to occupy living and common-area space at the communities, such as meals, transportation and activities. While these revenue streams are subject to the application of Topic 606, the revenues associated with these services are generally recognized on a monthly basis, the period in which the related services are performed. Therefore, the adoption of ASC 606 did not have a material effect on the Company’s condensed consolidated financial statements since the revenue recognition under ASC 606 is similar to the recognition pattern prior to the adoption of ASC 606.

XML

Real Estate Investments, Net

9 Months Ended

Sep. 30, 2018

Real Estate [Abstract]

Real Estate Investments, Net

REAL ESTATE INVESTMENTS, NET

The following tables summarize the Company’s investment in owned properties as of September 30, 2018 and December 31, 2017 (dollars in thousands):

	September 30, 2018			December 31, 2017
Land	$	163,665		$	151,879
Buildings and improvements	1,168,192			1,114,605
Integral equipment, furniture and fixtures	85,592			80,729
Identified intangible assets	2,382			2,382
Real estate investments	1,419,831			1,349,595
Accumulated depreciation and amortization	(230,382		)	(197,334		)
Real estate investments, net	$	1,189,449		$	1,152,261

As of September 30, 2018, 92 of the Company’s 193 facilities were leased to subsidiaries of Ensign under eight master leases (the “Ensign Master Leases”) which commenced on June 1, 2014. The obligations under the Ensign Master Leases are guaranteed by Ensign. A default by any subsidiary of Ensign with regard to any facility leased pursuant to an Ensign Master Lease will result in a default under all of the Ensign Master Leases. As of September 30, 2018, annualized revenues from the Ensign Master Leases were $59.1 million and are escalated annually by an amount equal to the product of (1) the lesser of the percentage change in the Consumer Price Index (“CPI”) (but not less than zero) or 2.5%, and (2) the prior year’s rent. In addition to rent, the subsidiaries of Ensign that are tenants under the Ensign Master Leases are solely responsible for the costs related to the leased properties (including property taxes, insurance, and maintenance and repair costs).

As of September 30, 2018, 98 of the Company’s 193 facilities were leased to various other operators under triple-net leases. All of these leases contain annual escalators based on CPI, some of which are subject to a cap, or fixed rent escalators.

The Company’s three remaining properties as of September 30, 2018 are the independent living facilities that the Company owns and operates.

The Company has only two identified intangible assets which relate to a below-market ground lease and three acquired operating leases. The ground lease has a remaining term of 80 years.

As of September 30, 2018, the Company’s total future minimum rental revenues for all of its tenants were (dollars in thousands):

Year	Amount
Remaining 2018	$	35,223
2019	141,977
2020	142,525
2021	143,094
2022	143,678
Thereafter	1,169,183
	$	1,775,680

Recent Real Estate Acquisitions

The following table summarizes the Company’s acquisitions for the nine months ended September 30, 2018 (dollar amounts in thousands):

Type of Property	Purchase Price(1)			Initial Annual Cash Rent		Number of Properties		Number of Beds/Units(2)
Skilled nursing	$	57,074		$	5,144	7		621
Multi-service campuses	20,277		(3)	1,564		1		122
Assisted living	—			—		—		—
Total	$	77,351		$	6,708	$	8	743

(1) Purchase price includes capitalized acquisition costs.

(2) The number of beds/units includes operating beds at acquisition date.

(3) The Company has committed to fund approximately $1.4 million in revenue-producing capital expenditures over the next 24 months based on the in-place lease yield, which is included in the purchase price.

Lease Amendments and Related Agreements

Pristine Lease Termination. On February 27, 2018, the Company announced that it entered into a Lease Termination Agreement (the “LTA”) with Pristine for its nine remaining properties, with a target completion date of April 30, 2018. Under the LTA, Pristine agreed to continue to operate the facilities until possession could be surrendered, and the operations therein transitioned, to operator(s) designated by the Company. Among other things, Pristine also agreed to amend certain pending agreements to sell the rights to certain Ohio Medicaid beds (the “Bed Sales Agreements”) and cooperate with the Company to turn over any claim or control it might have had with respect to the sale process and the proceeds thereof, if any, to the Company. The transactions were timely completed, and on May 1, 2018, Trio Healthcare, Inc (“Trio”) took over operations in the seven facilities based primarily in the Dayton, Ohio area under a new 15-year master lease, while Hillstone Healthcare, Inc. (“Hillstone”) assumed the operation of the two facilities in Willard and Toledo, Ohio under a new 12-year master lease. In addition, amendments to the Bed Sales Agreements were subsequently executed, confirming the Company as the sole seller of the bed rights and the sole recipient of any proceeds therefrom. The aggregate annual base rent due under the new master leases with Trio and Hillstone is approximately $10.0 million, subject to CPI-based or fixed escalators.

Under the LTA, the Company agreed, upon Pristine’s full performance of the terms thereof, to terminate Pristine’s master lease and all future obligations of the tenant thereunder; however, under the terms of the master lease the Company’s security interest in Pristine’s accounts receivable has survived any such termination. Such security interest was subject to the prior lien and security interest of Pristine’s working capital lender, Capital One, National Association (“CONA”), with whom the Company has an existing intercreditor agreement that defines the relative rights and responsibilities of CONA and with its respect to the loan and lease collateral represented by Pristine’s accounts receivable and the Company’s respective security interests therein.

Sale of Real Estate Investments

During the nine months ended September 30, 2018, the Company sold three assisted living facilities consisting of 102 units located in Idaho with an aggregate carrying value of $10.9 million for an aggregate price of $13.0 million. In connection with the sale, the Company recognized a gain of $2.1 million.

Impairment of Real Estate Investment

During the nine months ended September 30, 2017, the Company recorded an impairment loss of $0.9 million related to its investment in La Villa Rehab & Healthcare Center (“La Villa”). In April 2017, the Company and Ensign mutually determined that La Villa had reached the natural end of its useful life as a skilled nursing facility and that the facility was no longer economically viable, the improvements thereon could not be economically repurposed to any other use, and the cost to remove the obsolete improvements and reclaim the underlying land for redevelopment was expected to exceed the market value of the land. Ensign agreed to wind up and terminate the operations of the facility and the Company transferred title to the property to Ensign. There was no adjustment to the contractual rent under the applicable master lease.

XML

Other Real Estate Investments

9 Months Ended

Sep. 30, 2018

Real Estate [Abstract]

Other Real Estate Investments

OTHER REAL ESTATE INVESTMENTS

In July 2016, the Company completed a $2.2 million preferred equity investment with an affiliate of Cascadia Development, LLC. The preferred equity investment yields a return equal to prime plus 9.5% but in no event less than 12.0% calculated on a quarterly basis on the outstanding carrying value of the investment. The investment was used to develop a 99-bed skilled nursing facility in Nampa, Idaho. In connection with its investment, CareTrust REIT holds an option to purchase the development at a fixed-formula price upon stabilization, with an initial lease yield of at least 9.0%. The project was completed in the fourth quarter 2017 and began lease-up during the first quarter of 2018.

In September 2016, the Company completed a $2.3 million preferred equity investment with an affiliate of Cascadia Development, LLC. The preferred equity investment yields a return equal to prime plus 9.5% but in no event less than 12.0% calculated on a quarterly basis on the outstanding carrying value of the investment. The investment was used to develop a 99-bed skilled nursing facility in Boise, Idaho. In connection with its investment, CareTrust REIT holds an option to purchase the development at a fixed-formula price upon stabilization, with an initial lease yield of at least 9.0%. The project was completed in the first quarter 2018 and began lease-up in the second quarter of 2018.

During the three months ended September 30, 2017, the Company recognized $0.2 million in interest income from its preferred equity investments. The Company recognized no interest income from its preferred equity investments in the three months ended September 30, 2018. During the nine months ended September 30, 2018 and 2017, the Company recognized $0.2 million and $1.5 million, respectively, in interest income from its preferred equity investments, of which $0 and $975,000, respectively, was received in cash. Any unpaid amounts were added to the outstanding carrying values of the preferred equity investments.

In October 2017, the Company provided the Providence Group a mortgage loan secured by a skilled nursing facility for approximately $12.5 million, which bears a fixed interest rate of 9%. The mortgage loan requires Providence Group to make monthly principal and interest payments and is set to mature on October 26, 2020. During the three and nine months ended September 30, 2018, the Company recognized $0.3 million and $0.9 million, respectively, of interest income related to the mortgage loan.

XML

Fair Value Measurements

9 Months Ended

Sep. 30, 2018

Fair Value Disclosures [Abstract]

Fair Value Measurements

FAIR VALUE MEASUREMENTS

Under GAAP, the Company is required to measure certain financial instruments at fair value on a recurring basis. In addition, the Company is required to measure other financial instruments and balances at fair value on a non-recurring basis (e.g., carrying value of impaired long-lived assets). Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The GAAP fair value framework uses a three-tiered approach. Fair value measurements are classified and disclosed in one of the following three categories:

• Level 1: unadjusted quoted prices in active markets that are accessible at the measurement date for identical assets or liabilities;

• Level 2: quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which significant inputs and significant value drivers are observable in active markets; and

• Level 3: prices or valuation techniques where little or no market data is available that requires inputs that are both significant to the fair value measurement and unobservable.

Financial Instruments: Considerable judgment is necessary to estimate the fair value of financial instruments. The estimates of fair value presented herein are not necessarily indicative of the amounts that could be realized upon disposition of the financial instruments. A summary of the face values, carrying amounts and fair values of the Company’s financial instruments as of September 30, 2018 and December 31, 2017 using Level 2 inputs for the Notes (as defined in Note 6, Debt, below), and Level 3, inputs for all other financial instruments, is as follows (dollars in thousands):

	September 30, 2018						December 31, 2017
	Face Value		Carrying Amount		Fair Value		Face Value		Carrying Amount		Fair Value
Financial assets:
Preferred equity investments	$	4,531	$	5,746	$	6,022	$	4,531	$	5,550	$	5,423
Mortgage loan receivable	12,423		12,337		12,423		12,517		12,399		12,517
Financial liabilities:
Senior unsecured notes payable	$	300,000	$	294,963	$	294,000	$	300,000	$	294,395	$	307,500

Cash and cash equivalents, accounts receivable, and accounts payable and accrued liabilities: These balances approximate their fair values due to the short-term nature of these instruments.

Other loans receivable: The carrying amounts were accounted for at the unpaid loan balance. These balances approximate their fair values due to the short-term nature of these instruments.

Preferred equity investments: The carrying amounts were accounted for at the unpaid principal balance, plus accrued return, net of reserves, assuming a hypothetical liquidation of the book values of the joint ventures. The fair values of the preferred equity investments were estimated using an internal valuation model that considered the expected future cash flows of the investment, the underlying collateral value and other credit enhancements.

Mortgage loan receivable: The mortgage loan receivable is recorded at amortized cost, which consists of the outstanding unpaid principal balance, net of unamortized costs and fees directly associated with the origination of the loan. The fair values of the mortgage loan receivable were estimated using an internal valuation model that considered the expected future cash flows of the investment, the underlying collateral value and other credit enhancements.

Senior unsecured notes payable: The fair value of the Notes (as defined below) was determined using third-party quotes derived from orderly trades.

Unsecured revolving credit facility and senior unsecured term loan: The fair values approximate their carrying values as the interest rates are variable and approximate prevailing market interest rates for similar debt arrangements.

XML

Debt

9 Months Ended

Sep. 30, 2018

Debt Disclosure [Abstract]

Debt

DEBT

The following table summarizes the balance of the Company’s indebtedness as of September 30, 2018 and December 31, 2017 (dollars in thousands):

	September 30, 2018							December 31, 2017
	Principal Amount		Deferred Loan Fees			Carrying Value		Principal Amount		Deferred Loan Fees			Carrying Value
Senior unsecured notes payable	$	300,000	$	(5,037	)	$	294,963	$	300,000	$	(5,605	)	$	294,395
Senior unsecured term loan	100,000		(412		)	99,588		100,000		(483		)	99,517
Unsecured revolving credit facility	90,000		—			90,000		165,000		—			165,000
	$	490,000	$	(5,449	)	$	484,551	$	565,000	$	(6,088	)	$	558,912

Senior Unsecured Notes Payable

On May 10, 2017, the Company’s wholly owned subsidiary, CTR Partnership, L.P. (the “Operating Partnership”), and its wholly owned subsidiary, CareTrust Capital Corp. (together with the Operating Partnership, the “Issuers”), completed an underwritten public offering of $300.0 million aggregate principal amount of 5.25% Senior Notes due 2025 (the “Notes”). The Notes were issued at par, resulting in gross proceeds of $300.0 million and net proceeds of approximately $294.0 million after deducting underwriting fees and other offering expenses. The Company used the net proceeds from the offering of the Notes to redeem all $260.0 million aggregate principal amount outstanding of its 5.875% Senior Notes due 2021, including payment of the redemption price at 102.938% and all accrued and unpaid interest thereon. The Company used the remaining portion of the net proceeds of the offering to pay borrowings outstanding under its senior unsecured revolving credit facility. The Notes mature on June 1, 2025 and bear interest at a rate of 5.25% per year. Interest on the Notes is payable on June 1 and December 1 of each year, beginning on December 1, 2017.

The Issuers may redeem the Notes any time before June 1, 2020 at a redemption price of 100% of the principal amount of the Notes redeemed plus accrued and unpaid interest on the Notes, if any, to, but not including, the redemption date, plus a “make-whole” premium described in the indenture governing the Notes and, at any time on or after June 1, 2020, at the redemption prices set forth in the indenture. At any time on or before June 1, 2020, up to 40% of the aggregate principal amount of the Notes may be redeemed with the net proceeds of certain equity offerings if at least 60% of the originally issued aggregate principal amount of the Notes remains outstanding. In such case, the redemption price will be equal to 105.25% of the aggregate principal amount of the Notes to be redeemed plus accrued and unpaid interest, if any, to, but not including, the redemption date. If certain changes of control of the Company occur, holders of the Notes will have the right to require the Issuers to repurchase their Notes at 101% of the principal amount plus accrued and unpaid interest, if any, to, but not including, the repurchase date.

The obligations under the Notes are fully and unconditionally guaranteed, jointly and severally, on an unsecured basis, by the Company and certain of the Company’s wholly owned existing and, subject to certain exceptions, future material subsidiaries (other than the Issuers); provided, however, that such guarantees are subject to automatic release under certain customary circumstances, as described in Note 12, Summarized Condensed Consolidating Information.

The indenture contains customary covenants such as limiting the ability of the Company and its restricted subsidiaries to: incur or guarantee additional indebtedness; incur or guarantee secured indebtedness; pay dividends or distributions on, or redeem or repurchase, capital stock; make certain investments or other restricted payments; sell assets; enter into transactions with affiliates; merge or consolidate or sell all or substantially all of their assets; and create restrictions on the ability of the Issuers and their restricted subsidiaries to pay dividends or other amounts to the Issuers. The indenture also requires the Company and its restricted subsidiaries to maintain a specified ratio of unencumbered assets to unsecured indebtedness. These covenants are subject to a number of important and significant limitations, qualifications and exceptions. The indenture also contains customary events of default.

As of September 30, 2018, the Company was in compliance with all applicable financial covenants under the indenture.

Unsecured Revolving Credit Facility and Term Loan

On August 5, 2015, the Company, CareTrust GP, LLC, the Operating Partnership, as the borrower, and certain of its wholly-owned subsidiaries entered into a credit and guaranty agreement with KeyBank National Association, as administrative agent, an issuing bank and swingline lender, and the lenders party thereto (the “Credit Agreement”). The Credit Agreement initially provided for an unsecured asset-based revolving credit facility (the “Revolving Facility”) with commitments in an aggregate principal amount of $300.0 million from a syndicate of banks and other financial institutions, and an accordion feature that allowed the Operating Partnership to increase the borrowing availability by up to an additional $200.0 million. A portion of the proceeds of the Revolving Facility were used to pay off and terminate the Company’s existing secured asset-based revolving credit facility under a credit agreement dated May 30, 2014, with SunTrust Bank, as administrative agent, and the lenders party thereto.

On February 1, 2016, the Company, CareTrust GP, LLC, the Operating Partnership, as the borrower, and certain of its wholly owned subsidiaries entered into the First Amendment (the “Amendment”) to the Credit Agreement. Pursuant to the Amendment, (i) commitments in respect of the Revolving Facility were increased by $100.0 million to $400.0 million total, (ii) a new $100.0 million non-amortizing unsecured term loan (the “Term Loan” and, together with the Revolving Facility, the “Credit Facility”) was funded, and (iii) the uncommitted incremental facility was increased by $50.0 million to $250.0 million. The Revolving Facility continues to mature on August 5, 2019, subject to two, six-month extension options. The Term Loan, which matures on February 1, 2023, may be prepaid at any time subject to a 2% premium in the first year after issuance and a 1% premium in the second year after issuance. Approximately $95.0 million of the proceeds of the Term Loan were used to pay off and terminate the Company’s existing secured mortgage indebtedness under the Fifth Amended and Restated Loan Agreement, dated May 30, 2014 with General Electric Capital Corporation, as agent and lender, and the other lenders party thereto. The Company expects to use borrowings under the Credit Facility for working capital purposes, to fund acquisitions and for general corporate purposes.

As of September 30, 2018, there was $90.0 million outstanding under the Revolving Facility.

The interest rates applicable to loans under the Revolving Facility are, at the Company’s option, equal to either a base rate plus a margin ranging from 0.75% to 1.40% per annum or applicable LIBOR plus a margin ranging from 1.75% to 2.40% per annum based on the debt to asset value ratio of the Company and its subsidiaries (subject to decrease at the Company’s election if the Company obtains certain specified investment grade ratings on its senior long term unsecured debt). In addition, the Company pays a commitment fee on the unused portion of the commitments under the Revolving Facility of 0.15% or 0.25% per annum, based upon usage of the Revolving Facility (unless the Company obtains certain specified investment grade ratings on its senior long term unsecured debt and elects to decrease the applicable margin as described above, in which case the Company will pay a facility fee on the revolving commitments ranging from 0.125% to 0.30% per annum based upon the credit ratings of its senior long term unsecured debt).

Pursuant to the Amendment, the interest rates applicable to the Term Loan are, at the Company’s option, equal to either a base rate plus a margin ranging from 0.95% to 1.60% per annum or applicable LIBOR plus a margin ranging from 1.95% to 2.60% per annum based on the debt to asset value ratio of the Company and its subsidiaries (subject to decrease at the Company’s election if the Company obtains certain specified investment grade ratings on its senior long term unsecured debt).

The Credit Facility is guaranteed, jointly and severally, by the Company and its wholly-owned subsidiaries that are party to the Credit Agreement (other than the Operating Partnership). The Credit Agreement contains customary covenants that, among other things, restrict, subject to certain exceptions, the ability of the Company and its subsidiaries to grant liens on their assets, incur indebtedness, sell assets, make investments, engage in acquisitions, mergers or consolidations, amend certain material agreements and pay certain dividends and other restricted payments. The Credit Agreement requires the Company to comply with financial maintenance covenants to be tested quarterly, consisting of a maximum debt to asset value ratio, a minimum fixed charge coverage ratio, a minimum tangible net worth, a maximum cash distributions to operating income ratio, a maximum secured debt to asset value ratio and a maximum secured recourse debt to asset value ratio. The Credit Agreement also contains certain customary events of default, including that the Company is required to operate in conformity with the requirements for qualification and taxation as a REIT.

As of September 30, 2018, the Company was in compliance with all applicable financial covenants under the Credit Agreement.

Interest Expense

During the three months ended September 30, 2018, the Company incurred $6.8 million of interest expense, which included $0.5 million of amortization of deferred financing costs. During the three months ended September 30, 2017, the Company incurred $5.6 million of interest expense, which included $0.5 million of amortization of deferred financing costs. During the nine months ended September 30, 2018, the Company incurred $21.2 million of interest expense, which included $1.5 million of amortization of deferred financing costs. During the nine months ended September 30, 2017, the Company incurred $17.7 million of interest expense, which included $1.6 million of amortization of deferred financing costs. As of September 30, 2018 and December 31, 2017, the Company’s interest payable was $5.3 million and $1.4 million, respectively.

Loss on the Extinguishment of Debt

During the nine months ended September 30, 2017, the loss on the extinguishment of debt included the redemption price, stated at 102.938%, of $7.6 million and a $4.2 million write-off of deferred financing costs associated with the redemption of the Company’s 5.875% Senior Notes due 2021.

XML

Equity

9 Months Ended

Sep. 30, 2018

Equity [Abstract]

Equity

EQUITY

Common Stock

At-The-Market Offering—During the second quarter of 2017, the Company entered into an equity distribution agreement to issue and sell, from time to time, up to $300.0 million in aggregate offering price of its common stock through an “at-the-market” equity offering program (the “ATM Program”). The following table summarizes the quarterly ATM Program activity for 2018 (in thousands, except per share amounts):

	For the Three Months Ended
	March 31, 2018		June 30, 2018		September 30, 2018		Total
Number of shares	—		2,989		4,772		7,761
Average sales price per share	$	—	$	16.13	$	17.62	$	17.04
Gross proceeds*	$	—	$	48,198	$	84,077	$	132,275

*Total gross proceeds is before $0.6 million and $1.1 million of commissions paid to the sales agents during the three months ended June 30, 2018 and September 30, 2018, respectively.

As of September 30, 2018, the Company had approximately $103.8 million available for future issuances under the ATM Program.

Dividends on Common Stock—The following table summarizes the cash dividends per share of common stock declared by the Company’s Board of Directors for 2018:

	For the Three Months Ended
	March 31, 2018		June 30, 2018		September 30, 2018
Dividends declared	$	0.205	$	0.205	$	0.205
Dividends payment date	April 13, 2018		July 13, 2018		October 15, 2018

XML

Stock-Based Compensation

9 Months Ended

Sep. 30, 2018

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Stock-Based Compensation

STOCK-BASED COMPENSATION

All stock-based awards are subject to the terms of the CareTrust REIT, Inc. and CTR Partnership, L.P. Incentive Award Plan (the “Plan”). The Plan provides for the granting of stock-based compensation, including stock options, restricted stock, performance awards, restricted stock units and other incentive awards to officers, employees and directors in connection with their employment with or services provided to the Company.

Restricted Stock Awards — In connection with the separation of Ensign’s healthcare business and its real estate business into two separate and independently publicly traded companies (the “Spin-Off”), employees of Ensign who had unvested shares of restricted stock were given one share of CareTrust REIT unvested restricted stock totaling 207,580 shares at the Spin-Off. These restricted shares are subject to a time vesting provision only and the Company does not recognize any stock compensation expense associated with these awards. During the nine months ended September 30, 2018, 10,960 shares vested or were forfeited. As of September 30, 2018, there were 4,020 unvested restricted stock awards outstanding that were issued in connection with the Spin-Off.

In February 2018, the Compensation Committee of the Company’s Board of Directors granted 141,060 shares of restricted stock to officers and employees. Each share had a fair market value on the date of grant of $15.13 per share, based on the market price of the Company’s common stock on that date, and the shares vest in four equal annual installments beginning on the first anniversary of the grant date. Additionally, the Compensation Committee granted 120,460 performance stock awards to officers and employees. Each share had a fair market value on the date of grant of $15.13 per share, based on the market price of the Company’s common stock on that date, and the shares may vest if the threshold performance criterion is met.

In May 2018, the Compensation Committee of the Company's Board of Directors granted 26,462 shares of restricted stock to members of the Board of Directors. Each share had a fair market value on the date of grant of $16.44 per share, based on the market price of the Company's common stock on that date, and the shares vest in full on the earlier to occur of May 30, 2019 or when the Company holds its 2019 Annual Meeting.

The following table summarizes the stock-based compensation expense recognized (dollars in thousands):

	For the Three Months Ended September 30,				For the Nine Months Ended September 30,
	2018		2017		2018		2017
Stock-based compensation expense	$	988	$	656	$	2,816	$	1,792

As of September 30, 2018, there was $5.4 million of unamortized stock-based compensation expense related to unvested awards and the weighted-average remaining vesting period of such awards was 2.2 years.

XML

Earnings Per Common Share

9 Months Ended

Sep. 30, 2018

Earnings Per Share [Abstract]

Earnings Per Common Share

EARNINGS PER COMMON SHARE

The following table presents the calculation of basic and diluted EPS for the Company’s common stock for the three and nine months ended September 30, 2018 and 2017, and reconciles the weighted-average common shares outstanding used in the calculation of basic EPS to the weighted-average common shares outstanding used in the calculation of diluted EPS (amounts in thousands, except per share amounts):

	For the Three Months Ended September 30,						For the Nine Months Ended September 30,
	2018			2017			2018			2017
Numerator:
Net income	$	14,510		$	11,311		$	42,384		$	23,622
Less: Net income allocated to participating securities	(84		)	(83		)	(282		)	(277		)
Numerator for basic and diluted earnings available to common stockholders	$	14,426		$	11,228		$	42,102		$	23,345
Denominator:
Weighted-average basic common shares outstanding	81,490			75,471			77,811			71,693
Weighted-average diluted common shares outstanding	81,490			75,471			77,811			71,693
Earnings per common share, basic	$	0.18		$	0.15		$	0.54		$	0.33
Earnings per common share, diluted	$	0.18		$	0.15		$	0.54		$	0.33

The Company’s unvested restricted shares associated with its incentive award plan and unvested restricted shares issued to employees of Ensign at the Spin-Off have been excluded from the above calculation of earnings per diluted share for the three and nine months ended September 30, 2018 and 2017, as their inclusion would have been anti-dilutive.

XML

Commitments and Contingencies

9 Months Ended

Sep. 30, 2018

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

COMMITMENTS AND CONTINGENCIES

U.S. Government Settlement—In October 2013, Ensign completed and executed a settlement agreement (the “Settlement Agreement”) with the U.S. Department of Justice (“DOJ”). This settlement agreement fully and finally resolved a DOJ investigation of Ensign related primarily to claims submitted to the Medicare program for rehabilitation services provided at skilled nursing facilities in California and certain ancillary claims. Pursuant to the Settlement Agreement, Ensign made a single lump-sum remittance to the government in the amount of $48.0 million in October 2013. Ensign denied engaging in any illegal conduct and agreed to the settlement amount without any admission of wrongdoing in order to resolve the allegations and avoid the uncertainty and expense of protracted litigation.

In connection with the settlement and effective as of October 1, 2013, Ensign entered into a five-year corporate integrity agreement (the “CIA”) with the Office of Inspector General-Health and Human Services. The CIA acknowledges the existence of Ensign’s current compliance program, and requires that Ensign continue, during the term of the CIA, to maintain a compliance program designed to promote compliance with the statutes, regulations, and written directives of Medicare, Medicaid, and all other Federal health care programs. Ensign is also required to maintain several elements of its existing program during the term of the CIA, including maintaining a compliance officer, a compliance committee of the board of directors, and a code of conduct. The CIA requires that Ensign conduct certain additional compliance-related activities during the term of the CIA, including various training and monitoring procedures, and maintaining a disciplinary process for compliance obligations.

Participation in federal healthcare programs by Ensign is not affected by the Settlement Agreement or the CIA. In the event of an uncured material breach of the CIA, Ensign could be excluded from participation in federal healthcare programs and/or subject to prosecution. The Company is subject to certain continuing operational obligations as part of Ensign’s compliance program pursuant to the CIA, but otherwise has no liability related to the DOJ investigation.

Legal Matters—The Company and its subsidiaries are and may become from time to time a party to various claims and lawsuits arising in the ordinary course of business, which are not individually or in the aggregate anticipated to have a material adverse effect on the Company’s results of operations, financial condition or cash flows. Claims and lawsuits may include matters involving general or professional liability asserted against the Company’s tenants, which are the responsibility of the Company’s tenants and for which the Company is entitled to be indemnified by its tenants under the insurance and indemnification provisions in the applicable leases.

XML

Concentration of Risk

9 Months Ended

Sep. 30, 2018

Risks and Uncertainties [Abstract]

Concentration of Risk

CONCENTRATION OF RISK

Major operator concentrations – As of September 30, 2018, Ensign leased 92 skilled nursing, multi-service campuses, assisted living and independent living facilities which had a total of 9,805 operational beds and are located in Arizona, California, Colorado, Idaho, Iowa, Nebraska, Nevada, Texas, Utah and Washington. The four states in which Ensign leases the highest concentration of properties are California, Texas, Utah and Arizona. As of September 30, 2018, Ensign represents $59.1 million, or 42%, of the Company’s rental income on an annualized run-rate basis.

Ensign is subject to the registration and reporting requirements of the SEC and is required to file with the SEC annual reports containing audited financial information and quarterly reports containing unaudited financial information. Ensign’s financial statements, as filed with the SEC, can be found at Ensign’s website http://www.ensigngroup.net.

XML

Summarized Condensed Consolidating Information

9 Months Ended

Sep. 30, 2018

Summarized Condensed Consolidating Information [Abstract]

Summarized Condensed Consolidating Information

SUMMARIZED CONDENSED CONSOLIDATING INFORMATION

The Notes issued by the Operating Partnership and CareTrust Capital Corp. on May 10, 2017 are jointly and severally, fully and unconditionally, guaranteed by CareTrust REIT, Inc., as the parent guarantor (the “Parent Guarantor”), and the wholly owned subsidiaries of the Parent Guarantor other than the Issuers (collectively, the “Subsidiary Guarantors” and, together with the Parent Guarantor, the “Guarantors”), subject to automatic release under certain customary circumstances, including if the Subsidiary Guarantor is sold or sells all or substantially all of its assets, the Subsidiary Guarantor is designated “unrestricted” for covenant purposes under the indenture governing the Notes, the Subsidiary Guarantor’s guarantee of other indebtedness which resulted in the creation of the guarantee of the Notes is terminated or released, or the requirements for legal defeasance or covenant defeasance or to discharge the indenture have been satisfied.

The following provides information regarding the entity structure of the Parent Guarantor, the Issuers and the Subsidiary Guarantors:

CareTrust REIT, Inc. – The Parent Guarantor was formed on October 29, 2013 in anticipation of the Spin-Off and the related transactions and was a wholly owned subsidiary of Ensign prior to the effective date of the Spin-Off on June 1, 2014. The Parent Guarantor did not conduct any operations or have any business prior to the date of the consummation of the Spin-Off related transactions.

CTR Partnership, L.P. and CareTrust Capital Corp. – The Issuers, each of which is a wholly owned subsidiary of the Parent Guarantor, were formed on May 8, 2014 and May 9, 2014, respectively, in anticipation of the Spin-Off and the related transactions. The Issuers did not conduct any operations or have any business prior to the date of the consummation of the Spin-Off related transactions.

Subsidiary Guarantors – The Subsidiary Guarantors consist of all of the subsidiaries of the Parent Guarantor other than the Issuers.

Pursuant to Rule 3-10 of Regulation S-X, the following summarized consolidating information is provided for the Parent Guarantor, the Issuers, and the Subsidiary Guarantors. There are no subsidiaries of the Company other than the Issuers and the Subsidiary Guarantors. This summarized financial information has been prepared from the financial statements of the Company and the books and records maintained by the Company.

CONDENSED CONSOLIDATING BALANCE SHEETS

SEPTEMBER 30, 2018

(in thousands, except share and per share amounts)

	Parent Guarantor			Issuers		Combined Subsidiary Guarantors		Elimination			Consolidated
Assets:
Real estate investments, net	$	—		$	856,659	$	332,790	$	—		$	1,189,449
Other real estate investments, net	—			12,337		5,746		—			18,083
Cash and cash equivalents	—			15,745		—		—			15,745
Accounts and other receivables, net	—			9,567		2,817		—			12,384
Prepaid expenses and other assets	—			3,789		3		—			3,792
Deferred financing costs, net	—			904		—		—			904
Investment in subsidiaries	737,296			474,524		—		(1,211,820		)	—
Intercompany	—			—		136,277		(136,277		)	—
Total assets	$	737,296		$	1,373,525	$	477,633	$	(1,348,097	)	$	1,240,357
Liabilities and Equity:
Senior unsecured notes payable, net	$	—		$	294,963	$	—	$	—		$	294,963
Senior unsecured term loan, net	—			99,588		—		—			99,588
Unsecured revolving credit facility	—			90,000		—		—			90,000
Accounts payable and accrued liabilities	—			15,401		3,109		—			18,510
Dividends payable	17,246			—		—		—			17,246
Intercompany	—			136,277		—		(136,277		)	—
Total liabilities	17,246			636,229		3,109		(136,277		)	520,307
Equity:
Common stock, $0.01 par value; 500,000,000 shares authorized, 83,353,226 shares issued and outstanding as of September 30, 2018	834			—		—		—			834
Additional paid-in capital	915,235			629,525		321,761		(951,286		)	915,235
Cumulative distributions in excess of earnings	(196,019		)	107,771		152,763		(260,534		)	(196,019		)
Total equity	720,050			737,296		474,524		(1,211,820		)	720,050
Total liabilities and equity	$	737,296		$	1,373,525	$	477,633	$	(1,348,097	)	$	1,240,357

CONDENSED CONSOLIDATING BALANCE SHEETS

DECEMBER 31, 2017

(in thousands, except share and per share amounts)

	Parent Guarantor			Issuers		Combined Subsidiary Guarantors		Elimination			Consolidated
Assets:
Real estate investments, net	$	—		$	805,826	$	346,435	$	—		$	1,152,261
Other real estate investments, net	—			12,399		5,550		—			17,949
Cash and cash equivalents	—			6,909		—		—			6,909
Accounts and other receivables, net	—			2,945		2,309		—			5,254
Prepaid expenses and other assets	—			893		2		—			895
Deferred financing costs, net	—			1,718		—		—			1,718
Investment in subsidiaries	619,075			444,120		—		(1,063,195		)	—
Intercompany	—			—		92,061		(92,061		)	—
Total assets	$	619,075		$	1,274,810	$	446,357	$	(1,155,256	)	$	1,184,986
Liabilities and Equity:
Senior unsecured notes payable, net	$	—		$	294,395	$	—	$	—		$	294,395
Senior unsecured term loan, net	—			99,517		—		—			99,517
Unsecured revolving credit facility	—			165,000		—		—			165,000
Accounts payable and accrued liabilities	—			15,176		2,237		—			17,413
Dividends payable	14,044			—		—		—			14,044
Intercompany	—			92,061		—		(92,061		)	—
Total liabilities	14,044			666,149		2,237		(92,061		)	590,369
Equity:
Common stock, $0.01 par value; 500,000,000 shares authorized, 75,478,202 shares issued and outstanding as of December 31, 2017	755			—		—		—			755
Additional paid-in capital	783,237			546,097		321,761		(867,858		)	783,237
Cumulative distributions in excess of earnings	(178,961		)	62,564		122,359		(195,337		)	(189,375		)
Total equity	605,031			608,661		444,120		(1,063,195		)	594,617
Total liabilities and equity	$	619,075		$	1,274,810	$	446,357	$	(1,155,256	)	$	1,184,986

CONDENSED CONSOLIDATING INCOME STATEMENTS

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2018

(in thousands)

	Parent Guarantor		Issuers		Combined Subsidiary Guarantors		Elimination			Consolidated
Revenues:
Rental income	$	—	$	20,554	$	14,778	$	—		$	35,332
Tenant reimbursements	—		1,804		1,186		—			2,990
Independent living facilities	—		—		871		—			871
Interest and other income	—		317		—		—			317
Total revenues	—		22,675		16,835		—			39,510
Expenses:
Depreciation and amortization	—		6,833		4,518		—			11,351
Interest expense	—		6,805		—		—			6,805
Property taxes	—		1,804		1,186		—			2,990
Independent living facilities	—		—		766		—			766
General and administrative	987		2,101		—		—			3,088
Total expenses	987		17,543		6,470		—			25,000
Income in Subsidiary	15,497		10,365		—		(25,862		)	—
Net income	$	14,510	$	15,497	$	10,365	$	(25,862	)	$	14,510

CONDENSED CONSOLIDATING INCOME STATEMENTS

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2017

(in thousands)

	Parent Guarantor		Issuers		Combined Subsidiary Guarantors		Elimination			Consolidated
Revenues:
Rental income	$	—	$	14,987	$	14,417	$	—		$	29,404
Tenant reimbursements	—		1,341		1,202		—			2,543
Independent living facilities	—		—		825		—			825
Interest and other income	—		—		176		—			176
Total revenues	—		16,328		16,620		—			32,948
Expenses:
Depreciation and amortization	—		5,014		4,731		—			9,745
Interest expense	—		5,592		—		—			5,592
Property taxes	—		1,341		1,202		—			2,543
Independent living facilities	—		—		698		—			698
General and administrative	671		2,388		—		—			3,059
Total expenses	671		14,335		6,631		—			21,637
Income in Subsidiary	11,982		9,989		—		(21,971		)	—
Net income	$	11,311	$	11,982	$	9,989	$	(21,971	)	$	11,311

CONDENSED CONSOLIDATING INCOME STATEMENTS

FOR THE NINE MONTHS ENDEDSEPTEMBER 30, 2018

(in thousands)

	Parent Guarantor		Issuers		Combined Subsidiary Guarantors		Elimination			Consolidated
Revenues:
Rental income	$	—	$	60,122	$	43,734	$	—		$	103,856
Tenant reimbursements	—		5,360		3,614		—			8,974
Independent living facilities	—		—		2,515		—			2,515
Interest and other income	—		1,039		196		—			1,235
Total revenues	—		66,521		50,059		—			116,580
Expenses:
Depreciation and amortization	—		20,488		13,739		—			34,227
Interest expense	—		21,182		—		—			21,182
Property taxes	—		5,360		3,614		—			8,974
Independent living facilities	—		—		2,226		—			2,226
General and administrative	2,822		6,740		76		—			9,638
Total expenses	2,822		53,770		19,655		—			76,247
Gain on sale of real estate	—		2,051		—		—			2,051
Income in Subsidiary	45,206		30,404		—		(75,610		)	—
Net income	$	42,384	$	45,206	$	30,404	$	(75,610	)	$	42,384

CONDENSED CONSOLIDATING INCOME STATEMENTS

FOR THE NINE MONTHS ENDEDSEPTEMBER 30, 2017

(in thousands)

	Parent Guarantor		Issuers		Combined Subsidiary Guarantors		Elimination			Consolidated
Revenues:
Rental income	$	—	$	42,503	$	42,751	$	—		$	85,254
Tenant reimbursements	—		3,577		3,676		—			7,253
Independent living facilities	—		—		2,407		—			2,407
Interest and other income	—		—		1,471		—			1,471
Total revenues	—		46,080		50,305		—			96,385
Expenses:
Depreciation and amortization	—		13,730		14,426		—			28,156
Interest expense	—		17,690		—		—			17,690
Loss on the extinguishment of debt	—		11,883		—		—			11,883
Property taxes	—		3,577		3,676		—			7,253
Independent living facilities	—		—		2,003		—			2,003
Impairment of real estate investment	—		—		890		—			890
General and administrative	1,948		6,416		62		—			8,426
Total expenses	1,948		53,296		21,057		—			76,301
Gain on disposition of other real estate investment	—		—		3,538		—			3,538
Income in Subsidiary	25,570		32,786		—		(58,356		)	—
Net income	$	23,622	$	25,570	$	32,786	$	(58,356	)	$	23,622

CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS

FOR THE NINE MONTHS ENDEDSEPTEMBER 30, 2018

(in thousands)

	Parent Guarantor			Issuers			Combined Subsidiary Guarantors			Elimination			Consolidated
Cash flows from operating activities:
Net cash (used in) provided by operating activities	$	(7	)	$	28,087		$	44,310		$	—		$	72,390
Cash flows from investing activities:
Acquisitions of real estate	—			(75,621		)	—			—			(75,621		)
Improvements to real estate	—			(5,376		)	(25		)	—			(5,401		)
Purchases of equipment, furniture and fixtures	—			(1,193		)	(69		)	—			(1,262		)
Investment in real estate mortgage and other loans receivable	—			(2,598		)	—			—			(2,598		)
Principal payments received on real estate mortgage and other loans receivable	—			893			—			—			893
Escrow deposit for acquisitions of real estate	—			(1,000		)	—			—			(1,000		)
Net proceeds from the sale of real estate	—			13,004			—			—			13,004
Distribution from subsidiary	45,827			—			—			(45,827		)	—
Intercompany financing	(129,251		)	44,216			—			85,035			—
Net cash used in investing activities	(83,424		)	(27,675		)	(94		)	39,208			(71,985		)
Cash flows from financing activities:
Proceeds from the issuance of common stock, net	130,546			—			—			—			130,546
Borrowings under unsecured revolving credit facility	—			60,000			—			—			60,000
Payments on unsecured revolving credit facility	—			(135,000		)	—			—			(135,000		)
Net-settle adjustment on restricted stock	(1,288		)	—			—			—			(1,288		)
Dividends paid on common stock	(45,827		)	—			—			—			(45,827		)
Distribution to Parent	—			(45,827		)	—			45,827			—
Intercompany financing	—			129,251			(44,216		)	(85,035		)	—
Net cash provided by (used in) financing activities	83,431			8,424			(44,216		)	(39,208		)	8,431
Net increase in cash and cash equivalents	—			8,836			—			—			8,836
Cash and cash equivalents beginning of period	—			6,909			—			—			6,909
Cash and cash equivalents end of period	$	—		$	15,745		$	—		$	—		$	15,745

CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS

FOR THE NINE MONTHS ENDEDSEPTEMBER 30, 2017

(in thousands)

	Parent Guarantor			Issuers			Combined Subsidiary Guarantors			Elimination			Consolidated
Cash flows from operating activities:
Net cash (used in) provided by operating activities:	$	(157	)	$	17,946		$	49,144		$	—		$	66,933
Cash flows from investing activities:
Acquisitions of real estate	—			(222,463		)	—			—			(222,463		)
Improvements to real estate	—			(571		)	(50		)	—			(621		)
Purchases of equipment, furniture and fixtures	—			(292		)	(67		)	—			(359		)
Escrow deposit for acquisitions of real estate	—			(1,000		)	—			—			(1,000		)
Sale of other real estate investment	—			—			7,500			—			7,500
Distribution from subsidiary	38,544			—			—			(38,544		)	—
Intercompany financing	(169,391		)	56,527			—			112,864			—
Net cash (used in) provided by investing activities	(130,847		)	(167,799		)	7,383			74,320			(216,943		)
Cash flows from financing activities:
Proceeds from the issuance of common stock, net	170,414			—			—			—			170,414
Proceeds from the issuance of senior unsecured notes payable	—			300,000			—			—			300,000
Borrowings under unsecured revolving credit facility	—			158,000			—			—			158,000
Payments on senior unsecured notes payable	—			(267,639		)	—			—			(267,639		)
Payments on unsecured revolving credit facility	—			(158,000		)	—			—			(158,000		)
Payments of deferred financing costs	—			(6,047		)	—			—			(6,047		)
Net-settle adjustment on restricted stock	(866		)	—			—			—			(866		)
Dividends paid on common stock	(38,544		)	—			—			—			(38,544		)
Distribution to Parent	—			(38,544		)	—			38,544			—
Intercompany financing	—			169,391			(56,527		)	(112,864		)	—
Net cash provided by (used in) financing activities	131,004			157,161			(56,527		)	(74,320		)	157,318
Net increase in cash and cash equivalents	—			7,308			—			—			7,308
Cash and cash equivalents beginning of period	—			7,500			—			—			7,500
Cash and cash equivalents end of period	$	—		$	14,808		$	—		$	—		$	14,808

XML

Subsequent Events

9 Months Ended

Sep. 30, 2018

Subsequent Events [Abstract]

Subsequent Events

SUBSEQUENT EVENTS

The Company evaluates subsequent events in accordance with ASC Topic 855, Subsequent Events. The Company evaluates subsequent events up until the date the condensed consolidated financial statements are issued.

In October 2018, the Company, in two separate transactions, acquired one skilled nursing facility and one multi-service campus. The aggregate purchase price was approximately $12.0 million, which includes estimated capitalized acquisition costs. These two acquisitions will generate initial annual cash rents of approximately $1.1 million and were funded using $7.0 million in cash on hand and $5.0 million in borrowings under the Company’s senior unsecured revolving credit facility.

XML

Summary of Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2018

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation—The accompanying condensed consolidated financial statements of the Company reflect, for all periods presented, the historical financial position, results of operations and cash flows of the Company and its consolidated subsidiaries consisting of (i) the net-leased skilled nursing, multi-service campuses, assisted living and independent living facilities, (ii) the operations of the three independent living facilities that the Company owns and operates; and (iii) the preferred equity investments and the mortgage loan receivable.

The accompanying condensed consolidated financial statements of the Company were prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and Article 10 of Regulation S-X. Accordingly, the condensed consolidated financial statements do not include all of the disclosures required by GAAP for a complete set of annual audited financial statements. The condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2017. In the opinion of management, all adjustments which are of a normal and recurring nature and considered necessary for a fair presentation of the results of the interim periods presented have been included. The results of operations for the interim periods are not necessarily indicative of results for the full year. All intercompany transactions and account balances within the Company have been eliminated.

Estimates and Assumptions

Estimates and Assumptions—The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Management believes that the assumptions and estimates used in preparation of the underlying consolidated financial statements are reasonable. Actual results, however, could differ from those estimates and assumptions.

Real Estate Depreciation and Amortization

Real Estate Depreciation and Amortization—Real estate costs related to the acquisition and improvement of properties are capitalized and amortized over the expected useful life of the asset on a straight-line basis. Repair and maintenance costs are charged to expense as incurred and significant replacements and betterments are capitalized. Repair and maintenance costs include all costs that do not extend the useful life of the real estate asset. The Company considers the period of future benefit of an asset to determine its appropriate useful life. Expenditures for tenant improvements are capitalized and amortized over the shorter of the tenant’s lease term or expected useful life. The Company anticipates the estimated useful lives of its assets by class to be generally as follows:

Buildings	25-40 years
Building improvements	10-25 years
Tenant improvements	Shorter of lease term or expected useful life
Integral equipment, furniture and fixtures	5 years
Identified intangible assets	Shorter of lease term or expected useful life

Real Estate Acquisition Valuation

Real Estate Acquisition Valuation— In accordance with Accounting Standards Codification (“ASC”) 805, Business Combinations, the Company records the acquisition of income-producing real estate as a business combination. If the acquisition does not meet the definition of a business, the Company records the acquisition as an asset acquisition. Under both methods, all assets acquired and liabilities assumed are measured at their acquisition date fair values. For transactions that are business combinations, acquisition costs are expensed as incurred and restructuring costs that do not meet the definition of a liability at the acquisition date are expensed in periods subsequent to the acquisition date. For transactions that are asset acquisitions, acquisition costs are capitalized as incurred.

The Company assesses the acquisition date fair values of all tangible assets, identifiable intangibles and assumed liabilities using methods similar to those used by independent appraisers, generally utilizing a discounted cash flow analysis that applies appropriate discount and/or capitalization rates and available market information. Estimates of future cash flows are based on a number of factors, including historical operating results, known and anticipated trends, and market and economic conditions. The fair value of tangible assets of an acquired property considers the value of the property as if it were vacant.

Estimates of the fair values of the tangible assets, identifiable intangibles and assumed liabilities require the Company’s management to make significant assumptions to estimate market lease rates, property-operating expenses, carrying costs during lease-up periods, discount rates, market absorption periods, and the number of years the property will be held for investment. The use of inappropriate assumptions would result in an incorrect valuation of the Company’s acquired tangible assets, identifiable intangibles and assumed liabilities, which would impact the amount of the Company’s net income.

As part of the Company’s real estate acquisitions, the Company may commit to provide contingent payments to a seller or lessee (e.g., an earn-out payable upon the applicable property achieving certain financial metrics). Typically, when the contingent payments are funded, cash rent is increased by the amount funded multiplied by a rate stipulated in the agreement. Generally, if the contingent payment is an earn-out provided to the seller, the payment is capitalized to the property’s basis. If the contingent payment is an earn-out provided to the lessee, the payment is recorded as a lease incentive and is amortized as a yield adjustment over the life of the lease.

Impairment of Long-Lived Assets

Impairment of Long-Lived Assets—At each reporting period, management evaluates the Company’s real estate investments for impairment indicators, including the evaluation of the useful lives of the Company’s assets. Management also assesses the carrying value of the Company’s real estate investments whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. The judgment regarding the existence of impairment indicators is based on factors such as, but not limited to, market conditions, operator performance and legal structure. If indicators of impairment are present, management evaluates the carrying value of the related real estate investments in relation to the future undiscounted cash flows of the underlying facilities. Provisions for impairment losses related to long-lived assets are recognized when expected future undiscounted cash flows are determined to be less than the carrying values of the assets. An adjustment is made to the net carrying value of the real estate investments for the excess of carrying value over fair value. All impairments are taken as a period cost at that time, and depreciation is adjusted going forward to reflect the new value assigned to the asset.

If the Company decides to sell real estate properties, it evaluates the recoverability of the carrying amounts of the assets. If the evaluation indicates that the carrying value is not recoverable from estimated net sales proceeds, the property is written down to estimated fair value less costs to sell.

In the event of impairment, the fair value of the real estate investment is determined by market research, which includes valuing the property in its current use as well as other alternative uses, and involves significant judgment. Management’s estimates of cash flows and fair values of the properties are based on current market conditions and consider matters such as rental rates and occupancies for comparable properties, recent sales data for comparable properties, and, where applicable, contracts or the results of negotiations with purchasers or prospective purchasers. The Company’s ability to accurately estimate future cash flows and estimate and allocate fair values impacts the timing and recognition of impairments. While the Company believes its assumptions are reasonable, changes in these assumptions may have a material impact on financial results.

Other Real Estate Investments, Net

Other Real Estate Investments, Net — Included in Other Real Estate Investments, Net are two preferred equity investments and one mortgage loan receivable. Preferred equity investments are accounted for at unpaid principal balance, plus accrued return, net of reserves. The Company recognizes return income on a quarterly basis based on the outstanding investment including any accrued and unpaid return, to the extent there is outside contributed equity or cumulative earnings from operations. As the preferred member of the joint venture, the Company is not entitled to share in the joint venture’s earnings or losses. Rather, the Company is entitled to receive a preferred return, which is deferred if the cash flow of the joint venture is insufficient to pay all of the accrued preferred return. The unpaid accrued preferred return is added to the balance of the preferred equity investment up to the estimated economic outcome assuming a hypothetical liquidation of the book value of the joint venture. The Company anticipates any unpaid accrued preferred return, whether recorded or unrecorded by the Company, will be repaid upon redemption or as available cash flow is distributed from the joint venture.

The Company’s mortgage loan receivable is recorded at amortized cost, which consists of the outstanding unpaid principal balance, net of unamortized costs and fees directly associated with the origination of the loan.

Interest income on the Company’s mortgage loan receivable is recognized over the life of the investment using the interest method. Origination costs and fees directly related to mortgage loans receivable are amortized over the term of the loan as an adjustment to interest income.

The Company evaluates at each reporting period each of its other real estate investments for indicators of impairment. An investment is impaired when, based on current information and events, it is probable that the Company will be unable to collect all amounts due according to the existing contractual terms. A reserve is established for the excess of the carrying value of the investment over its fair value.

Cash and Cash Equivalents

Cash and Cash Equivalents—Cash and cash equivalents consist of bank term deposits and money market funds with original maturities of three months or less at time of purchase and therefore approximate fair value. The fair value of these investments is determined based on “Level 1” inputs, which consist of unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets. The Company places its cash and short-term investments with high credit quality financial institutions.

The Company’s cash and cash equivalents balance periodically exceeds federally insurable limits. The Company monitors the cash balances in its operating accounts and adjusts the cash balances as appropriate; however, these cash balances could be impacted if the underlying financial institutions fail or are subject to other adverse conditions in the financial markets. To date, the Company has experienced no loss or lack of access to cash in its operating accounts.

Prepaid expenses and other assets

Prepaid expenses and other assets—Prepaid expenses and other assets consist of prepaid expenses, deposits, pre-acquisition costs and other loans receivable.

Deferred Financing Costs

Deferred Financing Costs—External costs incurred from placement of the Company’s debt are capitalized and amortized on a straight-line basis over the terms of the related borrowings, which approximates the effective interest method. Deferred financing costs on the Company’s Notes and Term Loan (each as defined in Note 6, Debt, below) are netted against the outstanding debt amounts on the Company’s balance sheet. Deferred financing costs on the Company’s Revolving Facility (as defined in Note 6, Debt, below) are included in assets on the Company’s balance sheet. Amortization of deferred financing costs is classified as interest expense in the Company’s condensed consolidated income statements. Accumulated amortization of deferred financing costs was $4.6 million and $3.2 million at September 30, 2018 and December 31, 2017, respectively.

When financings are terminated, unamortized deferred financing costs, as well as charges incurred for the termination, are expensed at the time the termination is made. Gains and losses from the extinguishment of debt are presented within income from continuing operations in the Company’s condensed consolidated income statements.

Revenue Recognition

Revenue Recognition —The Company recognizes rental revenue, including rental abatements, lease incentives and contractual fixed increases attributable to operating leases, if any, from tenants under lease arrangements with minimum fixed and determinable increases on a straight-line basis over the non-cancellable term of the related leases when collectability is reasonably assured. The Company evaluates the collectability of rents and other receivables on a regular basis based on factors including, among others, payment history, the operations, the asset type and current economic conditions. Tenant recoveries related to the reimbursement of real estate taxes, insurance, repairs and maintenance, and other operating expenses are recognized as revenue in the period the expenses are incurred and presented gross if the Company is the primary obligor and, with respect to purchasing goods and services from third-party suppliers, has discretion in selecting the supplier and bears the associated credit risk. For each of the three and nine months ended September 30, 2018 and 2017, such tenant reimbursement revenues consisted of real estate taxes. Contingent revenue, if any, is not recognized until all possible contingencies have been eliminated.

If the Company’s evaluation of applicable factors indicates it may not recover the full value of the receivable, the Company provides a reserve against the portion of the receivable that it estimates may not be recovered. This analysis requires the Company to determine whether there are factors indicating a receivable may not be fully collectible and to estimate the amount of the receivable that may not be collected. As of September 30, 2018 and December 31, 2017, Accounts and other receivables, net included $1.3 million and $0.8 million for unpaid cash rents and $11.6 million and $9.6 million for other tenant receivables, respectively, of which $10.4 million was reserved as of September 30, 2018 and December 31, 2017, related to the properties previously net leased to subsidiaries of Pristine Senior Living, LLC (“Pristine”). See Note 3, Real Estate Investments, Net for further discussion.

The Company evaluates the collectability of straight-line rent receivable balances on an ongoing basis and provides reserves against receivables it determines may not be fully recoverable. The Company recorded straight-line rental income of $0.7 million and $2,000 during the three months ended September 30, 2018 and 2017, respectively. The Company recorded straight-line rental income of $1.6 million and $0.1 million during the nine months ended September 30, 2018 and 2017, respectively. Accounts and other receivables, net included $2.1 million and $0.5 million in straight-line rents receivable at September 30, 2018 and December 31, 2017, respectively.

Income Taxes

Income Taxes—The Company has elected to be taxed as a real estate investment trust (“REIT”) under the Internal Revenue Code of 1986, as amended (the “Code”). The Company believes it has been organized and has operated, and the Company intends to continue to operate, in a manner to qualify for taxation as a REIT under the Code. To qualify as a REIT, the Company must meet certain organizational and operational requirements, including a requirement to distribute to its stockholders at least 90% of the Company’s annual REIT taxable income (computed without regard to the dividends paid deduction or net capital gain and which does not necessarily equal net income as calculated in accordance with GAAP). As a REIT, the Company generally will not be subject to federal income tax to the extent it distributes as qualifying dividends all of its REIT taxable income to its stockholders. If the Company fails to qualify as a REIT in any taxable year, it will be subject to federal income tax on its taxable income at regular corporate income tax rates and generally will not be permitted to qualify for treatment as a REIT for federal income tax purposes for the four taxable years following the year during which qualification is lost unless the Internal Revenue Service grants the Company relief under certain statutory provisions.

Stock-Based Compensation

Stock-Based Compensation—The Company accounts for share-based payment awards in accordance with ASC Topic 718, Compensation – Stock Compensation (“ASC 718”). ASC 718 requires that the cost resulting from all share-based payment transactions be recognized in the financial statements. ASC 718 requires all entities to apply a fair value-based measurement method in accounting for share-based payment transactions with directors, officers and employees except for equity instruments held by employee share ownership plans.

Concentration of Credit Risk

Concentration of Credit Risk—The Company is subject to concentrations of credit risk consisting primarily of operating leases on the Company’s owned properties. See Note 11, Concentration of Risk, for a discussion of major operator concentration.

Segment Disclosures

Segment Disclosures —The Financial Accounting Standards Board (“FASB”) accounting guidance regarding disclosures about segments of an enterprise and related information establishes standards for the manner in which public business enterprises report information about operating segments. The Company has one reportable segment consisting of investments in healthcare-related real estate assets.

Earnings (Loss) Per Share

Earnings (Loss) Per Share—The Company calculates earnings (loss) per share (“EPS”) in accordance with ASC Topic 260, Earnings Per Share. Basic EPS is computed by dividing net income applicable to common stock by the weighted-average number of common shares outstanding during the period. Diluted EPS reflects the additional dilution for all potentially-dilutive securities.

Recent Accounting Pronouncements

Recent Accounting Pronouncements

In February 2016, the FASB issued Accounting Standards Update (“ASU”) No. 2016-02, Leases (Topic 842) (“ASC 842”) that sets out the principles for the recognition, measurement, presentation, and disclosure of leases for both parties to a contract (i.e., lessees and lessors). ASC 842 requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase of the leased asset by the lessee. This classification will determine whether the lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. Leases with a term of 12 months or less will be accounted for similar to existing guidance for operating leases today. ASC 842 is expected to result in the recognition of a right-to-use asset and related liability to account for the Company’s future obligations for which it is the lessee. As of September 30, 2018, the remaining contractual payments under the Company’s lease agreements aggregated $0.2 million. Additionally, ASC 842 will require that lessees and lessors capitalize, as initial direct costs, only those costs that are incurred due to the execution of a lease. Under ASC 842, allocated payroll costs and other costs that are incurred regardless of whether the lease is obtained will no longer be capitalized as initial direct costs and instead will be expensed as incurred. During the nine months ended September 30, 2018, the Company did not capitalize any allocated payroll costs. Lessors will continue to account for leases using an approach that is substantially equivalent to existing guidance for sales-type leases, direct financing leases, and operating leases. ASC 842 is effective for reporting periods beginning after December 15, 2018, with early adoption permitted. Tenant recoveries that qualify as lease components, which relate to the right to use the leased asset (e.g., property taxes, insurance), will be accounted for under ASC 842. Tenant recoveries that qualify as non-lease components, which relate to payments for goods or services that are transferred separately from the right to use the underlying asset, including tenant recoveries related to payments for maintenance activities and common area expenses, will be accounted for under the new revenue recognition ASC 606 (as defined below) upon adoption of the new lease ASC 842 on January 1, 2019 for any new lease or any modified lease.

In July 2018, the FASB finalized an amendment to ASC 842 that allows lessors to elect, as a practical expedient, not to separate lease and non-lease components (such as services rendered) in a contract for the purpose of revenue recognition and disclosure. The practical expedient can only be applied to leasing arrangements for which (i) the timing and pattern of transfer are the same for the lease and non-lease components and (ii) the lease component, if accounted for separately, would be classified as an operating lease. Under this practical expedient, contracts that are predominantly lease-based would be accounted for under ASC 842, and contracts that are predominantly service-based would be accounted for under ASC 606. Further, this amendment also provides for an additional (and optional) transition method to adopt the new lease requirements by allowing entities to initially apply the requirements by recognizing a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. The Company plans to elect this practical expedient and apply the optional transition method for its operating leases, using the cumulative-effect adjustment to the opening balance sheet as of January 1, 2019. The Company is still evaluating the full impact of the adoption of ASC 842 on January 1, 2019 to its consolidated financial statements.

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326) (“ASU 2016-13”) that changes the impairment model for most financial instruments by requiring companies to recognize an allowance for expected losses, rather than incurred losses as required currently by the other-than-temporary impairment model. ASU 2016-13 will apply to most financial assets measured at amortized cost and certain other instruments, including trade and other receivables, loans, held-to-maturity debt securities, net investments in leases, and off-balance-sheet credit exposures (e.g., loan commitments). ASU 2016-13 is effective for reporting periods beginning after December 15, 2019, with early adoption permitted, and will be applied as a cumulative adjustment to retained earnings as of the effective date. The Company is currently assessing the potential effect the adoption of ASU 2016-13 will have on the Company’s condensed consolidated financial statements.

Recent Accounting Standards Adopted by the Company

On January 1, 2018, the Company adopted ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606) (“ASC 606”). ASC 606 requires an entity to recognize the revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. ASC 606 supersedes the revenue requirements in Revenue Recognition (Topic 605) and most industry-specific guidance throughout the Industry Topics of the ASC. ASC 606 does not apply to lease contracts within the scope of Leases (Topic 840). Based on a review of the Company’s revenue streams from independent living facilities, the Company’s consolidated financial statements include revenues generated through services provided to residents of independent living facilities that are ancillary to the residents’ contractual rights to occupy living and common-area space at the communities, such as meals, transportation and activities. While these revenue streams are subject to the application of Topic 606, the revenues associated with these services are generally recognized on a monthly basis, the period in which the related services are performed. Therefore, the adoption of ASC 606 did not have a material effect on the Company’s condensed consolidated financial statements since the revenue recognition under ASC 606 is similar to the recognition pattern prior to the adoption of ASC 606.

XML

Summary of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2018

Accounting Policies [Abstract]

Summary of Estimated Useful Lives

The Company anticipates the estimated useful lives of its assets by class to be generally as follows:

Buildings	25-40 years
Building improvements	10-25 years
Tenant improvements	Shorter of lease term or expected useful life
Integral equipment, furniture and fixtures	5 years
Identified intangible assets	Shorter of lease term or expected useful life

XML

Real Estate Investments, Net (Tables)

9 Months Ended

Sep. 30, 2018

Real Estate [Abstract]

Summary of Investment in Owned Properties

The following tables summarize the Company’s investment in owned properties as of September 30, 2018 and December 31, 2017 (dollars in thousands):

	September 30, 2018			December 31, 2017
Land	$	163,665		$	151,879
Buildings and improvements	1,168,192			1,114,605
Integral equipment, furniture and fixtures	85,592			80,729
Identified intangible assets	2,382			2,382
Real estate investments	1,419,831			1,349,595
Accumulated depreciation and amortization	(230,382		)	(197,334		)
Real estate investments, net	$	1,189,449		$	1,152,261

Schedule of Total Future Minimum Rental Revenues

As of September 30, 2018, the Company’s total future minimum rental revenues for all of its tenants were (dollars in thousands):

Year	Amount
Remaining 2018	$	35,223
2019	141,977
2020	142,525
2021	143,094
2022	143,678
Thereafter	1,169,183
	$	1,775,680

Schedule of Business Acquisitions

The following table summarizes the Company’s acquisitions for the nine months ended September 30, 2018 (dollar amounts in thousands):

Type of Property	Purchase Price(1)			Initial Annual Cash Rent		Number of Properties		Number of Beds/Units(2)
Skilled nursing	$	57,074		$	5,144	7		621
Multi-service campuses	20,277		(3)	1,564		1		122
Assisted living	—			—		—		—
Total	$	77,351		$	6,708	$	8	743

(1) Purchase price includes capitalized acquisition costs.

(2) The number of beds/units includes operating beds at acquisition date.

(3) The Company has committed to fund approximately $1.4 million in revenue-producing capital expenditures over the next 24 months based on the in-place lease yield, which is included in the purchase price.

XML

Fair Value Measurements (Tables)

9 Months Ended

Sep. 30, 2018

Fair Value Disclosures [Abstract]

Summary of Fair Value of Financial Instruments

A summary of the face values, carrying amounts and fair values of the Company’s financial instruments as of September 30, 2018 and December 31, 2017 using Level 2 inputs for the Notes (as defined in Note 6, Debt, below), and Level 3, inputs for all other financial instruments, is as follows (dollars in thousands):

	September 30, 2018						December 31, 2017
	Face Value		Carrying Amount		Fair Value		Face Value		Carrying Amount		Fair Value
Financial assets:
Preferred equity investments	$	4,531	$	5,746	$	6,022	$	4,531	$	5,550	$	5,423
Mortgage loan receivable	12,423		12,337		12,423		12,517		12,399		12,517
Financial liabilities:
Senior unsecured notes payable	$	300,000	$	294,963	$	294,000	$	300,000	$	294,395	$	307,500

XML

Debt (Tables)

9 Months Ended

Sep. 30, 2018

Debt Disclosure [Abstract]

Schedule of Long-term Debt Instruments

The following table summarizes the balance of the Company’s indebtedness as of September 30, 2018 and December 31, 2017 (dollars in thousands):

	September 30, 2018							December 31, 2017
	Principal Amount		Deferred Loan Fees			Carrying Value		Principal Amount		Deferred Loan Fees			Carrying Value
Senior unsecured notes payable	$	300,000	$	(5,037	)	$	294,963	$	300,000	$	(5,605	)	$	294,395
Senior unsecured term loan	100,000		(412		)	99,588		100,000		(483		)	99,517
Unsecured revolving credit facility	90,000		—			90,000		165,000		—			165,000
	$	490,000	$	(5,449	)	$	484,551	$	565,000	$	(6,088	)	$	558,912

XML

Equity (Tables)

9 Months Ended

Sep. 30, 2018

Equity [Abstract]

Summary of At-The-Market Offering Program

The following table summarizes the quarterly ATM Program activity for 2018 (in thousands, except per share amounts):

	For the Three Months Ended
	March 31, 2018		June 30, 2018		September 30, 2018		Total
Number of shares	—		2,989		4,772		7,761
Average sales price per share	$	—	$	16.13	$	17.62	$	17.04
Gross proceeds*	$	—	$	48,198	$	84,077	$	132,275

*Total gross proceeds is before $0.6 million and $1.1 million of commissions paid to the sales agents during the three months ended June 30, 2018 and September 30, 2018, respectively.

Schedule of Dividends on Common Stock

The following table summarizes the cash dividends per share of common stock declared by the Company’s Board of Directors for 2018:

	For the Three Months Ended
	March 31, 2018		June 30, 2018		September 30, 2018
Dividends declared	$	0.205	$	0.205	$	0.205
Dividends payment date	April 13, 2018		July 13, 2018		October 15, 2018

XML

Stock-Based Compensation (Tables)

9 Months Ended

Sep. 30, 2018

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of Stock-Based Compensation Expense

The following table summarizes the stock-based compensation expense recognized (dollars in thousands):

	For the Three Months Ended September 30,				For the Nine Months Ended September 30,
	2018		2017		2018		2017
Stock-based compensation expense	$	988	$	656	$	2,816	$	1,792

XML

Earnings Per Common Share (Tables)

9 Months Ended

Sep. 30, 2018

Earnings Per Share [Abstract]

Reconciliation of Weighted-Average Common Shares Outstanding Used in Calculation of Basic EPS to Diluted EPS

The following table presents the calculation of basic and diluted EPS for the Company’s common stock for the three and nine months ended September 30, 2018 and 2017, and reconciles the weighted-average common shares outstanding used in the calculation of basic EPS to the weighted-average common shares outstanding used in the calculation of diluted EPS (amounts in thousands, except per share amounts):

	For the Three Months Ended September 30,						For the Nine Months Ended September 30,
	2018			2017			2018			2017
Numerator:
Net income	$	14,510		$	11,311		$	42,384		$	23,622
Less: Net income allocated to participating securities	(84		)	(83		)	(282		)	(277		)
Numerator for basic and diluted earnings available to common stockholders	$	14,426		$	11,228		$	42,102		$	23,345
Denominator:
Weighted-average basic common shares outstanding	81,490			75,471			77,811			71,693
Weighted-average diluted common shares outstanding	81,490			75,471			77,811			71,693
Earnings per common share, basic	$	0.18		$	0.15		$	0.54		$	0.33
Earnings per common share, diluted	$	0.18		$	0.15		$	0.54		$	0.33

XML

Summarized Condensed Consolidating Information (Tables)

9 Months Ended

Sep. 30, 2018

Summarized Condensed Consolidating Information [Abstract]

Condensed Consolidating Balance Sheets

CONDENSED CONSOLIDATING BALANCE SHEETS

SEPTEMBER 30, 2018

(in thousands, except share and per share amounts)

	Parent Guarantor			Issuers		Combined Subsidiary Guarantors		Elimination			Consolidated
Assets:
Real estate investments, net	$	—		$	856,659	$	332,790	$	—		$	1,189,449
Other real estate investments, net	—			12,337		5,746		—			18,083
Cash and cash equivalents	—			15,745		—		—			15,745
Accounts and other receivables, net	—			9,567		2,817		—			12,384
Prepaid expenses and other assets	—			3,789		3		—			3,792
Deferred financing costs, net	—			904		—		—			904
Investment in subsidiaries	737,296			474,524		—		(1,211,820		)	—
Intercompany	—			—		136,277		(136,277		)	—
Total assets	$	737,296		$	1,373,525	$	477,633	$	(1,348,097	)	$	1,240,357
Liabilities and Equity:
Senior unsecured notes payable, net	$	—		$	294,963	$	—	$	—		$	294,963
Senior unsecured term loan, net	—			99,588		—		—			99,588
Unsecured revolving credit facility	—			90,000		—		—			90,000
Accounts payable and accrued liabilities	—			15,401		3,109		—			18,510
Dividends payable	17,246			—		—		—			17,246
Intercompany	—			136,277		—		(136,277		)	—
Total liabilities	17,246			636,229		3,109		(136,277		)	520,307
Equity:
Common stock, $0.01 par value; 500,000,000 shares authorized, 83,353,226 shares issued and outstanding as of September 30, 2018	834			—		—		—			834
Additional paid-in capital	915,235			629,525		321,761		(951,286		)	915,235
Cumulative distributions in excess of earnings	(196,019		)	107,771		152,763		(260,534		)	(196,019		)
Total equity	720,050			737,296		474,524		(1,211,820		)	720,050
Total liabilities and equity	$	737,296		$	1,373,525	$	477,633	$	(1,348,097	)	$	1,240,357

CONDENSED CONSOLIDATING BALANCE SHEETS

DECEMBER 31, 2017

(in thousands, except share and per share amounts)

	Parent Guarantor			Issuers		Combined Subsidiary Guarantors		Elimination			Consolidated
Assets:
Real estate investments, net	$	—		$	805,826	$	346,435	$	—		$	1,152,261
Other real estate investments, net	—			12,399		5,550		—			17,949
Cash and cash equivalents	—			6,909		—		—			6,909
Accounts and other receivables, net	—			2,945		2,309		—			5,254
Prepaid expenses and other assets	—			893		2		—			895
Deferred financing costs, net	—			1,718		—		—			1,718
Investment in subsidiaries	619,075			444,120		—		(1,063,195		)	—
Intercompany	—			—		92,061		(92,061		)	—
Total assets	$	619,075		$	1,274,810	$	446,357	$	(1,155,256	)	$	1,184,986
Liabilities and Equity:
Senior unsecured notes payable, net	$	—		$	294,395	$	—	$	—		$	294,395
Senior unsecured term loan, net	—			99,517		—		—			99,517
Unsecured revolving credit facility	—			165,000		—		—			165,000
Accounts payable and accrued liabilities	—			15,176		2,237		—			17,413
Dividends payable	14,044			—		—		—			14,044
Intercompany	—			92,061		—		(92,061		)	—
Total liabilities	14,044			666,149		2,237		(92,061		)	590,369
Equity:
Common stock, $0.01 par value; 500,000,000 shares authorized, 75,478,202 shares issued and outstanding as of December 31, 2017	755			—		—		—			755
Additional paid-in capital	783,237			546,097		321,761		(867,858		)	783,237
Cumulative distributions in excess of earnings	(178,961		)	62,564		122,359		(195,337		)	(189,375		)
Total equity	605,031			608,661		444,120		(1,063,195		)	594,617
Total liabilities and equity	$	619,075		$	1,274,810	$	446,357	$	(1,155,256	)	$	1,184,986

Condensed Consolidating Income Statements

CONDENSED CONSOLIDATING INCOME STATEMENTS

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2018

(in thousands)

	Parent Guarantor		Issuers		Combined Subsidiary Guarantors		Elimination			Consolidated
Revenues:
Rental income	$	—	$	20,554	$	14,778	$	—		$	35,332
Tenant reimbursements	—		1,804		1,186		—			2,990
Independent living facilities	—		—		871		—			871
Interest and other income	—		317		—		—			317
Total revenues	—		22,675		16,835		—			39,510
Expenses:
Depreciation and amortization	—		6,833		4,518		—			11,351
Interest expense	—		6,805		—		—			6,805
Property taxes	—		1,804		1,186		—			2,990
Independent living facilities	—		—		766		—			766
General and administrative	987		2,101		—		—			3,088
Total expenses	987		17,543		6,470		—			25,000
Income in Subsidiary	15,497		10,365		—		(25,862		)	—
Net income	$	14,510	$	15,497	$	10,365	$	(25,862	)	$	14,510

CONDENSED CONSOLIDATING INCOME STATEMENTS

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2017

(in thousands)

	Parent Guarantor		Issuers		Combined Subsidiary Guarantors		Elimination			Consolidated
Revenues:
Rental income	$	—	$	14,987	$	14,417	$	—		$	29,404
Tenant reimbursements	—		1,341		1,202		—			2,543
Independent living facilities	—		—		825		—			825
Interest and other income	—		—		176		—			176
Total revenues	—		16,328		16,620		—			32,948
Expenses:
Depreciation and amortization	—		5,014		4,731		—			9,745
Interest expense	—		5,592		—		—			5,592
Property taxes	—		1,341		1,202		—			2,543
Independent living facilities	—		—		698		—			698
General and administrative	671		2,388		—		—			3,059
Total expenses	671		14,335		6,631		—			21,637
Income in Subsidiary	11,982		9,989		—		(21,971		)	—
Net income	$	11,311	$	11,982	$	9,989	$	(21,971	)	$	11,311

CONDENSED CONSOLIDATING INCOME STATEMENTS

FOR THE NINE MONTHS ENDEDSEPTEMBER 30, 2018

(in thousands)

	Parent Guarantor		Issuers		Combined Subsidiary Guarantors		Elimination			Consolidated
Revenues:
Rental income	$	—	$	60,122	$	43,734	$	—		$	103,856
Tenant reimbursements	—		5,360		3,614		—			8,974
Independent living facilities	—		—		2,515		—			2,515
Interest and other income	—		1,039		196		—			1,235
Total revenues	—		66,521		50,059		—			116,580
Expenses:
Depreciation and amortization	—		20,488		13,739		—			34,227
Interest expense	—		21,182		—		—			21,182
Property taxes	—		5,360		3,614		—			8,974
Independent living facilities	—		—		2,226		—			2,226
General and administrative	2,822		6,740		76		—			9,638
Total expenses	2,822		53,770		19,655		—			76,247
Gain on sale of real estate	—		2,051		—		—			2,051
Income in Subsidiary	45,206		30,404		—		(75,610		)	—
Net income	$	42,384	$	45,206	$	30,404	$	(75,610	)	$	42,384

CONDENSED CONSOLIDATING INCOME STATEMENTS

FOR THE NINE MONTHS ENDEDSEPTEMBER 30, 2017

(in thousands)

	Parent Guarantor		Issuers		Combined Subsidiary Guarantors		Elimination			Consolidated
Revenues:
Rental income	$	—	$	42,503	$	42,751	$	—		$	85,254
Tenant reimbursements	—		3,577		3,676		—			7,253
Independent living facilities	—		—		2,407		—			2,407
Interest and other income	—		—		1,471		—			1,471
Total revenues	—		46,080		50,305		—			96,385
Expenses:
Depreciation and amortization	—		13,730		14,426		—			28,156
Interest expense	—		17,690		—		—			17,690
Loss on the extinguishment of debt	—		11,883		—		—			11,883
Property taxes	—		3,577		3,676		—			7,253
Independent living facilities	—		—		2,003		—			2,003
Impairment of real estate investment	—		—		890		—			890
General and administrative	1,948		6,416		62		—			8,426
Total expenses	1,948		53,296		21,057		—			76,301
Gain on disposition of other real estate investment	—		—		3,538		—			3,538
Income in Subsidiary	25,570		32,786		—		(58,356		)	—
Net income	$	23,622	$	25,570	$	32,786	$	(58,356	)	$	23,622

Condensed Consolidating Statements of Cash Flows

CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS

FOR THE NINE MONTHS ENDEDSEPTEMBER 30, 2018

(in thousands)

	Parent Guarantor			Issuers			Combined Subsidiary Guarantors			Elimination			Consolidated
Cash flows from operating activities:
Net cash (used in) provided by operating activities	$	(7	)	$	28,087		$	44,310		$	—		$	72,390
Cash flows from investing activities:
Acquisitions of real estate	—			(75,621		)	—			—			(75,621		)
Improvements to real estate	—			(5,376		)	(25		)	—			(5,401		)
Purchases of equipment, furniture and fixtures	—			(1,193		)	(69		)	—			(1,262		)
Investment in real estate mortgage and other loans receivable	—			(2,598		)	—			—			(2,598		)
Principal payments received on real estate mortgage and other loans receivable	—			893			—			—			893
Escrow deposit for acquisitions of real estate	—			(1,000		)	—			—			(1,000		)
Net proceeds from the sale of real estate	—			13,004			—			—			13,004
Distribution from subsidiary	45,827			—			—			(45,827		)	—
Intercompany financing	(129,251		)	44,216			—			85,035			—
Net cash used in investing activities	(83,424		)	(27,675		)	(94		)	39,208			(71,985		)
Cash flows from financing activities:
Proceeds from the issuance of common stock, net	130,546			—			—			—			130,546
Borrowings under unsecured revolving credit facility	—			60,000			—			—			60,000
Payments on unsecured revolving credit facility	—			(135,000		)	—			—			(135,000		)
Net-settle adjustment on restricted stock	(1,288		)	—			—			—			(1,288		)
Dividends paid on common stock	(45,827		)	—			—			—			(45,827		)
Distribution to Parent	—			(45,827		)	—			45,827			—
Intercompany financing	—			129,251			(44,216		)	(85,035		)	—
Net cash provided by (used in) financing activities	83,431			8,424			(44,216		)	(39,208		)	8,431
Net increase in cash and cash equivalents	—			8,836			—			—			8,836
Cash and cash equivalents beginning of period	—			6,909			—			—			6,909
Cash and cash equivalents end of period	$	—		$	15,745		$	—		$	—		$	15,745

CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS

FOR THE NINE MONTHS ENDEDSEPTEMBER 30, 2017

(in thousands)

	Parent Guarantor			Issuers			Combined Subsidiary Guarantors			Elimination			Consolidated
Cash flows from operating activities:
Net cash (used in) provided by operating activities:	$	(157	)	$	17,946		$	49,144		$	—		$	66,933
Cash flows from investing activities:
Acquisitions of real estate	—			(222,463		)	—			—			(222,463		)
Improvements to real estate	—			(571		)	(50		)	—			(621		)
Purchases of equipment, furniture and fixtures	—			(292		)	(67		)	—			(359		)
Escrow deposit for acquisitions of real estate	—			(1,000		)	—			—			(1,000		)
Sale of other real estate investment	—			—			7,500			—			7,500
Distribution from subsidiary	38,544			—			—			(38,544		)	—
Intercompany financing	(169,391		)	56,527			—			112,864			—
Net cash (used in) provided by investing activities	(130,847		)	(167,799		)	7,383			74,320			(216,943		)
Cash flows from financing activities:
Proceeds from the issuance of common stock, net	170,414			—			—			—			170,414
Proceeds from the issuance of senior unsecured notes payable	—			300,000			—			—			300,000
Borrowings under unsecured revolving credit facility	—			158,000			—			—			158,000
Payments on senior unsecured notes payable	—			(267,639		)	—			—			(267,639		)
Payments on unsecured revolving credit facility	—			(158,000		)	—			—			(158,000		)
Payments of deferred financing costs	—			(6,047		)	—			—			(6,047		)
Net-settle adjustment on restricted stock	(866		)	—			—			—			(866		)
Dividends paid on common stock	(38,544		)	—			—			—			(38,544		)
Distribution to Parent	—			(38,544		)	—			38,544			—
Intercompany financing	—			169,391			(56,527		)	(112,864		)	—
Net cash provided by (used in) financing activities	131,004			157,161			(56,527		)	(74,320		)	157,318
Net increase in cash and cash equivalents	—			7,308			—			—			7,308
Cash and cash equivalents beginning of period	—			7,500			—			—			7,500
Cash and cash equivalents end of period	$	—		$	14,808		$	—		$	—		$	14,808

XML

Organization - Narrative (Details) $ in Millions	9 Months Ended
	Sep. 30, 2018 USD ($) real_estate_investment unit facility bed
Real Estate Properties [Line Items]
Number of living facilities	193
Number of other real estate investments | real_estate_investment	2
Preferred equity investment | $	$ 5.7
Mortgage Loan Receivable
Real Estate Properties [Line Items]
Mortgage loan | $	$ 12.3
Skilled Nursing, Assisted Living and Independent Living Facilities | Assets Leased to Ensign
Real Estate Properties [Line Items]
Number of living facilities	190
Number of units available in living facilities | bed	18,693
Independent Living Facilities Owned and Operated by Company
Real Estate Properties [Line Items]
Number of living facilities	3
Number of units available in living facilities | unit	264

XML

Summary of Significant Accounting Policies - Narrative (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018 USD ($) investment facility loan	Sep. 30, 2017 USD ($)	Sep. 30, 2018 USD ($) investment facility segment loan	Sep. 30, 2017 USD ($)	Dec. 31, 2017 USD ($)
Accounting Policies [Abstract]
Accumulated amortization of deferred financing costs	$ 4,600		$ 4,600		$ 3,200
Straight-line rental income	700	$ 2	1,631	$ 117
Deferred straight-line rents receivable	$ 2,100		$ 2,100		500
Number of reportable segments | segment			1
Significant Accounting Policies
Number of living facilities | facility	193		193
Number of preferred equity investments | investment	2		2
Number of mortgage loans receivable | loan	1		1
Lease Agreements
Significant Accounting Policies
Remaining contractual payments as lessee	$ 200		$ 200
Independent Living Facilities Owned and Operated by Company
Significant Accounting Policies
Number of living facilities | facility	3		3
Accrued Income Receivable
Significant Accounting Policies
Reserve on receivables	$ 1,300		$ 1,300		800
Trade Accounts Receivable
Significant Accounting Policies
Reserve on receivables	$ 11,600		$ 11,600		9,600
Eduro Healthcare LLC Loan | Bridge Loan
Significant Accounting Policies
Mortgage loan receivable interest rate (percent)	4.75%		4.75%
Loans receivable	$ 1,800		$ 1,800
Eduro Healthcare LLC Loan | Bridge Loan | Maximum
Significant Accounting Policies
Funding commitment	4,000		4,000
Pristine Senior Living LLC
Significant Accounting Policies
Reserve on receivables	$ 10,400		$ 10,400		$ 10,400
Base Rate | Eduro Healthcare LLC Loan | Bridge Loan
Significant Accounting Policies
Margin on mortgage loan receivable interest rate (percent)	2.50%		2.50%

XML

Summary of Significant Accounting Policies - Summary of Estimated Useful Lives (Details)	9 Months Ended
	Sep. 30, 2018
Buildings | Minimum
Property, Plant and Equipment [Line Items]
Estimated useful lives	25 years
Buildings | Maximum
Property, Plant and Equipment [Line Items]
Estimated useful lives	40 years
Building Improvements | Minimum
Property, Plant and Equipment [Line Items]
Estimated useful lives	10 years
Building Improvements | Maximum
Property, Plant and Equipment [Line Items]
Estimated useful lives	25 years
Integral Equipment, Furniture and Fixtures
Property, Plant and Equipment [Line Items]
Estimated useful lives	5 years

XML

Real Estate Investments, Net - Narrative (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018 USD ($) facility lease	Sep. 30, 2017 USD ($)	Sep. 30, 2018 USD ($) facility intangible_asset unit lease	Sep. 30, 2017 USD ($)	Dec. 31, 2017 USD ($)
Investment [Line Items]
Number of living facilities | facility	193		193
Number of facilities not leased | facility	3		3
Number of operating leases acquired | lease			3
Remaining lease term			80 years
Real estate investments, net	$ 1,189,449		$ 1,189,449		$ 1,152,261
Net proceeds from the sale of real estate			13,004	$ 0
Gain on sale of real estate	0	$ 0	2,051	0
Impairment of real estate investment	$ 0	$ 0	$ 0	$ 890
Off-Market Favorable Lease
Investment [Line Items]
Number of identified intangible assets | intangible_asset			2
Ensign Master Leases
Investment [Line Items]
Facilities subject to operating lease | facility	92		92
Number of master leases | lease	8		8
Annualized revenues from master leases	$ 59,100		$ 59,100
Escalation factor for calculating revenues after year two	0.00%		0.00%
Percentage change in the consumer price index	2.50%		2.50%
Various Other Operators
Investment [Line Items]
Facilities subject to operating lease | facility	98		98
Assisted Living Facilities | Idaho
Investment [Line Items]
Number of properties sold | facility			3
Number of units in properties sold | unit			102
Real estate investments, net	$ 10,900		$ 10,900
Net proceeds from the sale of real estate			$ 13,000

XML

Real Estate Investments, Net - Investment in Owned Properties (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017
Real Estate [Abstract]
Land	$ 163,665	$ 151,879
Buildings and improvements	1,168,192	1,114,605
Integral equipment, furniture and fixtures	85,592	80,729
Identified intangible assets	2,382	2,382
Real estate investments	1,419,831	1,349,595
Accumulated depreciation and amortization	(230,382)	(197,334)
Real estate investments, net	$ 1,189,449	$ 1,152,261

XML

Real Estate Investments, Net - Future Minimum Rental Revenues (Details) $ in Thousands	Sep. 30, 2018 USD ($)
Future Minimum Rental Revenues
Remaining 2018	$ 35,223
2019	141,977
2020	142,525
2021	143,094
2022	143,678
Thereafter	1,169,183
Total	$ 1,775,680

XML

Real Estate Investments, Net - Recent Real Estate Acquisitions (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2018 USD ($) property unit
Business Acquisition [Line Items]
Purchase Price	$ 77,351
Initial Annual Cash Rent	$ 6,708
Number of Properties | property	8
Number of Beds/Units | unit	743
Skilled Nursing Properties
Business Acquisition [Line Items]
Purchase Price	$ 57,074
Initial Annual Cash Rent	$ 5,144
Number of Properties | property	7
Number of Beds/Units | unit	621
Multi-Service Campus Properties
Business Acquisition [Line Items]
Purchase Price	$ 20,277
Initial Annual Cash Rent	$ 1,564
Number of Properties | property	1
Number of Beds/Units | unit	122
Funding commitment for revenue-producing capital expenditures	$ 1,400
Assisted Living Facilities
Business Acquisition [Line Items]
Purchase Price	0
Initial Annual Cash Rent	$ 0
Number of Properties | property	0
Number of Beds/Units | unit	0

XML

Real Estate Investments, Net - Lease Amendments and Related Agreements (Details) $ in Millions	May 01, 2018 USD ($) facility	Feb. 27, 2018 property
Pristine Lease Termination Agreement
Real Estate [Line Items]
Number of properties | property		9
Pristine Lease Termination Agreement | Trio Healthcare
Real Estate [Line Items]
Number of transitioned facilities	7
Pristine Lease Termination Agreement | Hillstone Healthcare
Real Estate [Line Items]
Number of transitioned facilities	2
Trio and Hillstone Master Lease
Real Estate [Line Items]
Aggregate annual base rent due under master lease | $	$ 10.0
Trio Healthcare Master Lease
Real Estate [Line Items]
Lease period	15 years
Hillstone Healthcare Master Lease
Real Estate [Line Items]
Lease period	12 years

XML

Other Real Estate Investments - Narrative (Details)	1 Months Ended		3 Months Ended		9 Months Ended
	Sep. 30, 2016 USD ($) bed	Jul. 31, 2016 USD ($) bed	Sep. 30, 2018 USD ($)	Sep. 30, 2017 USD ($)	Sep. 30, 2018 USD ($)	Sep. 30, 2017 USD ($)	Oct. 31, 2017 USD ($)
Real Estate Properties [Line Items]
Preferred equity investment			$ 5,700,000		$ 5,700,000
Interest received in cash from preferred equity investment					0	$ 1,500,000
Mortgage Loan Receivable
Real Estate Properties [Line Items]
Mortgage loan			12,300,000		12,300,000
Providence Group | Mortgage Loan Receivable
Real Estate Properties [Line Items]
Interest income			300,000		900,000
Mortgage loan							$ 12,500,000
Mortgage loan receivable interest rate (percent)							9.00%
Cascadia Development, LLC
Real Estate Properties [Line Items]
Preferred equity investment	$ 2,300,000	$ 2,200,000
Preferred equity investment minimum yield	12.00%	12.00%
Number of beds planned for construction | bed	99	99
Initial lease yield (percent)	9.00%	9.00%
Cascadia Development, LLC | Prime Rate
Real Estate Properties [Line Items]
Basis spread of preferred equity investment yield	9.50%	9.50%
Preferred Equity Investment
Real Estate Properties [Line Items]
Interest income			$ 0	$ 200,000	200,000	1,500,000
Interest received in cash from preferred equity investment					$ 0	$ 975,000

XML

Fair Value Measurements - Summary of Fair Value of Financial Instruments (Details) - USD ($)	Sep. 30, 2018	Dec. 31, 2017
Financial assets:
Preferred equity investment - face value	$ 4,531,000	$ 4,531,000
Mortgage Loan Receivable
Financial assets:
Mortgage loans receivable - face value	12,423,000	12,517,000
Senior unsecured notes payable
Financial liabilities:
Senior unsecured notes payable - face value	300,000,000	300,000,000
Carrying Amount | Level 2 | Senior unsecured notes payable
Financial liabilities:
Senior unsecured notes payable	294,963,000	294,395,000
Carrying Amount | Level 3
Financial assets:
Preferred equity investments	5,746,000	5,550,000
Carrying Amount | Level 3 | Mortgage Loan Receivable
Financial assets:
Mortgage loans receivable	12,337,000	12,399,000
Fair Value | Level 2 | Senior unsecured notes payable
Financial liabilities:
Senior unsecured notes payable	294,000,000	307,500,000
Fair Value | Level 3
Financial assets:
Preferred equity investments	6,022,000	5,423,000
Fair Value | Level 3 | Mortgage Loan Receivable
Financial assets:
Mortgage loans receivable	$ 12,423,000	$ 12,517,000

XML

Debt - Schedule of Debt (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017
Debt Instrument [Line Items]
Principal Amount	$ 490,000	$ 565,000
Deferred Loan Fees	(5,449)	(6,088)
Carrying Value	484,551	558,912
Senior unsecured notes payable
Debt Instrument [Line Items]
Principal Amount	300,000	300,000
Deferred Loan Fees	(5,037)	(5,605)
Carrying Value	294,963	294,395
Senior unsecured term loan
Debt Instrument [Line Items]
Principal Amount	100,000	100,000
Deferred Loan Fees	(412)	(483)
Carrying Value	99,588	99,517
Unsecured revolving credit facility
Debt Instrument [Line Items]
Principal Amount	90,000	165,000
Deferred Loan Fees	0	0
Carrying Value	$ 90,000	$ 165,000

XML

Debt - Narrative (Details)			3 Months Ended		9 Months Ended
	May 10, 2017 USD ($)	Feb. 01, 2016 USD ($) extension_option	Sep. 30, 2018 USD ($)	Sep. 30, 2017 USD ($)	Sep. 30, 2018 USD ($)	Sep. 30, 2017 USD ($)	Dec. 31, 2017 USD ($)	Aug. 05, 2015 USD ($)
Line of Credit Facility [Line Items]
Long-term Debt			$ 484,551,000		$ 484,551,000		$ 558,912,000
Outstanding amounts under Credit Facility			490,000,000		490,000,000		565,000,000
Interest expense			6,805,000	$ 5,592,000	21,182,000	$ 17,690,000
Amortization of deferred financing costs			500,000	$ 500,000	1,500,000	$ 1,600,000
Interest payable			$ 5,300,000		5,300,000		1,400,000
Loss on extinguishment of debt before write off of deferred financing costs					7,600,000
Write off of deferred financing costs					$ 4,200,000
Senior Unsecured Notes | 5.25% Senior Notes due 2025
Line of Credit Facility [Line Items]
Debt instrument, face amount	$ 300,000,000.0
Interest rate, stated percentage	5.25%
Gross proceeds from issuance of senior notes	$ 300,000,000
Net proceeds from issuance of senior notes	$ 294,000,000
Debt instrument, redemption price, percentage	100.00%
Debt instrument, redemption price, percentage upon change of control	101.00%
Senior Unsecured Notes | 5.25% Senior Notes due 2025 | Debt Instrument, Redemption, Period One
Line of Credit Facility [Line Items]
Debt instrument, redemption price, percentage	105.25%
Senior Unsecured Notes | 5.25% Senior Notes due 2025 | Debt Instrument, Redemption, Period One | Maximum
Line of Credit Facility [Line Items]
Debt instrument, redemption price, percentage of principal amount	40.00%
Senior Unsecured Notes | 5.25% Senior Notes due 2025 | Debt Instrument, Redemption, Period One | Minimum
Line of Credit Facility [Line Items]
Percentage of aggregate principal amount of notes outstanding	60.00%
Senior Unsecured Notes | 5.875% Senior Notes due 2021
Line of Credit Facility [Line Items]
Interest rate, stated percentage	5.875%		5.875%		5.875%
Payment for redemption of senior notes	$ 260,000,000
Debt instrument, redemption price, percentage	102.938%				102.938%
Revolving Facility
Line of Credit Facility [Line Items]
Long-term Debt			$ 90,000,000		$ 90,000,000		165,000,000
Outstanding amounts under Credit Facility			$ 90,000,000		$ 90,000,000		$ 165,000,000
Revolving Facility | Unsecured Revolving Credit Facility
Line of Credit Facility [Line Items]
Line of credit facility, borrowing capacity								$ 300,000,000.0
Line of credit facility, accordion feature								$ 200,000,000.0
Revolving Facility | Unsecured Revolving Credit Facility | Maximum
Line of Credit Facility [Line Items]
Line of credit facility, commitment fee percentage					0.25%
Line of credit facility, facility fee percentage					0.30%
Revolving Facility | Unsecured Revolving Credit Facility | Maximum | Base Rate
Line of Credit Facility [Line Items]
Debt instrument, basis spread					1.40%
Revolving Facility | Unsecured Revolving Credit Facility | Maximum | LIBOR
Line of Credit Facility [Line Items]
Debt instrument, basis spread					2.40%
Revolving Facility | Unsecured Revolving Credit Facility | Minimum
Line of Credit Facility [Line Items]
Line of credit facility, commitment fee percentage					0.15%
Line of credit facility, facility fee percentage					0.125%
Revolving Facility | Unsecured Revolving Credit Facility | Minimum | Base Rate
Line of Credit Facility [Line Items]
Debt instrument, basis spread					0.75%
Revolving Facility | Unsecured Revolving Credit Facility | Minimum | LIBOR
Line of Credit Facility [Line Items]
Debt instrument, basis spread					1.75%
Revolving Facility | Revolving Credit Facility As Amended
Line of Credit Facility [Line Items]
Line of credit facility, borrowing capacity		$ 400,000,000.0
Line of credit facility, increase to borrowing capacity		100,000,000.0
Line of credit facility, increase to uncommitted incremental facility		50,000,000.0
Line of credit facility, uncommitted incremental facility limit		$ 250,000,000.0
Number of extension options | extension_option		2
Line of credit facility, extension period		6 months
Revolving Facility | Revolving Credit Facility As Amended | Maximum | Base Rate
Line of Credit Facility [Line Items]
Debt instrument, basis spread					1.60%
Revolving Facility | Revolving Credit Facility As Amended | Maximum | LIBOR
Line of Credit Facility [Line Items]
Debt instrument, basis spread					2.60%
Revolving Facility | Revolving Credit Facility As Amended | Minimum | Base Rate
Line of Credit Facility [Line Items]
Debt instrument, basis spread					0.95%
Revolving Facility | Revolving Credit Facility As Amended | Minimum | LIBOR
Line of Credit Facility [Line Items]
Debt instrument, basis spread					1.95%
Revolving Facility | Senior unsecured term loan
Line of Credit Facility [Line Items]
Line of credit facility, borrowing capacity		$ 100,000,000.0
Line of credit facility, prepayment premium in first year		2.00%
Line of credit facility, prepayment premium in second year		1.00%
Mortgage Notes Payable
Line of Credit Facility [Line Items]
Payments on the mortgage notes payable		$ 95,000,000

XML

Equity - ATM Offering (Details) - USD ($) $ / shares in Units, shares in Thousands	3 Months Ended			9 Months Ended
	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Sep. 30, 2018	Sep. 30, 2017	Jun. 30, 2017
ATM Program activity
Gross proceeds				$ 130,546,000	$ 170,414,000
At-The-Market Offering
Class of Stock [Line Items]
Remaining offering amount available	$ 103,800,000			$ 103,800,000
ATM Program activity
Number of shares (in shares)	4,772	2,989	0	7,761
Average sales price per share (in usd per share)	$ 17.62	$ 16.13	$ 0.00	$ 17.04
Gross proceeds	$ 84,077,000	$ 48,198,000	$ 0	$ 132,275,000
Commissions paid on stock issuance	$ 1,100,000	$ 600,000
At-The-Market Offering | Maximum
Class of Stock [Line Items]
Authorized aggregate offering price of common stock						$ 300,000,000.0

XML

Equity - Dividends on Common Stock (Details) - $ / shares	3 Months Ended				9 Months Ended		12 Months Ended
	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017	Dec. 31, 2017
Dividends per share of common stock
Dividends declared per common share (in usd per share)	$ 0.205	$ 0.205	$ 0.205	$ 0.185	$ 0.615	$ 0.555	$ 0.74
Dividends payment date	Oct. 15, 2018	Jul. 13, 2018	Apr. 13, 2018

XML

Stock-Based Compensation - Narrative (Details) $ / shares in Units, $ in Millions		1 Months Ended		9 Months Ended
	Jun. 01, 2014 shares	May 31, 2018 $ / shares shares	Feb. 28, 2018 installment $ / shares shares	Sep. 30, 2018 USD ($) shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unamortized stock-based compensation expense related to unvested awards | $				$ 5.4
Weighted average remaining vesting period related to expense recognition				2 years 2 months
Ensign Employees
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock award conversion ratio related to the spin-off	1
Restricted Stock Award | Ensign Employees
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock awards unvested during spin-off (in shares)	207,580
Shares vested (in shares)				10,960
Unvested stock awards outstanding (in shares)				4,020
Restricted Stock Award | Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of awards granted (in shares)			141,060
Award grant date fair value (in usd per share) | $ / shares			$ 15.13
Number of equal annual vesting installments | installment			4
Restricted Stock Award | Director
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of awards granted (in shares)		26,462
Award grant date fair value (in usd per share) | $ / shares		$ 16.44
Performance Stock Award | Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of awards granted (in shares)			120,460
Award grant date fair value (in usd per share) | $ / shares			$ 15.13

XML

Stock-Based Compensation - Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock-based compensation expense	$ 988	$ 656	$ 2,816	$ 1,792

XML

Earnings Per Common Share - Reconciliation of Weighted-Average Common Shares Outstanding Used in Calculation of Basic EPS to Diluted EPS (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017	Dec. 31, 2017
Numerator:
Net income	$ 14,510	$ 11,311	$ 42,384	$ 23,622	$ 25,874
Less: Net income allocated to participating securities	(84)	(83)	(282)	(277)
Numerator for basic and diluted earnings available to common stockholders	$ 14,426	$ 11,228	$ 42,102	$ 23,345
Denominator:
Weighted-average basic common shares outstanding (in shares)	81,490	75,471	77,811	71,693
Weighted-average diluted common shares outstanding (in shares)	81,490	75,471	77,811	71,693
Earnings per common share, basic (in usd per share)	$ 0.18	$ 0.15	$ 0.54	$ 0.33
Earnings per common share, diluted (in usd per share)	$ 0.18	$ 0.15	$ 0.54	$ 0.33

XML

Commitments and Contingencies - Narrative (Details) - Ensign - USD ($) $ in Millions		1 Months Ended
	Oct. 01, 2013	Oct. 31, 2013
Loss Contingencies [Line Items]
Single lump-sum remittance to the government		$ 48.0
Corporate integrity agreement period	5 years

XML

Concentration of Risk - Narrative (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018 USD ($) facility	Sep. 30, 2017 USD ($)	Sep. 30, 2018 USD ($) state facility bed	Sep. 30, 2017 USD ($)
Concentration Risk [Line Items]
Number of living facilities	193		193
Description of highest concentration of properties			The four states in which Ensign leases the highest concentration of properties are California, Texas, Utah and Arizona.
Rental income | $	$ 35,332	$ 29,404	$ 103,856	$ 85,254
Skilled Nursing, Assisted Living and Independent Living Facilities | Assets Leased to Ensign
Concentration Risk [Line Items]
Number of living facilities	190		190
Number of units available in living facilities | bed			18,693
Ensign
Concentration Risk [Line Items]
Number of states where Ensign leases the highest concentration of properties | state			4
Ensign | Skilled Nursing, Assisted Living and Independent Living Facilities | Assets Leased to Ensign
Concentration Risk [Line Items]
Number of living facilities	92		92
Number of units available in living facilities | bed			9,805
Customer Concentration Risk | Rental Income
Concentration Risk [Line Items]
Rental income | $			$ 59,100
Concentration risk (percent)			42.00%

XML

Summarized Condensed Consolidating Information - Condensed Consolidating Balance Sheets (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017	Sep. 30, 2017	Dec. 31, 2016
Assets:
Real estate investments, net	$ 1,189,449	$ 1,152,261
Other real estate investments, net	18,083	17,949
Cash and cash equivalents	15,745	6,909	$ 14,808	$ 7,500
Accounts and other receivables, net	12,384	5,254
Prepaid expenses and other assets	3,792	895
Deferred financing costs, net	904	1,718
Investment in subsidiaries	0	0
Intercompany	0	0
Total assets	1,240,357	1,184,986
Liabilities and Equity:
Senior unsecured notes payable, net	294,963	294,395
Senior unsecured term loan, net	99,588	99,517
Unsecured revolving credit facility	90,000	165,000
Accounts payable and accrued liabilities	18,510	17,413
Dividends payable	17,246	14,044
Intercompany	0	0
Total liabilities	520,307	590,369
Equity:
Common stock, $0.01 par value; 500,000,000 shares authorized, 83,353,226 and 75,478,202 shares issued and outstanding as of September 30, 2018 and December 31, 2017, respectively	834	755
Additional paid-in capital	915,235	783,237
Cumulative distributions in excess of earnings	(196,019)	(189,375)
Total equity	720,050	594,617		452,430
Total liabilities and equity	1,240,357	1,184,986
Reportable Legal Entities | Parent Guarantor
Assets:
Real estate investments, net	0	0
Other real estate investments, net	0	0
Cash and cash equivalents	0	0	0	0
Accounts and other receivables, net	0	0
Prepaid expenses and other assets	0	0
Deferred financing costs, net	0	0
Investment in subsidiaries	737,296	619,075
Intercompany	0	0
Total assets	737,296	619,075
Liabilities and Equity:
Senior unsecured notes payable, net	0	0
Senior unsecured term loan, net	0	0
Unsecured revolving credit facility	0	0
Accounts payable and accrued liabilities	0	0
Dividends payable	17,246	14,044
Intercompany	0	0
Total liabilities	17,246	14,044
Equity:
Common stock, $0.01 par value; 500,000,000 shares authorized, 83,353,226 and 75,478,202 shares issued and outstanding as of September 30, 2018 and December 31, 2017, respectively	834	755
Additional paid-in capital	915,235	783,237
Cumulative distributions in excess of earnings	(196,019)	(178,961)
Total equity	720,050	605,031
Total liabilities and equity	737,296	619,075
Reportable Legal Entities | Issuers
Assets:
Real estate investments, net	856,659	805,826
Other real estate investments, net	12,337	12,399
Cash and cash equivalents	15,745	6,909	14,808	7,500
Accounts and other receivables, net	9,567	2,945
Prepaid expenses and other assets	3,789	893
Deferred financing costs, net	904	1,718
Investment in subsidiaries	474,524	444,120
Intercompany	0	0
Total assets	1,373,525	1,274,810
Liabilities and Equity:
Senior unsecured notes payable, net	294,963	294,395
Senior unsecured term loan, net	99,588	99,517
Unsecured revolving credit facility	90,000	165,000
Accounts payable and accrued liabilities	15,401	15,176
Dividends payable	0	0
Intercompany	136,277	92,061
Total liabilities	636,229	666,149
Equity:
Common stock, $0.01 par value; 500,000,000 shares authorized, 83,353,226 and 75,478,202 shares issued and outstanding as of September 30, 2018 and December 31, 2017, respectively	0	0
Additional paid-in capital	629,525	546,097
Cumulative distributions in excess of earnings	107,771	62,564
Total equity	737,296	608,661
Total liabilities and equity	1,373,525	1,274,810
Reportable Legal Entities | Combined Subsidiary Guarantors
Assets:
Real estate investments, net	332,790	346,435
Other real estate investments, net	5,746	5,550
Cash and cash equivalents	0	0	0	0
Accounts and other receivables, net	2,817	2,309
Prepaid expenses and other assets	3	2
Deferred financing costs, net	0	0
Investment in subsidiaries	0	0
Intercompany	136,277	92,061
Total assets	477,633	446,357
Liabilities and Equity:
Senior unsecured notes payable, net	0	0
Senior unsecured term loan, net	0	0
Unsecured revolving credit facility	0	0
Accounts payable and accrued liabilities	3,109	2,237
Dividends payable	0	0
Intercompany	0	0
Total liabilities	3,109	2,237
Equity:
Common stock, $0.01 par value; 500,000,000 shares authorized, 83,353,226 and 75,478,202 shares issued and outstanding as of September 30, 2018 and December 31, 2017, respectively	0	0
Additional paid-in capital	321,761	321,761
Cumulative distributions in excess of earnings	152,763	122,359
Total equity	474,524	444,120
Total liabilities and equity	477,633	446,357
Elimination
Assets:
Real estate investments, net	0	0
Other real estate investments, net	0	0
Cash and cash equivalents	0	0	$ 0	$ 0
Accounts and other receivables, net	0	0
Prepaid expenses and other assets	0	0
Deferred financing costs, net	0	0
Investment in subsidiaries	(1,211,820)	(1,063,195)
Intercompany	(136,277)	(92,061)
Total assets	(1,348,097)	(1,155,256)
Liabilities and Equity:
Senior unsecured notes payable, net	0	0
Senior unsecured term loan, net	0	0
Unsecured revolving credit facility	0	0
Accounts payable and accrued liabilities	0	0
Dividends payable	0	0
Intercompany	(136,277)	(92,061)
Total liabilities	(136,277)	(92,061)
Equity:
Common stock, $0.01 par value; 500,000,000 shares authorized, 83,353,226 and 75,478,202 shares issued and outstanding as of September 30, 2018 and December 31, 2017, respectively	0	0
Additional paid-in capital	(951,286)	(867,858)
Cumulative distributions in excess of earnings	(260,534)	(195,337)
Total equity	(1,211,820)	(1,063,195)
Total liabilities and equity	$ (1,348,097)	$ (1,155,256)

XML

Summarized Condensed Consolidating Information - Condensed Consolidating Balance Sheets Share Data (Details) - $ / shares	Sep. 30, 2018	Dec. 31, 2017
Summarized Condensed Consolidating Information [Abstract]
Common stock, par value (in usd per share)	$ 0.01	$ 0.01
Common stock, authorized (shares)	500,000,000	500,000,000
Common stock, issued (shares)	83,353,226	75,478,202
Common stock, outstanding (shares)	83,353,226	75,478,202

XML

Summarized Condensed Consolidating Information - Condensed Consolidating Income Statements (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017	Dec. 31, 2017
Revenues:
Rental income	$ 35,332	$ 29,404	$ 103,856	$ 85,254
Tenant reimbursements	2,990	2,543	8,974	7,253
Independent living facilities	871	825	2,515	2,407
Interest and other income	317	176	1,235	1,471
Total revenues	39,510	32,948	116,580	96,385
Expenses:
Depreciation and amortization	11,351	9,745	34,227	28,156
Interest expense	6,805	5,592	21,182	17,690
Loss on the extinguishment of debt	0	0	0	11,883
Property taxes	2,990	2,543	8,974	7,253
Independent living facilities	766	698	2,226	2,003
Impairment of real estate investment	0	0	0	890
General and administrative	3,088	3,059	9,638	8,426
Total expenses	25,000	21,637	76,247	76,301
Gain on sale of real estate	0	0	2,051	0
Gain on disposition of other real estate investment	0	0	0	3,538
Income in Subsidiary	0	0	0	0
Net income	14,510	11,311	42,384	23,622	$ 25,874
Reportable Legal Entities | Parent Guarantor
Revenues:
Rental income	0	0	0	0
Tenant reimbursements	0	0	0	0
Independent living facilities	0	0	0	0
Interest and other income	0	0	0	0
Total revenues	0	0	0	0
Expenses:
Depreciation and amortization	0	0	0	0
Interest expense	0	0	0	0
Loss on the extinguishment of debt				0
Property taxes	0	0	0	0
Independent living facilities	0	0	0	0
Impairment of real estate investment				0
General and administrative	987	671	2,822	1,948
Total expenses	987	671	2,822	1,948
Gain on sale of real estate			0
Gain on disposition of other real estate investment				0
Income in Subsidiary	15,497	11,982	45,206	25,570
Net income	14,510	11,311	42,384	23,622
Reportable Legal Entities | Issuers
Revenues:
Rental income	20,554	14,987	60,122	42,503
Tenant reimbursements	1,804	1,341	5,360	3,577
Independent living facilities	0	0	0	0
Interest and other income	317	0	1,039	0
Total revenues	22,675	16,328	66,521	46,080
Expenses:
Depreciation and amortization	6,833	5,014	20,488	13,730
Interest expense	6,805	5,592	21,182	17,690
Loss on the extinguishment of debt				11,883
Property taxes	1,804	1,341	5,360	3,577
Independent living facilities	0	0	0	0
Impairment of real estate investment				0
General and administrative	2,101	2,388	6,740	6,416
Total expenses	17,543	14,335	53,770	53,296
Gain on sale of real estate			2,051
Gain on disposition of other real estate investment				0
Income in Subsidiary	10,365	9,989	30,404	32,786
Net income	15,497	11,982	45,206	25,570
Reportable Legal Entities | Combined Subsidiary Guarantors
Revenues:
Rental income	14,778	14,417	43,734	42,751
Tenant reimbursements	1,186	1,202	3,614	3,676
Independent living facilities	871	825	2,515	2,407
Interest and other income	0	176	196	1,471
Total revenues	16,835	16,620	50,059	50,305
Expenses:
Depreciation and amortization	4,518	4,731	13,739	14,426
Interest expense	0	0	0	0
Loss on the extinguishment of debt				0
Property taxes	1,186	1,202	3,614	3,676
Independent living facilities	766	698	2,226	2,003
Impairment of real estate investment				890
General and administrative	0	0	76	62
Total expenses	6,470	6,631	19,655	21,057
Gain on sale of real estate			0
Gain on disposition of other real estate investment				3,538
Income in Subsidiary	0	0	0	0
Net income	10,365	9,989	30,404	32,786
Elimination
Revenues:
Rental income	0	0	0	0
Tenant reimbursements	0	0	0	0
Independent living facilities	0	0	0	0
Interest and other income	0	0	0	0
Total revenues	0	0	0	0
Expenses:
Depreciation and amortization	0	0	0	0
Interest expense	0	0	0	0
Loss on the extinguishment of debt				0
Property taxes	0	0	0	0
Independent living facilities	0	0	0	0
Impairment of real estate investment				0
General and administrative	0	0	0	0
Total expenses	0	0	0	0
Gain on sale of real estate			0
Gain on disposition of other real estate investment				0
Income in Subsidiary	(25,862)	(21,971)	(75,610)	(58,356)
Net income	$ (25,862)	$ (21,971)	$ (75,610)	$ (58,356)

XML

Summarized Condensed Consolidating Information - Condensed Consolidating Statements of Cash Flows (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Cash flows from operating activities:
Net cash (used in) provided by operating activities	$ 72,390	$ 66,933
Cash flows from investing activities:
Acquisitions of real estate	(75,621)	(222,463)
Improvements to real estate	(5,401)	(621)
Purchases of equipment, furniture and fixtures	(1,262)	(359)
Investment in real estate mortgage and other loans receivable	(2,598)	0
Principal payments received on real estate mortgage and other loans receivable	893	0
Escrow deposits for acquisitions of real estate	(1,000)	(1,000)
Net proceeds from the sale of real estate	13,004	0
Sale of other real estate investment	0	7,500
Distribution from subsidiary	0	0
Intercompany financing	0	0
Net cash used in investing activities	(71,985)	(216,943)
Cash flows from financing activities:
Proceeds from the issuance of common stock, net	130,546	170,414
Proceeds from the issuance of senior unsecured notes payable	0	300,000
Borrowings under unsecured revolving credit facility	60,000	158,000
Payments on senior unsecured notes payable	0	(267,639)
Payments on unsecured revolving credit facility	(135,000)	(158,000)
Payments of deferred financing costs	0	(6,047)
Net-settle adjustment on restricted stock	(1,288)	(866)
Dividends paid on common stock	(45,827)	(38,544)
Distribution to Parent	0	0
Intercompany financing	0	0
Net cash provided by financing activities	8,431	157,318
Net increase in cash and cash equivalents	8,836	7,308
Cash and cash equivalents, beginning of period	6,909	7,500
Cash and cash equivalents, end of period	15,745	14,808
Reportable Legal Entities | Parent Guarantor
Cash flows from operating activities:
Net cash (used in) provided by operating activities	(7)	(157)
Cash flows from investing activities:
Acquisitions of real estate	0	0
Improvements to real estate	0	0
Purchases of equipment, furniture and fixtures	0	0
Investment in real estate mortgage and other loans receivable	0
Principal payments received on real estate mortgage and other loans receivable	0
Escrow deposits for acquisitions of real estate	0	0
Net proceeds from the sale of real estate	0
Sale of other real estate investment		0
Distribution from subsidiary	45,827	38,544
Intercompany financing	(129,251)	(169,391)
Net cash used in investing activities	(83,424)	(130,847)
Cash flows from financing activities:
Proceeds from the issuance of common stock, net	130,546	170,414
Proceeds from the issuance of senior unsecured notes payable		0
Borrowings under unsecured revolving credit facility	0	0
Payments on senior unsecured notes payable		0
Payments on unsecured revolving credit facility	0	0
Payments of deferred financing costs		0
Net-settle adjustment on restricted stock	(1,288)	(866)
Dividends paid on common stock	(45,827)	(38,544)
Distribution to Parent	0	0
Intercompany financing	0	0
Net cash provided by financing activities	83,431	131,004
Net increase in cash and cash equivalents	0	0
Cash and cash equivalents, beginning of period	0	0
Cash and cash equivalents, end of period	0	0
Reportable Legal Entities | Issuers
Cash flows from operating activities:
Net cash (used in) provided by operating activities	28,087	17,946
Cash flows from investing activities:
Acquisitions of real estate	(75,621)	(222,463)
Improvements to real estate	(5,376)	(571)
Purchases of equipment, furniture and fixtures	(1,193)	(292)
Investment in real estate mortgage and other loans receivable	(2,598)
Principal payments received on real estate mortgage and other loans receivable	893
Escrow deposits for acquisitions of real estate	(1,000)	(1,000)
Net proceeds from the sale of real estate	13,004
Sale of other real estate investment		0
Distribution from subsidiary	0	0
Intercompany financing	44,216	56,527
Net cash used in investing activities	(27,675)	(167,799)
Cash flows from financing activities:
Proceeds from the issuance of common stock, net	0	0
Proceeds from the issuance of senior unsecured notes payable		300,000
Borrowings under unsecured revolving credit facility	60,000	158,000
Payments on senior unsecured notes payable		(267,639)
Payments on unsecured revolving credit facility	(135,000)	(158,000)
Payments of deferred financing costs		(6,047)
Net-settle adjustment on restricted stock	0	0
Dividends paid on common stock	0	0
Distribution to Parent	(45,827)	(38,544)
Intercompany financing	129,251	169,391
Net cash provided by financing activities	8,424	157,161
Net increase in cash and cash equivalents	8,836	7,308
Cash and cash equivalents, beginning of period	6,909	7,500
Cash and cash equivalents, end of period	15,745	14,808
Reportable Legal Entities | Combined Subsidiary Guarantors
Cash flows from operating activities:
Net cash (used in) provided by operating activities	44,310	49,144
Cash flows from investing activities:
Acquisitions of real estate	0	0
Improvements to real estate	(25)	(50)
Purchases of equipment, furniture and fixtures	(69)	(67)
Investment in real estate mortgage and other loans receivable	0
Principal payments received on real estate mortgage and other loans receivable	0
Escrow deposits for acquisitions of real estate	0	0
Net proceeds from the sale of real estate	0
Sale of other real estate investment		7,500
Distribution from subsidiary	0	0
Intercompany financing	0	0
Net cash used in investing activities	(94)	7,383
Cash flows from financing activities:
Proceeds from the issuance of common stock, net	0	0
Proceeds from the issuance of senior unsecured notes payable		0
Borrowings under unsecured revolving credit facility	0	0
Payments on senior unsecured notes payable		0
Payments on unsecured revolving credit facility	0	0
Payments of deferred financing costs		0
Net-settle adjustment on restricted stock	0	0
Dividends paid on common stock	0	0
Distribution to Parent	0	0
Intercompany financing	(44,216)	(56,527)
Net cash provided by financing activities	(44,216)	(56,527)
Net increase in cash and cash equivalents	0	0
Cash and cash equivalents, beginning of period	0	0
Cash and cash equivalents, end of period	0	0
Elimination
Cash flows from operating activities:
Net cash (used in) provided by operating activities	0	0
Cash flows from investing activities:
Acquisitions of real estate	0	0
Improvements to real estate	0	0
Purchases of equipment, furniture and fixtures	0	0
Investment in real estate mortgage and other loans receivable	0
Principal payments received on real estate mortgage and other loans receivable	0
Escrow deposits for acquisitions of real estate	0	0
Net proceeds from the sale of real estate	0
Sale of other real estate investment		0
Distribution from subsidiary	(45,827)	(38,544)
Intercompany financing	85,035	112,864
Net cash used in investing activities	39,208	74,320
Cash flows from financing activities:
Proceeds from the issuance of common stock, net	0	0
Proceeds from the issuance of senior unsecured notes payable		0
Borrowings under unsecured revolving credit facility	0	0
Payments on senior unsecured notes payable		0
Payments on unsecured revolving credit facility	0	0
Payments of deferred financing costs		0
Net-settle adjustment on restricted stock	0	0
Dividends paid on common stock	0	0
Distribution to Parent	45,827	38,544
Intercompany financing	(85,035)	(112,864)
Net cash provided by financing activities	(39,208)	(74,320)
Net increase in cash and cash equivalents	0	0
Cash and cash equivalents, beginning of period	0	0
Cash and cash equivalents, end of period	$ 0	$ 0

XML

Subsequent Events - Narrative (Details) $ in Thousands	1 Months Ended	9 Months Ended
	Oct. 31, 2018 USD ($) property transaction	Sep. 30, 2018 USD ($) property
Subsequent Event [Line Items]
Number of properties acquired | property		8
Aggregate purchase price		$ 77,351
Initial annual cash rents		$ 6,708
Skilled Nursing Properties
Subsequent Event [Line Items]
Number of properties acquired | property		7
Aggregate purchase price		$ 57,074
Initial annual cash rents		$ 5,144
Multi-Service Campus Properties
Subsequent Event [Line Items]
Number of properties acquired | property		1
Aggregate purchase price		$ 20,277
Initial annual cash rents		$ 1,564
Subsequent Event
Subsequent Event [Line Items]
Number of acquisition transactions | transaction	2
Aggregate purchase price	$ 12,000
Initial annual cash rents	1,100
Cash paid for acquisition	7,000
Borrowings utilized to fund acquisition	$ 5,000
Subsequent Event | Skilled Nursing Properties
Subsequent Event [Line Items]
Number of properties acquired | property	1
Subsequent Event | Multi-Service Campus Properties
Subsequent Event [Line Items]
Number of properties acquired | property	1